,words,labels,sentence_id,full sentence
716,The,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
717,ratio,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
718,of,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
719,fasting,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
720,urinary,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
721,hydroxyproline,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
722,to,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
723,creatinine,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
724,did,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
725,not,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
726,decrease,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
727,",",O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
728,indicating,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
729,no,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
730,significant,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
731,reduction,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
732,of,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
733,bone,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
734,resorption,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
735,in,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
736,our,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
737,subjects,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
738,.,O,23.0,"The ratio of fasting urinary hydroxyproline to creatinine did not decrease , indicating no significant reduction of bone resorption in our subjects ."
806,This,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
807,review,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
808,aims,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
809,to,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
810,address,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
811,the,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
812,potential,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
813,mechanisms,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
814,of,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
815,action,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
816,of,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
817,dietary,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
818,polyphenols,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
819,in,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
820,the,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
821,regulation,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
822,of,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
823,glucose,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
824,homeostasis,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
825,and,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
826,insulin,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
827,sensitivity,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
828,based,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
829,on,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
830,in,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
831,vitro,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
832,and,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
833,in,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
834,vivo,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
835,studies,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
836,",",O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
837,and,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
838,to,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
839,provide,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
840,a,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
841,comprehensive,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
842,overview,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
843,of,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
844,the,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
845,anti,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
846,-,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
847,diabetic,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
848,effects,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
849,of,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
850,commonly,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
851,consumed,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
852,dietary,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
853,polyphenols,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
854,including,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
855,polyphenol,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
856,-,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
857,rich,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
858,mixed,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
859,diets,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
860,",",O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
861,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
862,and,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
863,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
864,",",O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
865,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
866,and,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
867,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
868,",",O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
869,cinnamon,B-http://purl.bioontology.org/ontology/SNOMEDCT/227388008,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
870,",",O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
871,grape,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
872,",",O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
873,pomegranate,B-http://purl.bioontology.org/ontology/SNOMEDCT/227441008,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
874,",",O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
875,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
876,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
877,",",O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
878,berries,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
879,and,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
880,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
881,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
882,",",O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
883,with,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
884,a,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
885,focus,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
886,on,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
887,human,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
888,clinical,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
889,trials,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
890,.,O,26.0,"This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and insulin sensitivity based on in vitro and in vivo studies , and to provide a comprehensive overview of the anti - diabetic effects of commonly consumed dietary polyphenols including polyphenol - rich mixed diets , tea and coffee , chocolate and cocoa , cinnamon , grape , pomegranate , red wine , berries and olive oil , with a focus on human clinical trials ."
1154,Type,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1155,2,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1156,diabetes,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1157,is,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1158,another,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1159,global,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1160,health,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1161,threat,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1162,closely,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1163,associated,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1164,with,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1165,obesity,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1166,that,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1167,boosts,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1168,the,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1169,risk,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1170,of,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1171,cancer,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1172,driven,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1173,by,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1174,high,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1175,BMI,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1176,.,O,36.0,Type 2 diabetes is another global health threat closely associated with obesity that boosts the risk of cancer driven by high BMI .
1177,Education,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1178,to,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1179,promote,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1180,positive,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1181,choices,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1182,and,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1183,physical,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1184,activity,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1185,and,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1186,resolute,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1187,public,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1188,health,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1189,interventions,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1190,on,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1191,food,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1192,delivery,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1193,are,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1194,requested,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1195,to,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1196,reduce,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1197,the,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1198,burden,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1199,of,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1200,obesity,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1201,-,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1202,related,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1203,cancer,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1204,and,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1205,lighten,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1206,the,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1207,unsustainable,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1208,growing,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1209,expenses,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1210,to,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1211,health,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1212,systems,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1213,.,O,37.0,Education to promote positive choices and physical activity and resolute public health interventions on food delivery are requested to reduce the burden of obesity - related cancer and lighten the unsustainable growing expenses to health systems .
1620,Soy,B-http://purl.bioontology.org/ontology/SNOMEDCT/227537006;http://purl.bioontology.org/ontology/SNOMEDCT/227519005,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1621,sauce,I-http://purl.bioontology.org/ontology/SNOMEDCT/227537006;http://purl.bioontology.org/ontology/SNOMEDCT/227519005,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1622,was,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1623,also,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1624,found,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1625,to,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1626,contain,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1627,both,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1628,isoflavones,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1629,",",O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1630,but,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1631,at,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1632,levels,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1633,lower,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1634,than,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1635,in,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1636,miso,B-http://purl.bioontology.org/ontology/SNOMEDCT/227354002,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1637,and,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1638,natto,B-http://purl.bioontology.org/ontology/SNOMEDCT/443621000124102,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
1639,.,O,50.0,"Soy sauce was also found to contain both isoflavones , but at levels lower than in miso and natto ."
2355,Furthermore,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2356,",",O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2357,ginger,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2358,administration,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2359,corrected,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2360,the,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2361,HFD,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2362,-,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2363,induced,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2364,changes,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2365,in,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2366,concentrations,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2367,of,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2368,intermediates,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2369,in,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2370,glycolysis,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2371,and,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2372,the,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2373,TCA,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2374,cycle,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2375,.,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2496,Intakes,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2497,of,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2498,dairy,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2499,produce,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2500,show,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2501,enormous,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2502,diversity,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2503,between,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2504,regions,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2505,",",O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2506,cultures,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2507,",",O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2508,and,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2509,individuals,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2510,around,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2511,the,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2512,world,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
2513,.,O,81.0,"Intakes of dairy produce show enormous diversity between regions , cultures , and individuals around the world ."
3069,Forty,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3070,-,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3071,six,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3072,subjects,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3073,(,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3074,33F/13,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3075,M,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3076,",",O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3077,body,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3078,mass,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3079,index,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3080,:,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3081,32.5,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3082,±,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3083,0.7,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3084,kg,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3085,/,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3086,m²,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3087,",",O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3088,age,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3089,:,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3090,50,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3091,±,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3092,1,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3093,years,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3094,",",O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3095,mean,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3096,±,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3097,SEMs,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3098,),O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3099,consumed,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3100,a,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3101,standard,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3102,sandwich,B-http://purl.bioontology.org/ontology/SNOMEDCT/735008002,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3103,with,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3104,one,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3105,of,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3106,the,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3107,six,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3108,beverages,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3109,on,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3110,separate,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3111,mornings,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3112,in,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3113,randomized,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3114,order,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3115,.,O,95.0,"Forty - six subjects ( 33F/13 M , body mass index : 32.5 ± 0.7 kg / m² , age : 50 ± 1 years , mean ± SEMs ) consumed a standard sandwich with one of the six beverages on separate mornings in randomized order ."
3130,Plasma,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3131,glucose,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3132,and,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3133,insulin,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3134,concentrations,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3135,were,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3136,measured,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3137,from,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3138,blood,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3139,obtained,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3140,pre-,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3141,and,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3142,post,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3143,-,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3144,meal,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3145,at,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3146,30,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3147,-,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3148,min,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3149,intervals,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3150,for,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3151,4,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3152,h,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3153,and,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3154,incremental,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3155,areas,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3156,under,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3157,the,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3158,curve,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3159,(,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3160,AUC,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3161,),O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3162,were,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3163,computed,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3164,.,O,97.0,Plasma glucose and insulin concentrations were measured from blood obtained pre- and post - meal at 30 - min intervals for 4 h and incremental areas under the curve ( AUC ) were computed .
3751,In,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3752,severe,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3753,responders,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3754,that,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3755,had,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3756,been,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3757,treated,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3758,with,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3759,bST,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3760,",",O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3761,changes,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3762,observed,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3763,during,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3764,mastitis,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3765,resembled,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3766,those,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3767,in,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3768,moderate,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3769,responders,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3770,treated,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3771,with,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3772,the,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3773,placebo,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
3774,.,O,120.0,"In severe responders that had been treated with bST , changes observed during mastitis resembled those in moderate responders treated with the placebo ."
4317,The,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4318,total,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4319,stilbene,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4320,intake,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4321,from,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4322,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4323,origin,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4324,was,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4325,estimated,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4326,for,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4327,the,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4328,Brazilian,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4329,population,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4330,as,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4331,5.3,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4332,mg,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4333,/,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4334,day,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4335,per,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4336,person,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4337,(,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4338,on,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4339,the,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4340,basis,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4341,of,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4342,a,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4343,regular,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4344,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4345,consumption,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4346,of,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4347,160,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4348,mL,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4349,/,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4350,day,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4351,),O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4352,.,O,136.0,The total stilbene intake from wine origin was estimated for the Brazilian population as 5.3 mg / day per person ( on the basis of a regular wine consumption of 160 mL / day ) .
4443,This,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4444,study,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4445,aimed,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4446,to,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4447,characterise,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4448,the,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4449,street,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4450,food,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4451,environment,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4452,in,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4453,Chişinău,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4454,",",O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4455,Moldova,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4456,",",O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4457,including,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4458,the,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4459,vending,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4460,sites,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4461,and,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4462,vendors,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4463,",",O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4464,food,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4465,availability,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4466,and,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4467,nutritional,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4468,composition,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4469,of,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4470,foods,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4471,and,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4472,beverages,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4473,.,O,140.0,"This study aimed to characterise the street food environment in Chişinău , Moldova , including the vending sites and vendors , food availability and nutritional composition of foods and beverages ."
4761,Prevention,O,151.0,Prevention of diet - related diseases in Moldova may benefit from the improvement of the nutritional profile of street food .
4762,of,O,151.0,Prevention of diet - related diseases in Moldova may benefit from the improvement of the nutritional profile of street food .
4763,diet,O,151.0,Prevention of diet - related diseases in Moldova may benefit from the improvement of the nutritional profile of street food .
4764,-,O,151.0,Prevention of diet - related diseases in Moldova may benefit from the improvement of the nutritional profile of street food .
4765,related,O,151.0,Prevention of diet - related diseases in Moldova may benefit from the improvement of the nutritional profile of street food .
4766,diseases,O,151.0,Prevention of diet - related diseases in Moldova may benefit from the improvement of the nutritional profile of street food .
4767,in,O,151.0,Prevention of diet - related diseases in Moldova may benefit from the improvement of the nutritional profile of street food .
4768,Moldova,O,151.0,Prevention of diet - related diseases in Moldova may benefit from the improvement of the nutritional profile of street food .
4769,may,O,151.0,Prevention of diet - related diseases in Moldova may benefit from the improvement of the nutritional profile of street food .
4770,benefit,O,151.0,Prevention of diet - related diseases in Moldova may benefit from the improvement of the nutritional profile of street food .
4771,from,O,151.0,Prevention of diet - related diseases in Moldova may benefit from the improvement of the nutritional profile of street food .
4772,the,O,151.0,Prevention of diet - related diseases in Moldova may benefit from the improvement of the nutritional profile of street food .
4773,improvement,O,151.0,Prevention of diet - related diseases in Moldova may benefit from the improvement of the nutritional profile of street food .
4774,of,O,151.0,Prevention of diet - related diseases in Moldova may benefit from the improvement of the nutritional profile of street food .
4775,the,O,151.0,Prevention of diet - related diseases in Moldova may benefit from the improvement of the nutritional profile of street food .
4776,nutritional,O,151.0,Prevention of diet - related diseases in Moldova may benefit from the improvement of the nutritional profile of street food .
4777,profile,O,151.0,Prevention of diet - related diseases in Moldova may benefit from the improvement of the nutritional profile of street food .
4778,of,O,151.0,Prevention of diet - related diseases in Moldova may benefit from the improvement of the nutritional profile of street food .
4779,street,O,151.0,Prevention of diet - related diseases in Moldova may benefit from the improvement of the nutritional profile of street food .
4780,food,O,151.0,Prevention of diet - related diseases in Moldova may benefit from the improvement of the nutritional profile of street food .
4781,.,O,151.0,Prevention of diet - related diseases in Moldova may benefit from the improvement of the nutritional profile of street food .
4833,We,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4834,hypothesized,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4835,that,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4836,substituting,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4837,canola,B-http://purl.bioontology.org/ontology/SNOMEDCT/713648000;http://purl.bioontology.org/ontology/SNOMEDCT/226908006,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4838,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/713648000;http://purl.bioontology.org/ontology/SNOMEDCT/226908006,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4839,(,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4840,10,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4841,%,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4842,ALA,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4843,),O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4844,for,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4845,the,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4846,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4847,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4848,(,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4849,1,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4850,%,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4851,ALA,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4852,),O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4853,in,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4854,the,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4855,diet,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4856,of,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4857,cancer,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4858,bearing,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4859,mice,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4860,would,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4861,slow,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4862,tumor,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4863,growth,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4864,by,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4865,increasing,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4866,n-3,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4867,fatty,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4868,acids,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4869,in,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4870,the,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4871,diet,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
4872,.,O,154.0,We hypothesized that substituting canola oil ( 10 % ALA ) for the corn oil ( 1 % ALA ) in the diet of cancer bearing mice would slow tumor growth by increasing n-3 fatty acids in the diet .
5303,Our,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5304,study,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5305,concludes,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5306,that,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5307,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5308,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5309,may,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5310,play,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5311,a,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5312,role,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5313,in,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5314,the,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5315,epigenetic,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5316,therapy,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5317,by,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5318,altering,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5319,NF,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5320,-,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5321,κB,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5322,and,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5323,apoptotic,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5324,pathways,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5325,via,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5326,targeting,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5327,noncoding,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5328,RNAs,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5329,and,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5330,methylation,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5331,machinery,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5332,that,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5333,affecting,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5334,epigenome,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5335,to,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5336,prevent,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5337,colon,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5338,carcinogenesis,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5339,.,O,170.0,Our study concludes that olive oil may play a role in the epigenetic therapy by altering NF - κB and apoptotic pathways via targeting noncoding RNAs and methylation machinery that affecting epigenome to prevent colon carcinogenesis .
5407,Several,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5408,milk,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5409,peptides,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5410,have,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5411,been,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5412,shown,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5413,to,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5414,have,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5415,antihypertensive,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5416,effects,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5417,in,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5418,animal,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5419,and,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5420,in,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5421,clinical,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5422,studies,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
5423,.,O,174.0,Several milk peptides have been shown to have antihypertensive effects in animal and in clinical studies .
6022,Tomato,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6023,(,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6024,Solanum,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6025,lycopersicum,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6026,),O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6027,is,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6028,one,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6029,of,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6030,the,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6031,most,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6032,essential,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6033,herbaceous,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6034,plants,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6035,that,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6036,have,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6037,been,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6038,probed,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6039,against,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6040,various,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6041,life,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6042,sight,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6043,related,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6044,disorders,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6045,owing,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6046,to,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6047,array,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6048,of,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6049,phytochemicals,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6050,.,O,195.0,Tomato ( Solanum lycopersicum ) is one of the most essential herbaceous plants that have been probed against various life sight related disorders owing to array of phytochemicals .
6353,The,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6354,DGAs,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6355,note,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6356,that,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6357,children,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6358,are,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6359,consuming,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6360,100,B-http://purl.bioontology.org/ontology/SNOMEDCT/129560007;http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6361,%,I-http://purl.bioontology.org/ontology/SNOMEDCT/129560007;http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6362,fruit,I-http://purl.bioontology.org/ontology/SNOMEDCT/129560007;http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6363,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/129560007;http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6364,within,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6365,recommendations,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6366,(,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6367,that,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6368,is,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6369,",",O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6370,120,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6371,to,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6372,180,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6373,mL,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6374,/,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6375,d,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6376,for,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6377,children,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6378,aged,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6379,1,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6380,to,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6381,6,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6382,y,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6383,and,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6384,236,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6385,to,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6386,355,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6387,mL,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6388,/,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6389,d,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6390,for,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6391,children,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6392,aged,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6393,7,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6394,to,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6395,18,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6396,y,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6397,),O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6398,.,O,207.0,"The DGAs note that children are consuming 100 % fruit juice within recommendations ( that is , 120 to 180 mL / d for children aged 1 to 6 y and 236 to 355 mL / d for children aged 7 to 18 y ) ."
6560,Reducing,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6561,or,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6562,eliminating,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6563,100,B-http://purl.bioontology.org/ontology/SNOMEDCT/129560007;http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6564,%,I-http://purl.bioontology.org/ontology/SNOMEDCT/129560007;http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6565,fruit,I-http://purl.bioontology.org/ontology/SNOMEDCT/129560007;http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6566,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/129560007;http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6567,could,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6568,lead,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6569,to,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6570,unintended,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6571,consequences,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6572,such,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6573,as,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6574,reduced,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6575,daily,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6576,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6577,intake,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6578,and,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6579,increased,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6580,consumption,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6581,of,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6582,less,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6583,nutritious,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6584,beverages,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6585,(,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6586,for,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6587,example,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6588,",",O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6589,sugar,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6590,-,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6591,sweetened,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6592,beverages,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6593,),O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6594,.,O,213.0,"Reducing or eliminating 100 % fruit juice could lead to unintended consequences such as reduced daily fruit intake and increased consumption of less nutritious beverages ( for example , sugar - sweetened beverages ) ."
6703,These,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6704,include,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6705,nutrition,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6706,",",O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6707,particularly,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6708,calcium,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6709,and,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6710,protein,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6711,intake,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6712,",",O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6713,physical,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6714,activity,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6715,",",O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6716,endocrine,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6717,status,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6718,",",O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6719,as,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6720,well,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6721,as,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6722,exposure,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6723,to,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6724,a,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6725,wide,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6726,variety,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6727,of,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6728,risk,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6729,factors,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6730,.,O,218.0,"These include nutrition , particularly calcium and protein intake , physical activity , endocrine status , as well as exposure to a wide variety of risk factors ."
6731,The,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6732,role,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6733,of,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6734,calcium,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6735,intake,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6736,in,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6737,determining,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6738,bone,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6739,mineral,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6740,mass,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6741,is,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6742,well,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6743,recognized,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6744,to,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6745,be,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6746,the,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6747,most,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6748,critical,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6749,nutritional,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6750,factor,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6751,to,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6752,achieve,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6753,optimal,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6754,peak,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6755,bone,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6756,mass,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6757,.,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
7847,We,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7848,developed,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7849,a,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7850,comprehensive,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7851,composition,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7852,database,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7853,of,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7854,629,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7855,cereal,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7856,-,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7857,based,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7858,gluten,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7859,free,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7860,(,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7861,GF,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7862,),O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7863,products,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7864,available,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7865,in,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7866,Spain,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
7867,.,O,260.0,We developed a comprehensive composition database of 629 cereal - based gluten free ( GF ) products available in Spain .
8105,The,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8106,purpose,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8107,of,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8108,this,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8109,research,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8110,was,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8111,to,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8112,estimate,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8113,the,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8114,potential,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8115,nutrient,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8116,contribution,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8117,of,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8118,fortified,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8119,maize,B-http://purl.bioontology.org/ontology/SNOMEDCT/63766005,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8120,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/63766005,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8121,",",O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8122,oil,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8123,",",O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8124,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8125,",",O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8126,salt,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8127,",",O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8128,and,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8129,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8130,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8131,in,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8132,153,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8133,countries,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8134,",",O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8135,using,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8136,the,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8137,national,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8138,intake,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8139,(,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8140,or,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8141,availability,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8142,),O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8143,of,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8144,the,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8145,food,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8146,and,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8147,the,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8148,nutrient,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8149,levels,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8150,required,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8151,for,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8152,fortification,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8153,.,O,271.0,"The purpose of this research was to estimate the potential nutrient contribution of fortified maize flour , oil , rice , salt , and wheat flour in 153 countries , using the national intake ( or availability ) of the food and the nutrient levels required for fortification ."
8781,Kurakkan,B-http://purl.bioontology.org/ontology/SNOMEDCT/63766005,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8782,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/63766005,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8783,pittu,I-http://purl.bioontology.org/ontology/SNOMEDCT/63766005,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8784,and,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8785,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8786,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8787,roti,I-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8788,were,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8789,classified,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8790,as,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8791,medium,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8792,-,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8793,GI,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8794,foods,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8795,with,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8796,GI,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8797,values,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8798,of,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8799,85+/-6,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8800,and,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8801,72+/-6,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8802,.,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8961,Diet,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8962,-,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8963,induced,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8964,obese,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8965,rats,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8966,were,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8967,randomized,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8968,to,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8969,isocaloric,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8970,diets,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8971,:,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8972,Control,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8973,",",O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8974,Whey,B-http://purl.bioontology.org/ontology/SNOMEDCT/226770007,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8975,",",O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8976,Lactalbumin,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8977,",",O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8978,Lactoferrin,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8979,",",O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8980,or,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8981,pair,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8982,-,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8983,fed,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8984,to,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8985,lactoferrin,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
8986,.,O,293.0,"Diet - induced obese rats were randomized to isocaloric diets : Control , Whey , Lactalbumin , Lactoferrin , or pair - fed to lactoferrin ."
9594,Recent,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9595,deep,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9596,sequencing,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9597,data,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9598,revealed,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9599,that,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9600,six,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9601,FT,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9602,homologs,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9603,are,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9604,expressed,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9605,in,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9606,shoot,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9607,apical,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9608,meristem,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9609,and,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9610,leaves,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9611,during,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9612,floral,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9613,transition,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
9614,.,O,318.0,Recent deep sequencing data revealed that six FT homologs are expressed in shoot apical meristem and leaves during floral transition .
10201,In,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10202,humans,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10203,",",O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10204,acute,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10205,toxic,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10206,effects,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10207,of,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10208,potato,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10209,GAs,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10210,(,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10211,α,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10212,-,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10213,solanine,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10214,and,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10215,α,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10216,-,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10217,chaconine,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10218,),O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10219,include,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10220,gastrointestinal,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10221,symptoms,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10222,such,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10223,as,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10224,nausea,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10225,",",O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10226,vomiting,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10227,and,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10228,diarrhoea,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10229,.,O,343.0,"In humans , acute toxic effects of potato GAs ( α - solanine and α - chaconine ) include gastrointestinal symptoms such as nausea , vomiting and diarrhoea ."
10275,In,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10276,humans,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10277,",",O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10278,no,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10279,evidence,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10280,of,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10281,health,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10282,problems,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10283,associated,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10284,with,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10285,repeated,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10286,or,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10287,long,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10288,-,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10289,term,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10290,intake,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10291,of,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10292,GAs,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10293,via,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10294,potatoes,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10295,has,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10296,been,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10297,identified,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10298,.,O,345.0,"In humans , no evidence of health problems associated with repeated or long - term intake of GAs via potatoes has been identified ."
10403,For,O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10404,adult,O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10405,age,O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10406,groups,O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10407,",",O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10408,the,O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10409,MOEs,O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10410,indicate,O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10411,a,O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10412,health,O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10413,concern,O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10414,only,O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10415,for,O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10416,the,O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10417,food,O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10418,consumption,O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10419,surveys,O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10420,with,O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10421,the,O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10422,highest,O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10423,P95,O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10424,exposures,O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10425,.,O,351.0,"For adult age groups , the MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures ."
10514,It,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10515,can,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10516,also,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10517,be,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10518,considered,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10519,as,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10520,a,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10521,substitute,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10522,for,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10523,animal,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10524,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10525,due,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10526,to,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10527,various,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10528,allergy,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10529,concerns,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10530,associated,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10531,with,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10532,dairy,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10533,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10534,.,O,355.0,It can also be considered as a substitute for animal milk due to various allergy concerns associated with dairy milk .
10682,It,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10683,also,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10684,covers,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10685,fats,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10686,digestibility,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10687,",",O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10688,protein,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10689,stability,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10690,",",O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10691,protein,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10692,solubility,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10693,and,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10694,digestibility,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10695,.,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
11040,The,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11041,main,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11042,cause,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11043,of,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11044,obesity,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11045,is,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11046,energy,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11047,imbalance,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11048,",",O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11049,of,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11050,which,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11051,contributing,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11052,factors,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11053,include,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11054,a,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11055,sedentary,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11056,lifestyle,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11057,",",O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11058,epigenetic,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11059,factors,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11060,and,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11061,excessive,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11062,caloric,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11063,intake,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11064,through,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11065,food,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11066,and,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11067,beverages,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11068,.,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11106,Our,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11107,objective,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11108,was,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11109,to,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11110,evaluate,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11111,the,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11112,association,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11113,between,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11114,the,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11115,substitution,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11116,of,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11117,a,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11118,serving,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11119,per,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11120,day,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11121,of,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11122,water,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11123,for,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11124,another,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11125,beverage,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11126,(,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11127,or,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11128,group,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11129,of,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11130,them,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11131,),O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11132,and,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11133,the,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11134,incidence,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11135,of,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11136,obesity,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11137,and,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11138,weight,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11139,change,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11140,in,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11141,a,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11142,Mediterranean,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11143,cohort,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11144,",",O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11145,using,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11146,mathematical,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11147,models,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11148,.,O,373.0,"Our objective was to evaluate the association between the substitution of a serving per day of water for another beverage ( or group of them ) and the incidence of obesity and weight change in a Mediterranean cohort , using mathematical models ."
11624,Increased,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11625,IgE,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11626,serum,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11627,levels,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11628,were,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11629,found,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11630,in,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11631,36.8,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11632,%,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11633,of,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11634,exposed,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11635,and,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11636,in,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11637,9.7,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11638,%,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11639,of,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11640,the,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11641,control,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11642,workers,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11643,(,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11644,P,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11645,less,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11646,than,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11647,0.01,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11648,),O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11649,.,O,389.0,Increased IgE serum levels were found in 36.8 % of exposed and in 9.7 % of the control workers ( P less than 0.01 ) .
11730,Ventilatory,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11731,capacity,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11732,was,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11733,measured,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11734,by,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11735,recording,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11736,maximum,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11737,expiratory,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11738,flow,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11739,-,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11740,volume,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11741,(,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11742,MEFV,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11743,),O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11744,curves,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11745,.,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
12731,The,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12732,possible,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12733,population,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12734,-,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12735,preventable,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12736,fraction,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12737,for,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12738,modifying,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12739,diet,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12740,in,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12741,relation,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12742,to,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12743,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12744,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12745,vegetable,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12746,consumption,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12747,was,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12748,calculated,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12749,as,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12750,well,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12751,as,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12752,an,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12753,overall,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12754,statement,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12755,about,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12756,the,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12757,degree,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12758,of,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12759,evidence,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12760,for,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12761,the,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12762,cancer,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12763,-,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12764,preventive,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12765,effect,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12766,of,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12767,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12768,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12769,vegetable,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/22836000,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12770,consumption,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12771,for,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12772,each,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12773,cancer,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12774,site,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12775,.,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
13006,The,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13007,prevalence,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13008,of,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13009,hypersensitivity,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13010,to,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13011,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/412071004,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13012,and,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13013,soy,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13014,appears,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13015,similar,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13016,to,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13017,sesame,B-http://purl.bioontology.org/ontology/SNOMEDCT/260167008,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13018,seed,I-http://purl.bioontology.org/ontology/SNOMEDCT/260167008,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13019,",",O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13020,cashew,B-http://purl.bioontology.org/ontology/SNOMEDCT/227493005;http://purl.bioontology.org/ontology/SNOMEDCT/13577000,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13021,nut,I-http://purl.bioontology.org/ontology/SNOMEDCT/227493005;http://purl.bioontology.org/ontology/SNOMEDCT/13577000,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13022,",",O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13023,hazelnut,B-http://purl.bioontology.org/ontology/SNOMEDCT/256353000,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13024,and,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13025,walnut,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13026,",",O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13027,but,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13028,allergy,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13029,to,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13030,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13031,",",O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13032,brazil,B-http://purl.bioontology.org/ontology/SNOMEDCT/256351003;http://purl.bioontology.org/ontology/SNOMEDCT/13577000,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13033,nut,I-http://purl.bioontology.org/ontology/SNOMEDCT/256351003;http://purl.bioontology.org/ontology/SNOMEDCT/13577000,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13034,and,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13035,shell,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13036,fish,I-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13037,are,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13038,uncommon,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13039,.,O,432.0,"The prevalence of hypersensitivity to wheat and soy appears similar to sesame seed , cashew nut , hazelnut and walnut , but allergy to fish , brazil nut and shell fish are uncommon ."
13100,Milk,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13101,consumption,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13102,decreases,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13103,inflammatory,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13104,stress,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13105,in,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13106,overweight,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13107,and,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13108,obese,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13109,subjects,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13110,.,O,435.0,Milk consumption decreases inflammatory stress in overweight and obese subjects .
13299,Postprandial,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13300,serum,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13301,insulin,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13302,concentration,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13303,AUC,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13304,was,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13305,significantly,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13306,higher,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13307,during,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13308,the,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13309,POT,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13310, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13311,+,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13312, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13313,CA,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13314,meal,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13315,compared,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13316,with,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13317,the,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13318,POT,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13319,meal,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13320,(,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13321,P,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13322, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13323,=,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13324, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13325,0·001,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13326,),O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13327,and,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13328,the,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13329,CA,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13330,meal,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13331,(,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13332,P,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13333, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13334,<,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13335, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13336,0·05,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13337,),O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13338,",",O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13339,which,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13340,in,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13341,turn,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13342,was,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13343,significantly,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13344,higher,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13345,than,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13346,the,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13347,POT,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13348,meal,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13349,(,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13350,P,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13351, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13352,<,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13353, ,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13354,0·05,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13355,),O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13356,.,O,442.0,"Postprandial serum insulin concentration AUC was significantly higher during the POT   +   CA meal compared with the POT meal ( P   =   0·001 ) and the CA meal ( P   <   0·05 ) , which in turn was significantly higher than the POT meal ( P   <   0·05 ) ."
13559,Dietary,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13560,intake,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13561,was,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13562,recorded,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13563,daily,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13564,for,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13565,seven,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13566,consecutive,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13567,days,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13568,in,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13569,pre,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13570,-,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13571,coded,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13572,food,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13573,records,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13574,supplemented,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13575,with,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13576,open,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13577,-,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13578,answer,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13579,possibilities,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
13580,.,O,451.0,Dietary intake was recorded daily for seven consecutive days in pre - coded food records supplemented with open - answer possibilities .
14118,Food,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14119,manufacturers,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14120,should,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14121,declare,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14122,the,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14123,presence,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14124,of,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14125,allergenic,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14126,food,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14127,ingredients,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14128,in,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14129,the,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14130,ingredient,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14131,listings,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14132,on,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14133,product,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14134,labels,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14135,so,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14136,that,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14137,allergic,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14138,consumers,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14139,can,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14140,know,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14141,to,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14142,avoid,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14143,these,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14144,potentially,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14145,hazardous,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14146,products,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14147,.,O,472.0,Food manufacturers should declare the presence of allergenic food ingredients in the ingredient listings on product labels so that allergic consumers can know to avoid these potentially hazardous products .
14148,A,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14149,large,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14150,clinical,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14151,/,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14152,serologic,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14153,study,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14154,was,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14155,carried,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14156,out,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14157,to,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14158,determine,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14159,the,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14160,prevalence,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14161,of,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14162,Apiaceae,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14163,(,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14164,carrot,B-http://purl.bioontology.org/ontology/SNOMEDCT/256319004,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14165,",",O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14166,celery,B-http://purl.bioontology.org/ontology/SNOMEDCT/256326004,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14167,",",O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14168,and,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14169,fennel,B-http://purl.bioontology.org/ontology/SNOMEDCT/227396003,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14170,),O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14171,hypersensitivity,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14172,in,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14173,patients,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14174,with,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14175,birch,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14176,pollen,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14177,allergy,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14178,",",O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14179,and,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14180,to,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14181,investigate,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14182,its,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14183,relationship,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14184,with,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14185,apple,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14186,and,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14187,hazelnut,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14188,allergy,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14189,and,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14190,with,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14191,birch,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14192,pollen,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14193,-,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14194,specific,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14195,IgE,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14196,levels,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14197,.,O,473.0,"A large clinical / serologic study was carried out to determine the prevalence of Apiaceae ( carrot , celery , and fennel ) hypersensitivity in patients with birch pollen allergy , and to investigate its relationship with apple and hazelnut allergy and with birch pollen - specific IgE levels ."
14198,A,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14199,total,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14200,of,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14201,196,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14202,birch,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14203,pollen,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14204,-,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14205,hypersensitive,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14206,patients,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14207,with,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14208,oral,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14209,allergy,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14210,syndrome,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14211,(,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14212,OAS,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14213,),O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14214,caused,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14215,by,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14216,different,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14217,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14218,foods,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14219,were,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14220,examined,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14221,in,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14222,the,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14223,cross,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14224,-,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14225,sectional,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14226,part,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14227,of,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14228,the,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14229,study,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14230,.,O,474.0,A total of 196 birch pollen - hypersensitive patients with oral allergy syndrome ( OAS ) caused by different vegetable foods were examined in the cross - sectional part of the study .
14741,It,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14742,orchestrates,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14743,metabolic,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14744,responses,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14745,to,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14746,feeding,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14747,by,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14748,secreting,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14749,factors,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14750,essential,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14751,for,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14752,maintaining,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14753,metabolic,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14754,homeostasis,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14755,",",O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14756,converting,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14757,carbohydrates,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14758,to,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14759,triglycerides,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14760,for,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14761,storage,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14762,",",O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14763,and,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14764,releasing,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14765,lipids,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14766,packaged,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14767,as,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14768,lipoproteins,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14769,for,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14770,distribution,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14771,to,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14772,other,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14773,tissues,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
14774,.,O,490.0,"It orchestrates metabolic responses to feeding by secreting factors essential for maintaining metabolic homeostasis , converting carbohydrates to triglycerides for storage , and releasing lipids packaged as lipoproteins for distribution to other tissues ."
15173,Food,O,504.0,"Food cravings are extremely common , particularly among women ."
15174,cravings,O,504.0,"Food cravings are extremely common , particularly among women ."
15175,are,O,504.0,"Food cravings are extremely common , particularly among women ."
15176,extremely,O,504.0,"Food cravings are extremely common , particularly among women ."
15177,common,O,504.0,"Food cravings are extremely common , particularly among women ."
15178,",",O,504.0,"Food cravings are extremely common , particularly among women ."
15179,particularly,O,504.0,"Food cravings are extremely common , particularly among women ."
15180,among,O,504.0,"Food cravings are extremely common , particularly among women ."
15181,women,O,504.0,"Food cravings are extremely common , particularly among women ."
15182,.,O,504.0,"Food cravings are extremely common , particularly among women ."
15591,Diet,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15592,in,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15593,the,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15594,year,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15595,before,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15596,sigmoidoscopy,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15597,was,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15598,measured,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15599,with,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15600,a,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15601,food,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15602,frequency,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15603,questionnaire,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15604,.,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15773,The,O,528.0,The impact of meat protein on metabolic regulation is still disputed and may be influenced by protein level .
15774,impact,O,528.0,The impact of meat protein on metabolic regulation is still disputed and may be influenced by protein level .
15775,of,O,528.0,The impact of meat protein on metabolic regulation is still disputed and may be influenced by protein level .
15776,meat,O,528.0,The impact of meat protein on metabolic regulation is still disputed and may be influenced by protein level .
15777,protein,O,528.0,The impact of meat protein on metabolic regulation is still disputed and may be influenced by protein level .
15778,on,O,528.0,The impact of meat protein on metabolic regulation is still disputed and may be influenced by protein level .
15779,metabolic,O,528.0,The impact of meat protein on metabolic regulation is still disputed and may be influenced by protein level .
15780,regulation,O,528.0,The impact of meat protein on metabolic regulation is still disputed and may be influenced by protein level .
15781,is,O,528.0,The impact of meat protein on metabolic regulation is still disputed and may be influenced by protein level .
15782,still,O,528.0,The impact of meat protein on metabolic regulation is still disputed and may be influenced by protein level .
15783,disputed,O,528.0,The impact of meat protein on metabolic regulation is still disputed and may be influenced by protein level .
15784,and,O,528.0,The impact of meat protein on metabolic regulation is still disputed and may be influenced by protein level .
15785,may,O,528.0,The impact of meat protein on metabolic regulation is still disputed and may be influenced by protein level .
15786,be,O,528.0,The impact of meat protein on metabolic regulation is still disputed and may be influenced by protein level .
15787,influenced,O,528.0,The impact of meat protein on metabolic regulation is still disputed and may be influenced by protein level .
15788,by,O,528.0,The impact of meat protein on metabolic regulation is still disputed and may be influenced by protein level .
15789,protein,O,528.0,The impact of meat protein on metabolic regulation is still disputed and may be influenced by protein level .
15790,level,O,528.0,The impact of meat protein on metabolic regulation is still disputed and may be influenced by protein level .
15791,.,O,528.0,The impact of meat protein on metabolic regulation is still disputed and may be influenced by protein level .
16423,Liver,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16424,biopsies,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16425,were,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16426,collected,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16427,at,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16428,2,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16429,d,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16430,postpartum,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16431,",",O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16432,and,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16433,protein,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16434,content,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16435,was,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16436,analyzed,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16437,by,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16438,label,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16439,-,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16440,free,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16441,quantitative,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16442,shotgun,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16443,proteomics,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16444,(,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16445,nanoscale,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16446,liquid,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16447,chromatography,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16448,coupled,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16449,to,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16450,tandem,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16451,mass,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16452,spectrometry,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16453,),O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
16454,.,O,546.0,"Liver biopsies were collected at 2 d postpartum , and protein content was analyzed by label - free quantitative shotgun proteomics ( nanoscale liquid chromatography coupled to tandem mass spectrometry ) ."
17238,The,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17239,specificity,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17240,and,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17241,sensitivity,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17242,were,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17243,considered,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17244,to,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17245,be,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17246,sufficient,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17247,for,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17248,the,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17249,detection,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17250,of,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17251,trace,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17252,amounts,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17253,of,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17254,peach,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17255,or,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17256,apple,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17257,contamination,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17258,in,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17259,processed,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17260,foods,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17261,.,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17696,We,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17697,fed,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17698,eight,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17699,kinds,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17700,of,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17701,high,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17702,-,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17703,fat,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17704,diets,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17705,(,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17706,HFDs,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17707,),O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17708,of,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17709,animal,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17710,or,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17711,plant,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17712,origin,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17713,to,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17714,mice,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17715,evaluated,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17716,their,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17717,effect,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17718,on,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17719,gastric,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17720,pathogenesis,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17721,.,O,592.0,We fed eight kinds of high - fat diets ( HFDs ) of animal or plant origin to mice evaluated their effect on gastric pathogenesis .
17722,Five,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17723,types,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17724,of,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17725,dietary,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17726,fat,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17727,were,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17728,divided,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17729,according,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17730,to,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17731,their,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17732,observed,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17733,effects,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17734,:,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17735,Obese,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17736,with,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17737,high,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17738,metaplasia,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17739,(,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17740,group,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17741,I,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17742,;,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17743,beef,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17744,tallow,I-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17745,",",O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17746,lard,B-http://purl.bioontology.org/ontology/SNOMEDCT/226899009,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17747,",",O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17748,and,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17749,hydrogenated,B-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17750,coconut,I-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17751,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17752,),O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17753,",",O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17754,non,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17755,-,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17756,obese,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17757,with,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17758,high,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17759,metaplasia,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17760,(,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17761,group,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17762,II,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17763,;,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17764,linseed,B-http://purl.bioontology.org/ontology/SNOMEDCT/41573001;http://purl.bioontology.org/ontology/SNOMEDCT/710178007,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17765,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41573001;http://purl.bioontology.org/ontology/SNOMEDCT/710178007,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17766,),O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17767,",",O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17768,obese,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17769,without,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17770,metaplasia,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17771,(,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17772,group,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17773,III,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17774,;,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17775,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17776,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17777,and,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17778,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17779,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17780,),O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17781,",",O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17782,non,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17783,-,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17784,obese,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17785,without,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17786,metaplasia,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17787,(,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17788,group,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17789,IV,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17790,",",O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17791,soybean,B-http://purl.bioontology.org/ontology/SNOMEDCT/226911007,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17792,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/226911007,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17793,),O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17794,and,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17795,lean,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17796,without,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17797,metaplasia,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17798,(,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17799,group,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17800,V,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17801,;,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17802,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107;http://purl.bioontology.org/ontology/SNOMEDCT/226888007,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17803,butter,I-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107;http://purl.bioontology.org/ontology/SNOMEDCT/226888007,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17804,),O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17805,.,O,593.0,"Five types of dietary fat were divided according to their observed effects : Obese with high metaplasia ( group I ; beef tallow , lard , and hydrogenated coconut oil ) , non - obese with high metaplasia ( group II ; linseed oil ) , obese without metaplasia ( group III ; corn oil and olive oil ) , non - obese without metaplasia ( group IV , soybean oil ) and lean without metaplasia ( group V ; cocoa butter ) ."
17806,The,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17807,group,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17808,I,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17809,and,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17810,II,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17811,diets,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17812,induced,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17813,leptin,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17814,",",O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17815,phosphorylated,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17816,leptin,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17817,receptor,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17818,(,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17819,ObR,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17820,),O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17821,",",O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17822,signal,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17823,transducer,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17824,and,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17825,activator,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17826,3,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17827,(,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17828,STAT3,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17829,),O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17830,",",O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17831,and,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17832,increased,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17833,intracellular,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17834,β,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17835,-,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17836,catenin,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17837,accumulation,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17838,in,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17839,the,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17840,stomach,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
17841,.,O,594.0,"The group I and II diets induced leptin , phosphorylated leptin receptor ( ObR ) , signal transducer and activator 3 ( STAT3 ) , and increased intracellular β - catenin accumulation in the stomach ."
18006,Polyphenols,O,600.0,Polyphenols are a heterogeneous group of phytochemicals containing phenol rings .
18007,are,O,600.0,Polyphenols are a heterogeneous group of phytochemicals containing phenol rings .
18008,a,O,600.0,Polyphenols are a heterogeneous group of phytochemicals containing phenol rings .
18009,heterogeneous,O,600.0,Polyphenols are a heterogeneous group of phytochemicals containing phenol rings .
18010,group,O,600.0,Polyphenols are a heterogeneous group of phytochemicals containing phenol rings .
18011,of,O,600.0,Polyphenols are a heterogeneous group of phytochemicals containing phenol rings .
18012,phytochemicals,O,600.0,Polyphenols are a heterogeneous group of phytochemicals containing phenol rings .
18013,containing,O,600.0,Polyphenols are a heterogeneous group of phytochemicals containing phenol rings .
18014,phenol,O,600.0,Polyphenols are a heterogeneous group of phytochemicals containing phenol rings .
18015,rings,O,600.0,Polyphenols are a heterogeneous group of phytochemicals containing phenol rings .
18016,.,O,600.0,Polyphenols are a heterogeneous group of phytochemicals containing phenol rings .
18125,Recently,O,606.0,"Recently however , there has been a decline in consumption , perhaps influenced by erroneous reports of being an unhealthy food ."
18126,however,O,606.0,"Recently however , there has been a decline in consumption , perhaps influenced by erroneous reports of being an unhealthy food ."
18127,",",O,606.0,"Recently however , there has been a decline in consumption , perhaps influenced by erroneous reports of being an unhealthy food ."
18128,there,O,606.0,"Recently however , there has been a decline in consumption , perhaps influenced by erroneous reports of being an unhealthy food ."
18129,has,O,606.0,"Recently however , there has been a decline in consumption , perhaps influenced by erroneous reports of being an unhealthy food ."
18130,been,O,606.0,"Recently however , there has been a decline in consumption , perhaps influenced by erroneous reports of being an unhealthy food ."
18131,a,O,606.0,"Recently however , there has been a decline in consumption , perhaps influenced by erroneous reports of being an unhealthy food ."
18132,decline,O,606.0,"Recently however , there has been a decline in consumption , perhaps influenced by erroneous reports of being an unhealthy food ."
18133,in,O,606.0,"Recently however , there has been a decline in consumption , perhaps influenced by erroneous reports of being an unhealthy food ."
18134,consumption,O,606.0,"Recently however , there has been a decline in consumption , perhaps influenced by erroneous reports of being an unhealthy food ."
18135,",",O,606.0,"Recently however , there has been a decline in consumption , perhaps influenced by erroneous reports of being an unhealthy food ."
18136,perhaps,O,606.0,"Recently however , there has been a decline in consumption , perhaps influenced by erroneous reports of being an unhealthy food ."
18137,influenced,O,606.0,"Recently however , there has been a decline in consumption , perhaps influenced by erroneous reports of being an unhealthy food ."
18138,by,O,606.0,"Recently however , there has been a decline in consumption , perhaps influenced by erroneous reports of being an unhealthy food ."
18139,erroneous,O,606.0,"Recently however , there has been a decline in consumption , perhaps influenced by erroneous reports of being an unhealthy food ."
18140,reports,O,606.0,"Recently however , there has been a decline in consumption , perhaps influenced by erroneous reports of being an unhealthy food ."
18141,of,O,606.0,"Recently however , there has been a decline in consumption , perhaps influenced by erroneous reports of being an unhealthy food ."
18142,being,O,606.0,"Recently however , there has been a decline in consumption , perhaps influenced by erroneous reports of being an unhealthy food ."
18143,an,O,606.0,"Recently however , there has been a decline in consumption , perhaps influenced by erroneous reports of being an unhealthy food ."
18144,unhealthy,O,606.0,"Recently however , there has been a decline in consumption , perhaps influenced by erroneous reports of being an unhealthy food ."
18145,food,O,606.0,"Recently however , there has been a decline in consumption , perhaps influenced by erroneous reports of being an unhealthy food ."
18146,.,O,606.0,"Recently however , there has been a decline in consumption , perhaps influenced by erroneous reports of being an unhealthy food ."
18147,This,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18148,review,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18149,provides,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18150,an,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18151,overview,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18152,of,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18153,the,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18154,nutritional,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18155,value,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18156,of,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18157,potatoes,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18158,and,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18159,examines,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18160,the,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18161,evidence,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18162,for,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18163,associations,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18164,between,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18165,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18166,consumption,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18167,and,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18168,non,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18169,-,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18170,communicable,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18171,diseases,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18172,.,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18361,Experimental,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18362,and,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18363,clinical,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18364,studies,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18365,provide,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18366,evidence,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18367,that,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18368,food,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18369,intake,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18370,restricted,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18371,to,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18372,the,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18373,normal,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18374,activity,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18375,phase,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18376,is,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18377,a,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18378,potent,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18379,synchronizer,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18380,for,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18381,the,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18382,circadian,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18383,system,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18384,and,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18385,can,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18386,prevent,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18387,the,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18388,detrimental,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18389,metabolic,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18390,effects,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18391,associated,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18392,with,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18393,circadian,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18394,disruption,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
18395,.,O,615.0,Experimental and clinical studies provide evidence that food intake restricted to the normal activity phase is a potent synchronizer for the circadian system and can prevent the detrimental metabolic effects associated with circadian disruption .
19175,A,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19176,recent,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19177,case,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19178,-,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19179,control,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19180,study,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19181,reported,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19182,that,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19183,several,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19184,food,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19185,items,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19186,and,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19187,cooking,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19188,methods,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19189,are,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19190,associated,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19191,with,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19192,increased,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19193,or,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19194,decreased,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19195,risk,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19196,of,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19197,stomach,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19198,cancer,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19199,among,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19200,Koreans,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19201,.,O,639.0,A recent case - control study reported that several food items and cooking methods are associated with increased or decreased risk of stomach cancer among Koreans .
19202,An,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19203,increased,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19204,risk,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19205,of,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19206,stomach,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19207,cancer,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19208,was,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19209,noted,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19210,among,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19211,people,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19212,who,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19213,frequently,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19214,consume,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19215,broiled,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19216,meats,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19217,and,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19218,fishes,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19219,",",O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19220,salted,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19221,side,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19222,dishes,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19223,(,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19224,salted,B-http://purl.bioontology.org/ontology/SNOMEDCT/227170009;http://purl.bioontology.org/ontology/SNOMEDCT/735971005,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19225,/,I-http://purl.bioontology.org/ontology/SNOMEDCT/227170009;http://purl.bioontology.org/ontology/SNOMEDCT/735971005,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19226,fermented,I-http://purl.bioontology.org/ontology/SNOMEDCT/227170009;http://purl.bioontology.org/ontology/SNOMEDCT/735971005,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19227,fish,I-http://purl.bioontology.org/ontology/SNOMEDCT/227170009;http://purl.bioontology.org/ontology/SNOMEDCT/735971005,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19228,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/227170009;http://purl.bioontology.org/ontology/SNOMEDCT/735971005,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19229,),O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19230,and,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19231,salty,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19232,stewed,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19233,foods,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19234,",",O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19235,such,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19236,as,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19237,soybean,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19238,paste,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19239,thick,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19240,stew,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19241,.,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19261,Analysis,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19262,by,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19263,cooking,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19264,method,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19265,showed,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19266,that,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19267,risk,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19268,of,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19269,stomach,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19270,cancer,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19271,from,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19272,the,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19273,same,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19274,foods,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19275,varied,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19276,with,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19277,preparation,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19278,.,O,642.0,Analysis by cooking method showed that risk of stomach cancer from the same foods varied with preparation .
19279,For,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19280,meat,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19281,and,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19282,fish,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19283,",",O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19284,pan,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19285,frying,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19286,was,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19287,associated,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19288,with,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19289,decreased,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19290,risk,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19291,",",O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19292,whereas,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19293,stewing,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19294,or,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19295,broiling,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19296,was,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19297,associated,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19298,with,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19299,increased,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19300,risk,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19301,.,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
20029,The,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20030,involved,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20031,mechanisms,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20032,included,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20033,protecting,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20034,vascular,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20035,endothelial,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20036,function,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20037,",",O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20038,regulating,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20039,lipids,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20040,metabolism,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20041,",",O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20042,modulating,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20043,blood,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20044,pressure,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20045,",",O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20046,inhibiting,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20047,platelets,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20048,function,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20049,",",O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20050,alleviating,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20051,ischemia,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20052,/,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20053,reperfusion,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20054,injury,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20055,",",O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20056,suppressing,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20057,thrombosis,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20058,",",O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20059,reducing,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20060,oxidative,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20061,stress,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20062,",",O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20063,and,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20064,attenuating,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20065,inflammation,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20066,.,O,669.0,"The involved mechanisms included protecting vascular endothelial function , regulating lipids metabolism , modulating blood pressure , inhibiting platelets function , alleviating ischemia / reperfusion injury , suppressing thrombosis , reducing oxidative stress , and attenuating inflammation ."
20415,The,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20416,subjects,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20417,were,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20418,asked,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20419,for,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20420,dietary,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20421,data,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20422,referring,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20423,to,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20424,the,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20425,year,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20426,preceding,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20427,the,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20428,diagnosis,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20429,of,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20430,NPC,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20431,and,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20432,",",O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20433,with,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20434,help,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20435,of,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20436,their,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20437,families,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20438,",",O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20439,during,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20440,childhood,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20441,and,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20442,after,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20443,weaning,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20444,.,O,680.0,"The subjects were asked for dietary data referring to the year preceding the diagnosis of NPC and , with help of their families , during childhood and after weaning ."
20523,Moreover,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20524,",",O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20525,subjects,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20526,who,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20527,had,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20528,been,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20529,directly,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20530,weaned,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20531,from,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20532,mother,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20533,'s,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20534,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20535,on,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20536,to,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20537,an,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20538,adult,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20539,diet,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20540,were,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20541,found,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20542,to,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20543,be,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20544,at,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20545,higher,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20546,risk,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20547,for,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20548,NPC,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20549,.,O,682.0,"Moreover , subjects who had been directly weaned from mother 's milk on to an adult diet were found to be at higher risk for NPC ."
20887,Intakes,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20888,of,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20889,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20890,(,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20891,OR,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20892,=,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20893,0.7,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20894,),O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20895,",",O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20896,raw,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20897,and,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20898,cooked,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20899,vegetables,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20900,(,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20901,OR,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20902,=,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20903,0.6,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20904,for,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20905,both,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20906,),O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20907,and,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20908,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20909,other,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20910,than,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20911,citrus,B-http://purl.bioontology.org/ontology/SNOMEDCT/102259006;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20912,fruit,I-http://purl.bioontology.org/ontology/SNOMEDCT/102259006;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20913,(,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20914,OR,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20915,=,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20916,0.7,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20917,),O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20918,showed,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20919,a,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20920,negative,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20921,association,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20922,with,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20923,risk,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20924,.,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
21003,The,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21004,beneficial,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21005,role,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21006,of,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21007,most,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21008,vegetables,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21009,is,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21010,confirmed,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21011,",",O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21012,with,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21013,more,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21014,than,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21015,20,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21016,%,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21017,reduction,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21018,in,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21019,risk,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21020,of,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21021,colorectal,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21022,cancer,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21023,from,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21024,the,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21025,addition,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21026,of,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21027,one,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21028,daily,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21029,serving,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21030,.,O,696.0,"The beneficial role of most vegetables is confirmed , with more than 20 % reduction in risk of colorectal cancer from the addition of one daily serving ."
21031,Milk,O,697.0,Milk loss due to increased somatic cell counts ( SCC ) results in economic losses for dairy producers .
21032,loss,O,697.0,Milk loss due to increased somatic cell counts ( SCC ) results in economic losses for dairy producers .
21033,due,O,697.0,Milk loss due to increased somatic cell counts ( SCC ) results in economic losses for dairy producers .
21034,to,O,697.0,Milk loss due to increased somatic cell counts ( SCC ) results in economic losses for dairy producers .
21035,increased,O,697.0,Milk loss due to increased somatic cell counts ( SCC ) results in economic losses for dairy producers .
21036,somatic,O,697.0,Milk loss due to increased somatic cell counts ( SCC ) results in economic losses for dairy producers .
21037,cell,O,697.0,Milk loss due to increased somatic cell counts ( SCC ) results in economic losses for dairy producers .
21038,counts,O,697.0,Milk loss due to increased somatic cell counts ( SCC ) results in economic losses for dairy producers .
21039,(,O,697.0,Milk loss due to increased somatic cell counts ( SCC ) results in economic losses for dairy producers .
21040,SCC,O,697.0,Milk loss due to increased somatic cell counts ( SCC ) results in economic losses for dairy producers .
21041,),O,697.0,Milk loss due to increased somatic cell counts ( SCC ) results in economic losses for dairy producers .
21042,results,O,697.0,Milk loss due to increased somatic cell counts ( SCC ) results in economic losses for dairy producers .
21043,in,O,697.0,Milk loss due to increased somatic cell counts ( SCC ) results in economic losses for dairy producers .
21044,economic,O,697.0,Milk loss due to increased somatic cell counts ( SCC ) results in economic losses for dairy producers .
21045,losses,O,697.0,Milk loss due to increased somatic cell counts ( SCC ) results in economic losses for dairy producers .
21046,for,O,697.0,Milk loss due to increased somatic cell counts ( SCC ) results in economic losses for dairy producers .
21047,dairy,O,697.0,Milk loss due to increased somatic cell counts ( SCC ) results in economic losses for dairy producers .
21048,producers,O,697.0,Milk loss due to increased somatic cell counts ( SCC ) results in economic losses for dairy producers .
21049,.,O,697.0,Milk loss due to increased somatic cell counts ( SCC ) results in economic losses for dairy producers .
21566,Cinnamon,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21567,",",O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21568,from,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21569,the,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21570,genus,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21571,Cinnamomum,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21572,and,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21573,Lauraceae,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21574,family,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21575,",",O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21576,has,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21577,been,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21578,used,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21579,as,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21580,a,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21581,popular,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21582,spice,B-http://purl.bioontology.org/ontology/SNOMEDCT/24515005,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21583,for,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21584,thousands,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21585,of,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21586,years,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21587,around,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21588,the,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21589,world,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21590,.,O,717.0,"Cinnamon , from the genus Cinnamomum and Lauraceae family , has been used as a popular spice for thousands of years around the world ."
21818,Biogenic,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21819,amines,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21820,have,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21821,been,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21822,reported,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21823,in,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21824,a,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21825,variety,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21826,of,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21827,foods,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21828,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21829,such,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21830,as,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21831,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21832,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21833,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21834,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21835,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21836,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21837,vegetables,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21838,",",O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21839,and,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21840,wines,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21841,.,O,726.0,"Biogenic amines have been reported in a variety of foods , such as fish , meat , cheese , vegetables , and wines ."
21906,The,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21907,formation,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21908,of,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21909,biogenic,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21910,amines,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21911,in,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21912,food,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21913,by,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21914,the,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21915,microbial,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21916,decarboxylation,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21917,of,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21918,amino,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21919,acids,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21920,can,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21921,result,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21922,in,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21923,consumers,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21924,suffering,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21925,allergic,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21926,reactions,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21927,",",O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21928,characterized,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21929,by,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21930,difficulty,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21931,in,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21932,breathing,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21933,",",O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21934,itching,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21935,",",O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21936,rash,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21937,",",O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21938,vomiting,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21939,",",O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21940,fever,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21941,",",O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21942,and,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21943,hypertension,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21944,.,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
22119,Liquid,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22120,chromatography,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22121,-,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22122,mass,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22123,spectrometry,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22124,(,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22125,LC,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22126,-,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22127,MS,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22128,),O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22129,was,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22130,used,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22131,to,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22132,assess,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22133,compositional,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22134,differences,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22135,between,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22136,mango,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22137,fractions,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22138,in,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22139,flesh,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22140,extracts,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22141,.,O,740.0,Liquid chromatography - mass spectrometry ( LC - MS ) was used to assess compositional differences between mango fractions in flesh extracts .
22276,This,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22277,study,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22278,shows,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22279,that,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22280,there,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22281,is,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22282,a,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22283,diversity,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22284,of,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22285,potentially,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22286,beneficial,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22287,bioactivities,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22288,within,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22289,the,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22290,flesh,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22291,and,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22292,peel,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22293,of,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22294,mango,B-http://purl.bioontology.org/ontology/SNOMEDCT/260179008;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22295,fruit,I-http://purl.bioontology.org/ontology/SNOMEDCT/260179008;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22296,",",O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22297,although,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22298,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22299,-,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22300,to,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22301,-,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22302,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22303,variation,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22304,can,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22305,be,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22306,large,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22307,.,O,745.0,"This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit , although fruit - to - fruit variation can be large ."
22582,Both,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22583,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22584,and,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22585,fresh,B-http://purl.bioontology.org/ontology/SNOMEDCT/226796009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22586,cream,I-http://purl.bioontology.org/ontology/SNOMEDCT/226796009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22587,were,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22588,shown,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22589,by,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22590,quantitative,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22591,real,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22592,-,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22593,time,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22594,PCR,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22595,to,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22596,increase,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22597,the,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22598,quantity,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22599,of,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22600,mRNA,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22601,for,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22602,uncoupling,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22603,protein,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22604,2,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22605,(,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22606,UCP2,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22607,),O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22608,",",O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22609,an,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22610,energy,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22611,expenditure,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22612,gene,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22613,",",O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22614,in,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22615,a,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22616,dose,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22617,-,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22618,dependent,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22619,manner,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22620,.,O,756.0,"Both milk and fresh cream were shown by quantitative real - time PCR to increase the quantity of mRNA for uncoupling protein 2 ( UCP2 ) , an energy expenditure gene , in a dose - dependent manner ."
22621,The,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22622,increase,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22623,in,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22624,UCP2,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22625,mRNA,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22626,was,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22627,found,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22628,to,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22629,be,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22630,reduced,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22631,by,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22632,treatment,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22633,with,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22634,PPARdelta,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22635,-,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22636,short,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22637,interfering,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22638,(,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22639,si)RNA,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22640,.,O,757.0,The increase in UCP2 mRNA was found to be reduced by treatment with PPARdelta - short interfering ( si)RNA .
22766,Slices,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22767,were,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22768,fried,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22769,using,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22770,equivalent,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22771,thermal,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22772,driving,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22773,forces,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22774,",",O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22775,maintaining,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22776,a,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22777,constant,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22778,difference,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22779,between,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22780,oil,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22781,temperature,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22782,and,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22783,the,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22784,boiling,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22785,point,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22786,of,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22787,water,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22788,at,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22789,the,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22790,working,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22791,pressure,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22792,(,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22793,ΔT,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22794,=,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22795,60,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22796,and,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22797,80,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22798,°,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22799,C,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22800,),O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
22801,.,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( ΔT = 60 and 80 ° C ) ."
23223,The,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23224,relation,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23225,between,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23226,alcohol,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23227,consumption,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23228,and,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23229,mortality,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23230,is,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23231,a,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23232,J,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23233,-,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23234,shaped,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23235,curve,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23236,in,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23237,most,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23238,of,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23239,the,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23240,many,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23241,studies,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23242,published,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23243,on,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23244,this,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23245,topic,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23246,.,O,778.0,The relation between alcohol consumption and mortality is a J - shaped curve in most of the many studies published on this topic .
23316,In,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23317,particular,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23318,",",O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23319,resveratrol,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23320,seems,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23321,to,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23322,play,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23323,a,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23324,positive,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23325,effect,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23326,on,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23327,longevity,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23328,because,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23329,it,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23330,increases,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23331,the,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23332,expression,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23333,level,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23334,of,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23335,Sirt1,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23336,",",O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23337,besides,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23338,its,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23339,antioxidant,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23340,",",O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23341,anti,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23342,-,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23343,inflammatory,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23344,and,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23345,anticarcinogenic,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23346,properties,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23347,.,O,781.0,"In particular , resveratrol seems to play a positive effect on longevity because it increases the expression level of Sirt1 , besides its antioxidant , anti - inflammatory and anticarcinogenic properties ."
23348,Moderate,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23349,wine,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23350,drinking,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23351,is,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23352,part,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23353,of,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23354,the,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23355,Mediterranean,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23356,diet,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23357,",",O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23358,together,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23359,with,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23360,abundant,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23361,and,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23362,variable,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23363,plant,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23364,foods,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23365,",",O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23366,high,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23367,consumption,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23368,of,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23369,cereals,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23370,",",O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23371,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23372,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23373,as,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23374,the,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23375,main,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23376,(,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23377,added,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23378,),O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23379,fat,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23380,and,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23381,a,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23382,low,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23383,intake,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23384,of,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23385,(,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23386,red,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23387,),O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23388,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23389,.,O,782.0,"Moderate wine drinking is part of the Mediterranean diet , together with abundant and variable plant foods , high consumption of cereals , olive oil as the main ( added ) fat and a low intake of ( red ) meat ."
23474,Yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23475,intake,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23476,has,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23477,received,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23478,special,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23479,attention,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23480,because,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23481,its,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23482,association,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23483,with,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23484,health,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23485,benefits,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23486,is,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23487,more,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23488,consistent,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23489,than,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23490,that,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23491,of,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23492,other,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23493,types,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23494,of,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23495,dairy,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23496,products,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23497,.,O,786.0,Yogurt intake has received special attention because its association with health benefits is more consistent than that of other types of dairy products .
23520,We,O,788.0,We also discuss the possible mechanisms involved in these associations .
23521,also,O,788.0,We also discuss the possible mechanisms involved in these associations .
23522,discuss,O,788.0,We also discuss the possible mechanisms involved in these associations .
23523,the,O,788.0,We also discuss the possible mechanisms involved in these associations .
23524,possible,O,788.0,We also discuss the possible mechanisms involved in these associations .
23525,mechanisms,O,788.0,We also discuss the possible mechanisms involved in these associations .
23526,involved,O,788.0,We also discuss the possible mechanisms involved in these associations .
23527,in,O,788.0,We also discuss the possible mechanisms involved in these associations .
23528,these,O,788.0,We also discuss the possible mechanisms involved in these associations .
23529,associations,O,788.0,We also discuss the possible mechanisms involved in these associations .
23530,.,O,788.0,We also discuss the possible mechanisms involved in these associations .
23626,The,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23627,intake,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23628,of,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23629,fermented,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23630,dairy,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23631,products,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23632,",",O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23633,especially,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23634,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23635,",",O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23636,has,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23637,been,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23638,inversely,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23639,associated,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23640,with,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23641,variables,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23642,of,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23643,glucose,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23644,metabolism,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
23645,.,O,792.0,"The intake of fermented dairy products , especially yogurt , has been inversely associated with variables of glucose metabolism ."
24084,Pasteurization,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24085,alone,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24086,led,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24087,to,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24088,increased,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24089,uptake,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24090,of,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24091,water,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24092,and,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24093,nonviable,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24094,tofus,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24095,.,O,808.0,Pasteurization alone led to increased uptake of water and nonviable tofus .
24424,They,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24425,have,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24426,been,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24427,shown,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24428,to,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24429,improve,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24430,mineral,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24431,balance,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24432,and,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24433,bone,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24434,properties,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24435,as,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24436,well,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24437,as,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24438,causing,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24439,increases,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24440,in,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24441,bifidobacteria,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24442,in,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24443,the,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24444,gut,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24445,",",O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24446,therefore,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24447,a,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24448,prebiotic,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24449,effect,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24450,.,O,823.0,"They have been shown to improve mineral balance and bone properties as well as causing increases in bifidobacteria in the gut , therefore a prebiotic effect ."
24681,Conditional,O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24682,logistic,O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24683,regression,O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24684,models,O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24685,were,O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24686,used,O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24687,to,O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24688,calculate,O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24689,odds,O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24690,ratios,O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24691,(,O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24692,ORs,O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24693,),O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24694,and,O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24695,95,O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24696,%,O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24697,confidence,O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24698,intervals,O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24699,(,O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24700,95,O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24701,%,O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24702,CIs,O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24703,),O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
24704,.,O,833.0,Conditional logistic regression models were used to calculate odds ratios ( ORs ) and 95 % confidence intervals ( 95 % CIs ) .
25067,Rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005;http://purl.bioontology.org/ontology/SNOMEDCT/391858005,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25068,bran,I-http://purl.bioontology.org/ontology/SNOMEDCT/67324005;http://purl.bioontology.org/ontology/SNOMEDCT/391858005,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25069,and,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25070,barley,B-http://purl.bioontology.org/ontology/SNOMEDCT/735124003,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25071,may,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25072,also,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25073,lower,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25074,cholesterol,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25075,but,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25076,most,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25077,people,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25078,do,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25079,not,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25080,eat,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25081,enough,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25082,barley,B-http://purl.bioontology.org/ontology/SNOMEDCT/735124003,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25083,to,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25084,have,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25085,an,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25086,effect,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25087,.,O,846.0,Rice bran and barley may also lower cholesterol but most people do not eat enough barley to have an effect .
25150,This,O,849.0,This confirms an earlier report from a small British cohort .
25151,confirms,O,849.0,This confirms an earlier report from a small British cohort .
25152,an,O,849.0,This confirms an earlier report from a small British cohort .
25153,earlier,O,849.0,This confirms an earlier report from a small British cohort .
25154,report,O,849.0,This confirms an earlier report from a small British cohort .
25155,from,O,849.0,This confirms an earlier report from a small British cohort .
25156,a,O,849.0,This confirms an earlier report from a small British cohort .
25157,small,O,849.0,This confirms an earlier report from a small British cohort .
25158,British,O,849.0,This confirms an earlier report from a small British cohort .
25159,cohort,O,849.0,This confirms an earlier report from a small British cohort .
25160,.,O,849.0,This confirms an earlier report from a small British cohort .
25161,The,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25162,protective,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25163,effect,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25164,does,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25165,not,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25166,seem,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25167,to,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25168,be,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25169,due,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25170,to,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25171,cholesterol,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25172,-,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25173,lowering,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25174,.,O,850.0,The protective effect does not seem to be due to cholesterol - lowering .
25310,Men,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25311,reported,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25312,eating,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25313,eggs,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25314,",",O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25315,whole,B-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25316,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25317,",",O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25318,butter,B-http://purl.bioontology.org/ontology/SNOMEDCT/226888007,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25319,",",O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25320,white,B-http://purl.bioontology.org/ontology/SNOMEDCT/226590000;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25321,bread,I-http://purl.bioontology.org/ontology/SNOMEDCT/226590000;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25322,",",O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25323,cereals,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25324,",",O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25325,and,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25326,candy,B-http://purl.bioontology.org/ontology/SNOMEDCT/227607007,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25327,less,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25328,frequently,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25329,and,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25330,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25331,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25332,",",O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25333,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25334,",",O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25335,low,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25336,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25337,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25338,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25339,",",O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25340,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25341,",",O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25342,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25343,",",O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25344,ice,B-http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25345,cream,I-http://purl.bioontology.org/ontology/SNOMEDCT/227708009;http://purl.bioontology.org/ontology/SNOMEDCT/255621006,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25346,",",O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25347,margarine,B-http://purl.bioontology.org/ontology/SNOMEDCT/226890008,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25348,",",O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25349,fruits,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25350,and,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25351,vegetables,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25352,",",O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25353,and,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25354,whole,B-http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25355,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25356,wheat,I-http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25357,bread,I-http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25358,more,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25359,frequently,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25360,as,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25361,adults,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25362,",",O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25363,indicating,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25364,that,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25365,diets,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25366,changed,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25367,in,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25368,the,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25369,hypothesized,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25370,direction,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25371,to,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25372,correspond,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25373,to,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25374,national,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25375,changes,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25376,in,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25377,food,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25378,-,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25379,consumption,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25380,practices,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25381,.,O,855.0,"Men reported eating eggs , whole milk , butter , white bread , cereals , and candy less frequently and red meat , fish , low - fat milk , cheese , yogurt , ice cream , margarine , fruits and vegetables , and whole - wheat bread more frequently as adults , indicating that diets changed in the hypothesized direction to correspond to national changes in food - consumption practices ."
25617,Young,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25618,Holstein,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25619,male,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25620,calves,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25621,",",O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25622,fitted,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25623,with,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25624,re,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25625,-,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25626,entrant,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25627,duodenal,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25628,fistulae,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25629,",",O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25630,were,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25631,fed,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25632,25,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25633,%,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25634,fat,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25635,milk,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25636,replacers,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25637,containing,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25638,either,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25639,butter,B-http://purl.bioontology.org/ontology/SNOMEDCT/226888007,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25640,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/226888007,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25641,",",O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25642,lard,B-http://purl.bioontology.org/ontology/SNOMEDCT/226899009,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25643,",",O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25644,or,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25645,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25646,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25647,in,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25648,a,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25649,3,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25650,X,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25651,3,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25652,Latin,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25653,square,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25654,experiment,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25655,.,O,864.0,"Young Holstein male calves , fitted with re - entrant duodenal fistulae , were fed 25 % fat milk replacers containing either butter oil , lard , or corn oil in a 3 X 3 Latin square experiment ."
25825,Fecal,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25826,dry,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25827,matter,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25828,",",O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25829,a,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25830,measure,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25831,of,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25832,the,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25833,severity,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25834,of,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25835,diarrhea,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25836,",",O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25837,was,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25838,markedly,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25839,lower,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25840,for,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25841,the,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25842,milk,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25843,replacer,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25844,filled,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25845,with,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25846,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25847,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25848,than,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25849,for,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25850,the,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25851,other,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25852,two,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25853,milk,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25854,replacers,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25855,.,O,873.0,"Fecal dry matter , a measure of the severity of diarrhea , was markedly lower for the milk replacer filled with corn oil than for the other two milk replacers ."
25890,It,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25891,is,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25892,the,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25893,main,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25894,glycoside,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25895,in,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25896,olives,B-http://purl.bioontology.org/ontology/SNOMEDCT/227436000,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25897,",",O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25898,the,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25899,degradation,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25900,of,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25901,which,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25902,results,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25903,in,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25904,the,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25905,formation,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25906,of,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25907,hydroxytyrosol,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25908,in,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25909,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25910,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
25911,.,O,876.0,"It is the main glycoside in olives , the degradation of which results in the formation of hydroxytyrosol in olive oil ."
26293,This,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26294,review,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26295,summarizes,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26296,the,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26297,main,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26298,protective,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26299,effects,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26300,on,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26301,the,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26302,cardiovascular,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26303,system,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26304,and,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26305,cancer,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26306,resulting,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26307,from,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26308,moderate,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26309,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26310,and,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26311,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26312,intake,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26313,due,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26314,mainly,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26315,to,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26316,their,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26317,common,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26318,components,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26319,",",O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26320,alcohol,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26321,and,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26322,polyphenols,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26323,.,O,890.0,"This review summarizes the main protective effects on the cardiovascular system and cancer resulting from moderate wine and beer intake due mainly to their common components , alcohol and polyphenols ."
26526,Hygiene,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26527,and,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26528,milk,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26529,processing,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26530,capability,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26531,and,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26532,shelf,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26533,life,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26534,of,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26535,products,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26536,can,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26537,be,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26538,improved,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26539,.,O,900.0,Hygiene and milk processing capability and shelf life of products can be improved .
26656,Training,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26657,-,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26658,of,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26659,-,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26660,trainers,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26661,workshops,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26662,in,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26663,milk,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26664,processing,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26665,and,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26666,hygiene,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26667,were,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26668,developed,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26669,and,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26670,given,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26671,in,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26672,Rwanda,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26673,and,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26674,Nepal,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26675,based,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26676,on,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26677,the,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26678,rapid,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26679,needs,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26680,assessments,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26681,",",O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26682,and,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26683,these,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26684,were,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26685,well,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26686,received,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26687,.,O,904.0,"Training - of - trainers workshops in milk processing and hygiene were developed and given in Rwanda and Nepal based on the rapid needs assessments , and these were well received ."
26742,Continued,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26743,improvements,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26744,in,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26745,the,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26746,dairy,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26747,value,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26748,chain,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26749,depend,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26750,on,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26751,available,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26752,resources,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26753,for,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26754,education,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
26755,.,O,907.0,Continued improvements in the dairy value chain depend on available resources for education .
27067,Male,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27068,Wistar,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27069,rats,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27070,fed,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27071,lifelong,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27072,on,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27073,diets,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27074,differing,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27075,in,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27076,the,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27077,fat,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27078,source,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27079,were,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27080,killed,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27081,at,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27082,6,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27083,and,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27084,at,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27085,24,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27086,months,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27087,of,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27088,age,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27089,.,O,917.0,Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age .
27137,Sunflower,O,921.0,"Sunflower oil induced fibrosis , ultrastructural alterations and high oxidation ."
27138,oil,O,921.0,"Sunflower oil induced fibrosis , ultrastructural alterations and high oxidation ."
27139,induced,O,921.0,"Sunflower oil induced fibrosis , ultrastructural alterations and high oxidation ."
27140,fibrosis,O,921.0,"Sunflower oil induced fibrosis , ultrastructural alterations and high oxidation ."
27141,",",O,921.0,"Sunflower oil induced fibrosis , ultrastructural alterations and high oxidation ."
27142,ultrastructural,O,921.0,"Sunflower oil induced fibrosis , ultrastructural alterations and high oxidation ."
27143,alterations,O,921.0,"Sunflower oil induced fibrosis , ultrastructural alterations and high oxidation ."
27144,and,O,921.0,"Sunflower oil induced fibrosis , ultrastructural alterations and high oxidation ."
27145,high,O,921.0,"Sunflower oil induced fibrosis , ultrastructural alterations and high oxidation ."
27146,oxidation,O,921.0,"Sunflower oil induced fibrosis , ultrastructural alterations and high oxidation ."
27147,.,O,921.0,"Sunflower oil induced fibrosis , ultrastructural alterations and high oxidation ."
27238,Non,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27239,-,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27240,selective,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27241,use,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27242,of,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27243,pesticide,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27244,to,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27245,increase,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27246,productivity,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27247,leaves,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27248,residues,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27249,on,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27250,crops,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27251,.,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27376,The,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27377,results,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27378,showed,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27379,that,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27380,the,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27381,greatest,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27382,reduction,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27383,of,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27384,deltamethrin,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27385,",",O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27386,cypermethrin,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27387,",",O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27388,chlorpyrifos,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27389,and,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27390,endosulfan,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27391,with,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27392,10,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27393,%,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27394,acetic,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27395,acid,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27396,was,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27397,(,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27398,79.68,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27399, ,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27400,±,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27401, ,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27402,0.81,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27403,%,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27404,),O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27405,",",O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27406,(,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27407,89.99,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27408, ,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27409,±,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27410, ,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27411,0.12,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27412,%,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27413,),O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27414,",",O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27415,(,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27416,94.21,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27417, ,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27418,±,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27419, ,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27420,0.02,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27421,%,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27422,),O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27423,and,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27424,(,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27425,70.32,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27426, ,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27427,±,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27428, ,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27429,0.25,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27430,%,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27431,),O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27432,",",O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27433,respectively,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27434,of,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27435,tested,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27436,washing,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27437,solutions,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27438,.,O,930.0,"The results showed that the greatest reduction of deltamethrin , cypermethrin , chlorpyrifos and endosulfan with 10 % acetic acid was ( 79.68   ±   0.81 % ) , ( 89.99   ±   0.12 % ) , ( 94.21   ±   0.02 % ) and ( 70.32   ±   0.25 % ) , respectively of tested washing solutions ."
27520,The,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27521,dietary,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27522,guidelines,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27523,are,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27524,based,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27525,on,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27526,29,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27527,systematic,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27528,reviews,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27529,of,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27530,English,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27531,language,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27532,meta,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27533,-,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27534,analyses,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27535,in,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27536,PubMed,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27537,summarizing,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27538,randomized,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27539,controlled,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27540,trials,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27541,and,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27542,prospective,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27543,cohort,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27544,studies,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27545,on,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27546,nutrients,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27547,",",O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27548,foods,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27549,and,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27550,food,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27551,patterns,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27552,and,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27553,the,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27554,risk,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27555,of,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27556,10,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27557,major,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27558,chronic,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27559,diseases,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27560,:,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27561,coronary,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27562,heart,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27563,disease,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27564,",",O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27565,stroke,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27566,",",O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27567,heart,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27568,failure,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27569,",",O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27570,diabetes,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27571,",",O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27572,breast,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27573,cancer,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27574,",",O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27575,colorectal,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27576,cancer,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27577,",",O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27578,lung,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27579,cancer,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27580,",",O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27581,chronic,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27582,obstructive,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27583,pulmonary,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27584,disease,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27585,",",O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27586,dementia,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27587,and,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27588,depression,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27589,.,O,934.0,"The dietary guidelines are based on 29 systematic reviews of English language meta - analyses in PubMed summarizing randomized controlled trials and prospective cohort studies on nutrients , foods and food patterns and the risk of 10 major chronic diseases : coronary heart disease , stroke , heart failure , diabetes , breast cancer , colorectal cancer , lung cancer , chronic obstructive pulmonary disease , dementia and depression ."
27684,Plausible,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27685,evidence,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27686,was,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27687,based,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27688,on,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27689,strong,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27690,evidence,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27691,from,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27692,prospective,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27693,cohort,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27694,studies,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27695,only,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27696,.,O,939.0,Plausible evidence was based on strong evidence from prospective cohort studies only .
27757,Three,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27758,guidelines,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27759,on,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27760,vegetables,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27761,",",O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27762,fruits,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27763,",",O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27764,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27765,and,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27766,alcoholic,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27767,beverages,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27768,have,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27769,been,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27770,sharpened,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27771,",",O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27772,and,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27773,the,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27774,2006,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27775,guideline,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27776,on,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27777,salt,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27778,stayed,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27779,the,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27780,same,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
27781,.,O,942.0,"Three guidelines on vegetables , fruits , fish and alcoholic beverages have been sharpened , and the 2006 guideline on salt stayed the same ."
28200,The,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28201,magnitude,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28202,and,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28203,strength,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28204,of,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28205,the,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28206,association,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28207,for,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28208,mate,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28209,amount,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28210,and,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28211,",",O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28212,to,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28213,a,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28214,lesser,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28215,extent,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28216,",",O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28217,mate,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28218,temperature,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28219,were,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28220,higher,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28221,for,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28222,women,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28223,than,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28224,men,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28225,.,O,956.0,"The magnitude and strength of the association for mate amount and , to a lesser extent , mate temperature were higher for women than men ."
28226,The,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28227,joint,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28228,effects,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28229,of,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28230,mate,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28231,amount,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28232,and,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28233,mate,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28234,temperature,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28235,were,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28236,more,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28237,than,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28238,multiplicative,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28239,",",O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28240,following,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28241,a,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28242,statistically,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28243,significant,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28244,synergistic,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28245,interaction,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28246,(,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28247,p,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28248,=,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28249,0.02,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28250,),O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28251,which,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28252,was,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28253,particularly,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28254,evident,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28255,among,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28256,heavy,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28257,drinkers,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28258,(,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28259,>,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28260,1.50,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28261,l,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28262,/,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28263,day,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28264,),O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28265,of,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28266,very,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28267,hot,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28268,mate,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28269,(,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28270,odds,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28271,ratio,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28272,=,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28273,4.14,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28274,",",O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28275,95,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28276,%,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28277,confidence,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28278,interval,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28279,:,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28280,2.24,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28281,-,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28282,7.67,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28283,),O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28284,compared,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28285,to,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28286,light,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28287,drinkers,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28288,(,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28289,<,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28290,0.50,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28291,l,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28292,/,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28293,day,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28294,),O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28295,of,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28296,cold,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28297,/,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28298,warm,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28299,/,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28300,hot,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28301,mate,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28302,.,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28378,This,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28379,pooled,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28380,analysis,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28381,adds,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28382,evidence,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28383,for,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28384,a,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28385,carcinogenic,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28386,effect,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28387,of,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28388,chronic,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28389,thermal,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28390,injury,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28391,in,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28392,the,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28393,esophagus,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28394,induced,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28395,by,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28396,the,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28397,consumption,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28398,of,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28399,very,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28400,hot,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28401,drinks,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28402,",",O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28403,including,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28404,mate,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
28405,.,O,961.0,"This pooled analysis adds evidence for a carcinogenic effect of chronic thermal injury in the esophagus induced by the consumption of very hot drinks , including mate ."
29209,Fewer,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29210,studies,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29211,investigated,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29212,the,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29213,association,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29214,between,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29215,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29216,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29217,and,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29218,other,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29219,health,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29220,outcomes,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29221,such,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29222,as,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29223,cognitive,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29224,outcomes,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29225,",",O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29226,dental,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29227,health,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29228,",",O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29229,injuries,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29230,and,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29231,respiratory,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29232,disease,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29233,.,O,989.0,"Fewer studies investigated the association between green tea and other health outcomes such as cognitive outcomes , dental health , injuries and respiratory disease ."
29250,Spices,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29251,and,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29252,herbs,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29253,have,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29254,been,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29255,used,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29256,since,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29257,ancient,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29258,times,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29259,as,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29260,flavor,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29261,and,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29262,aroma,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29263,enhancers,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29264,",",O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29265,colorants,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29266,",",O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29267,preservatives,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29268,",",O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29269,and,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29270,traditional,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29271,medicines,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29272,.,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29273,There,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29274,are,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29275,more,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29276,than,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29277,30,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29278,spices,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29279,and,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29280,herbs,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29281,of,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29282,global,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29283,economic,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29284,and,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29285,culinary,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29286,importance,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29287,.,O,992.0,There are more than 30 spices and herbs of global economic and culinary importance .
29705,Herbs,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29706,and,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29707,spices,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29708,may,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29709,be,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29710,useful,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29711,for,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29712,improving,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29713,the,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29714,liking,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29715,of,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29716,lower,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29717,fat,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29718,foods,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29719,and,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29720,helping,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29721,Americans,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29722,maintain,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29723,a,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29724,diet,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29725,consistent,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29726,with,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29727,the,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29728,U.S.,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29729,Dietary,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29730,Guidelines,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29731,.,O,1007.0,Herbs and spices may be useful for improving the liking of lower fat foods and helping Americans maintain a diet consistent with the U.S. Dietary Guidelines .
29760,Male,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29761,Sprague,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29762,Dawley,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29763,rats,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29764,(,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29765,8,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29766,weeks,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29767,-,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29768,old,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29769,),O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29770,were,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29771,grouped,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29772,(,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29773,6,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29774,rats,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29775,/,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29776,group,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29777,),O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29778,in,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29779,four,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29780,experimental,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29781,groups,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29782,:,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29783,nan,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29784,(,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29785,normal,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29786,diet,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29787,and,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29788,water,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29789,),O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29790,",",O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29791,NL,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29792,(,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29793,normal,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29794,diet,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29795,and,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29796,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/226498009;http://purl.bioontology.org/ontology/SNOMEDCT/734881000;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29797,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/226498009;http://purl.bioontology.org/ontology/SNOMEDCT/734881000;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29798,),O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29799,",",O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29800,HA,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29801,(,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29802,high,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29803,-,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29804,fat,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29805,diet,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29806,and,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29807,water,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29808,),O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29809,",",O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29810,and,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29811,HL,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29812,(,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29813,high,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29814,-,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29815,fat,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29816,diet,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29817,and,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29818,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/226498009;http://purl.bioontology.org/ontology/SNOMEDCT/734881000;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29819,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/226498009;http://purl.bioontology.org/ontology/SNOMEDCT/734881000;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29820,),O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
29821,.,O,1009.0,"Male Sprague Dawley rats ( 8 weeks - old ) were grouped ( 6 rats / group ) in four experimental groups : nan ( normal diet and water ) , NL ( normal diet and tomato juice ) , HA ( high - fat diet and water ) , and HL ( high - fat diet and tomato juice ) ."
30676,However,O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30677,",",O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30678,the,O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30679,molecular,O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30680,targets,O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30681,in,O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30682,the,O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30683,genome,O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30684,are,O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30685,mostly,O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30686,unknown,O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30687,.,O,1039.0,"However , the molecular targets in the genome are mostly unknown ."
30899,To,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30900,assess,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30901,gene,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30902,expression,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30903,changes,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30904,",",O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30905,colonic,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30906,mucosal,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30907,cells,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30908,were,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30909,collected,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30910,after,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30911,the,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30912,mice,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30913,were,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30914,killed,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
30915,.,O,1043.0,"To assess gene expression changes , colonic mucosal cells were collected after the mice were killed ."
31131,One,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31132,of,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31133,the,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31134,reasons,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31135,is,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31136,that,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31137,these,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31138,studies,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31139,have,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31140,often,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31141,been,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31142,conducted,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31143,at,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31144,doses,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31145,or,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31146,concentrations,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31147,far,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31148,beyond,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31149,those,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31150,documented,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31151,in,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31152,humans,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31153,.,O,1053.0,One of the reasons is that these studies have often been conducted at doses or concentrations far beyond those documented in humans .
31900,In,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31901,African,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31902,-,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31903,Americans,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31904,",",O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31905,frequent,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31906,intake,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31907,of,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31908,dairy,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31909,foods,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31910,was,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31911,associated,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31912,with,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31913,a,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31914,doubling,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31915,in,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31916,risk,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31917,(,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31918,OR,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31919,=,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31920,1.9,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31921,",",O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31922,95,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31923,%,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31924,CI,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31925,=,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31926,1.1,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31927,-,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31928,3.4,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31929,),O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31930,in,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31931,non,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31932,-,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31933,energy,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31934,-,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31935,adjusted,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31936,models,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31937,",",O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31938,whereas,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31939,frequent,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31940,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31941,consumption,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31942,correlated,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31943,with,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31944,a,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31945,non,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31946,-,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31947,significant,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31948,30,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31949,%,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31950,lower,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31951,risk,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
31952,.,O,1082.0,"In African - Americans , frequent intake of dairy foods was associated with a doubling in risk ( OR = 1.9 , 95 % CI = 1.1 - 3.4 ) in non - energy - adjusted models , whereas frequent fruit consumption correlated with a non - significant 30 % lower risk ."
32240,Many,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32241,varieties,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32242,are,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32243,growing,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32244,around,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32245,the,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32246,world,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32247,",",O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32248,but,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32249,mainly,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32250,in,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32251,the,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32252,north,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32253,hemisphere,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32254,.,O,1095.0,"Many varieties are growing around the world , but mainly in the north hemisphere ."
32506,Methods,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32507,to,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32508,exploit,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32509,buckwheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/226723006,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32510,seeds,I-http://purl.bioontology.org/ontology/SNOMEDCT/226723006,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32511,and,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32512,flour,B-http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32513,to,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32514,produce,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32515,highly,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32516,effective,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32517,nutraceuticals,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32518,are,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32519,also,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32520,reviewed,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
32521,.,O,1106.0,Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed .
33506,are,O,1141.0,are now gaining importance .
33507,now,O,1141.0,are now gaining importance .
33508,gaining,O,1141.0,are now gaining importance .
33509,importance,O,1141.0,are now gaining importance .
33510,.,O,1141.0,are now gaining importance .
33645,ATPase,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33646,activity,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33647,and,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33648,the,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33649,activity,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33650,of,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33651,the,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33652,malate,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33653,-,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33654,aspartate,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33655,shuttle,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33656,were,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33657,not,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33658,affected,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33659,by,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33660,diet,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33661,.,O,1148.0,ATPase activity and the activity of the malate - aspartate shuttle were not affected by diet .
33723,Evidence,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33724,of,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33725,uncoupling,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33726,of,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33727,pyruvate,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33728,-,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33729,supported,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33730,respiration,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33731,from,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33732,ATP,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33733,synthesis,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33734,was,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33735,observed,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33736,in,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33737,mitochondria,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33738,from,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33739,rats,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33740,fed,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33741,coconut,B-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33742,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33743,but,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33744,not,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33745,in,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33746,rats,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33747,fed,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33748,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33749,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/735247006;http://purl.bioontology.org/ontology/SNOMEDCT/412357001,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
33750,.,O,1151.0,Evidence of uncoupling of pyruvate - supported respiration from ATP synthesis was observed in mitochondria from rats fed coconut oil but not in rats fed corn oil .
34040,Among,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34041,the,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34042,food,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34043,items,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34044,we,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34045,examined,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34046,",",O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34047,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34048,was,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34049,most,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34050,closely,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34051,correlated,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34052,with,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34053,the,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34054,incidence,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34055,of,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34056,testicular,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34057,cancer,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34058,at,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34059,ages,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34060,20,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34061,-,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34062,39,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34063,",",O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34064,followed,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34065,by,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34066,animal,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34067,fats,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34068,and,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34069,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34070,.,O,1161.0,"Among the food items we examined , cheese was most closely correlated with the incidence of testicular cancer at ages 20 - 39 , followed by animal fats and milk ."
34102,Stepwise,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34103,-,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34104,multiple,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34105,-,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34106,regression,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34107,analysis,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34108,revealed,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34109,that,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34110,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34111,+,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34112,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34113,(,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34114,1961,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34115,-,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34116,65,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34117,),O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34118,made,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34119,a,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34120,significant,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34121,contribution,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34122,to,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34123,the,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34124,incidence,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34125,of,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34126,testicular,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34127,cancer,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34128,(,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34129,standardized,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34130,regression,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34131,coefficient,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34132,[,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34133,R,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34134,],O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34135,=,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34136,0.654,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34137,),O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34138,.,O,1163.0,Stepwise - multiple - regression analysis revealed that milk + cheese ( 1961 - 65 ) made a significant contribution to the incidence of testicular cancer ( standardized regression coefficient [ R ] = 0.654 ) .
34251,The,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34252,results,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34253,of,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34254,our,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34255,study,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34256,suggest,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34257,a,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34258,role,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34259,of,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34260,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34261,and,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34262,dairy,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34263,products,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34264,in,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34265,the,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34266,development,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34267,and,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34268,growth,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34269,of,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34270,testicular,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34271,and,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34272,prostatic,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34273,cancers,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34274,.,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34581,These,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34582,effects,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34583,are,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34584,mainly,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34585,attributed,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34586,to,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34587,its,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34588,rich,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34589,dietary,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34590,fibers,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34591,",",O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34592,i.e.,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34593,",",O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34594,β,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34595,-,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34596,glucan,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34597,composition,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
34598,.,O,1179.0,"These effects are mainly attributed to its rich dietary fibers , i.e. , β - glucan composition ."
35082,The,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35083,aim,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35084,of,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35085,this,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35086,study,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35087,was,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35088,to,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35089,develop,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35090,a,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35091,rapid,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35092,",",O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35093,sensitive,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35094,",",O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35095,and,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35096,specific,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35097,enzyme,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35098,-,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35099,linked,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35100,immunosorbent,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35101,assay,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35102,(,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35103,ELISA,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35104,),O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35105,method,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35106,for,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35107,the,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35108,detection,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35109,of,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35110,walnut,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35111,protein,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35112,residues,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35113,.,O,1196.0,"The aim of this study was to develop a rapid , sensitive , and specific enzyme - linked immunosorbent assay ( ELISA ) method for the detection of walnut protein residues ."
35300,This,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35301,walnut,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35302,ELISA,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35303,can,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35304,be,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35305,used,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35306,to,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35307,detect,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35308,undeclared,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35309,walnut,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35310,residues,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35311,in,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35312,foods,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35313,and,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35314,ingredients,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35315,and,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35316,as,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35317,a,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35318,tool,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35319,to,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35320,validate,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35321,the,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35322,effectiveness,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35323,of,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35324,allergen,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35325,control,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35326,programs,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35327,for,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35328,walnuts,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35329,.,O,1203.0,This walnut ELISA can be used to detect undeclared walnut residues in foods and ingredients and as a tool to validate the effectiveness of allergen control programs for walnuts .
35707,The,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35708,ingestion,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35709,of,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35710,perchlorate,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35711,is,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35712,of,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35713,concern,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35714,because,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35715,of,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35716,its,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35717,ability,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35718,to,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35719,competitively,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35720,inhibit,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35721,iodide,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35722,uptake,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35723,by,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35724,the,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35725,thyroid,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35726,and,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35727,to,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35728,impair,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35729,synthesis,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35730,of,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35731,thyroid,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35732,hormones,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35733,.,O,1222.0,The ingestion of perchlorate is of concern because of its ability to competitively inhibit iodide uptake by the thyroid and to impair synthesis of thyroid hormones .
35863,Five,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35864,days,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35865,after,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35866,the,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35867,initiation,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35868,of,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35869,ruminal,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35870,infusions,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35871,",",O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35872,experimental,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35873,mastitis,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35874,was,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35875,induced,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35876,by,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35877,the,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35878,intramammary,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35879,infusion,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35880,of,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35881,100,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35882,microg,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35883,of,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35884,bacterial,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35885,lipopolysaccharide,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35886,(,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35887,LPS,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35888,),O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35889,.,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
36619,The,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36620,evidence,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36621,is,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36622,summarised,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36623,in,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36624,the,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36625,2018,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36626,World,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36627,Cancer,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36628,Research,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36629,Fund,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36630,/,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36631,American,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36632,Institute,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36633,for,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36634,Cancer,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36635,Research,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36636,report,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36637,Diet,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36638,",",O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36639,Nutrition,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36640,",",O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36641,Physical,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36642,Activity,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36643,and,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36644,Cancer,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36645,:,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36646,a,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36647,Global,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36648,Perspective,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36649,.,O,1253.0,"The evidence is summarised in the 2018 World Cancer Research Fund / American Institute for Cancer Research report Diet , Nutrition , Physical Activity and Cancer : a Global Perspective ."
36737,Cancer,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36738,protection,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36739,mainly,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36740,derives,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36741,from,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36742,a,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36743,systemic,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36744,metabolic,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36745,environment,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36746,that,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36747,promotes,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36748,healthy,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36749,cell,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36750,replication,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36751,and,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36752,tissue,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36753,integrity,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
36754,.,O,1257.0,Cancer protection mainly derives from a systemic metabolic environment that promotes healthy cell replication and tissue integrity .
37200,Individual,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37201,NOAELs,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37202,and,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37203,LOAELs,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37204,were,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37205,obtained,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37206,from,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37207,clinical,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37208,challenges,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37209,of,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37210,food,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37211,-,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37212,allergic,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37213,subjects,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37214,.,O,1273.0,Individual NOAELs and LOAELs were obtained from clinical challenges of food - allergic subjects .
37661,Processed,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37662,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37663,intake,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37664,is,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37665,associated,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37666,with,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37667,increased,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37668,risk,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37669,of,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37670,colorectal,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37671,cancer,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37672,.,O,1290.0,Processed meat intake is associated with increased risk of colorectal cancer .
37886,Rats,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37887,fed,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37888,a,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37889,diet,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37890,based,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37891,on,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37892,beef,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37893,",",O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37894,pork,B-http://purl.bioontology.org/ontology/SNOMEDCT/226934003,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37895,",",O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37896,or,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37897,chicken,B-http://purl.bioontology.org/ontology/SNOMEDCT/226955001;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37898,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226955001;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37899,had,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37900,less,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37901,fecal,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37902,NOC,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37903,than,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37904,controls,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37905,(,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37906,most,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37907,p,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37908,<,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37909,0.01,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37910,),O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
37911,.,O,1300.0,"Rats fed a diet based on beef , pork , or chicken meat had less fecal NOC than controls ( most p < 0.01 ) ."
38587,Only,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38588,the,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38589,papaya,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38590,extract,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38591,had,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38592,a,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38593,significant,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38594,antiproliferative,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38595,effect,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38596,measured,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38597,with,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38598,the,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38599,methylthiazolydiphenyl,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38600,-,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38601,tetrazolium,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38602,bromide,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38603,assay,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38604,.,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38772,Alcohol,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38773,consumption,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38774,was,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38775,categorized,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38776,into,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38777,amounts,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38778,consumed,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38779,(,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38780,grams,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38781,per,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38782,day,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38783,),O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38784,and,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38785,also,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38786,modelled,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38787,as,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38788,a,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38789,continuous,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38790,variable,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38791,using,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38792,restricted,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38793,cubic,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38794,splines,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38795,for,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38796,potential,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38797,non,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38798,-,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38799,linearity,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
38800,.,O,1334.0,Alcohol consumption was categorized into amounts consumed ( grams per day ) and also modelled as a continuous variable using restricted cubic splines for potential non - linearity .
39005,Confounding,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39006,in,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39007,relation,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39008,to,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39009,the,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39010,non,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39011,-,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39012,drinker,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39013,reference,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39014,category,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39015,may,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39016,be,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39017,of,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39018,particular,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39019,importance,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39020,.,O,1341.0,Confounding in relation to the non - drinker reference category may be of particular importance .
39294,We,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39295,also,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39296,discuss,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39297,the,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39298,major,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39299,contribution,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39300,of,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39301,obesity,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39302,and,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39303,alcohol,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39304,to,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39305,the,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39306,ten,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39307,most,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39308,common,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39309,cancers,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39310,as,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39311,well,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39312,as,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39313,measures,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39314,outlined,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39315,by,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39316,the,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39317,departing,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39318,Chief,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39319,Medical,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39320,Officer,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39321,to,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39322,combat,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39323,rising,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39324,levels,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39325,of,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39326,obesity,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39327,-,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39328,the,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39329,highest,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39330,of,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39331,any,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39332,country,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39333,in,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39334,the,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39335,west,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39336,.,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
40432,Height,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40433,",",O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40434,weight,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40435,",",O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40436,and,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40437,triceps,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40438,skinfolds,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40439,were,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40440,measured,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40441,.,O,1386.0,"Height , weight , and triceps skinfolds were measured ."
40537,More,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40538,overweight,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40539,than,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40540,thin,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40541,and,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40542,normal,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40543,-,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40544,weight,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40545,children,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40546,indicated,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40547,that,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40548,",",O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40549,to,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40550,prevent,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40551,obesity,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40552,",",O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40553,all,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40554,kinds,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40555,of,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40556,food,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40557,are,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40558,permissible,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40559,",",O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40560,but,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40561,only,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40562,in,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40563,limited,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40564,amounts,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40565,.,O,1390.0,"More overweight than thin and normal - weight children indicated that , to prevent obesity , all kinds of food are permissible , but only in limited amounts ."
40590,The,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40591,belief,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40592,in,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40593,the,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40594,fattening,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40595,value,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40596,of,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40597,potatoes,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40598,",",O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40599,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40600,",",O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40601,and,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40602,nuts,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40603,was,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40604,shared,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40605,by,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40606,a,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40607,higher,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40608,percentage,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40609,of,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40610,overweight,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40611,than,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40612,of,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40613,under-,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40614,and,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40615,normal,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40616,-,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40617,weight,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40618,children,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40619,.,O,1392.0,"The belief in the fattening value of potatoes , bread , and nuts was shared by a higher percentage of overweight than of under- and normal - weight children ."
40882,This,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40883,reduction,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40884,in,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40885,concentration,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40886,of,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40887,fecal,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40888,water,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40889,surfactants,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40890,resulted,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40891,in,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40892,a,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40893,lower,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40894,cytotoxicity,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40895,of,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40896,fecal,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40897,water,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
40898,.,O,1401.0,This reduction in concentration of fecal water surfactants resulted in a lower cytotoxicity of fecal water .
41136,In,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41137,40,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41138,-,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41139,42,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41140,-,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41141,y,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41142,-,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41143,old,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41144,men,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41145,",",O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41146,mean,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41147,tHcy,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41148,was,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41149,10.1,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41150,mumol,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41151,/,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41152,L,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41153,for,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41154,nonusers,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41155,and,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41156,12.0,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41157,mumol,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41158,/,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41159,L,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41160,for,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41161,drinkers,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41162,of,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41163,>,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41164,or,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41165,=,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41166,9,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41167,cups,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41168,of,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41169,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41170,/,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41171,d.,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41172,Corresponding,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41173,tHcy,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41174,concentrations,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41175,in,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41176,40,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41177,-,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41178,42,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41179,-,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41180,y,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41181,-,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41182,old,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41183,women,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41184,were,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41185,8.2,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41186,and,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41187,10.5,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41188,mumol,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41189,/,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41190,L,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41191,",",O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41192,respectively,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41193,.,O,1411.0,"In 40 - 42 - y - old men , mean tHcy was 10.1 mumol / L for nonusers and 12.0 mumol / L for drinkers of > or = 9 cups of coffee / d. Corresponding tHcy concentrations in 40 - 42 - y - old women were 8.2 and 10.5 mumol / L , respectively ."
41269,The,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41270,results,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41271,of,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41272,the,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41273,present,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41274,report,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41275,should,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41276,promote,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41277,future,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41278,studies,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41279,on,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41280,tHcy,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41281,as,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41282,a,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41283,possible,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41284,mediator,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41285,of,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41286,adverse,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41287,clinical,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41288,effects,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41289,related,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41290,to,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41291,heavy,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41292,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41293,consumption,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41294,.,O,1415.0,The results of the present report should promote future studies on tHcy as a possible mediator of adverse clinical effects related to heavy coffee consumption .
41404,Glycemic,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41405,indices,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41406,for,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41407,the,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41408,rice,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41409,(,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41410,38,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41411,+,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41412,/-,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41413,6,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41414,),O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41415,and,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41416,almond,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41417,meals,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41418,(,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41419,55,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41420,+,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41421,/-,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41422,7,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41423,),O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41424,were,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41425,less,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41426,than,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41427,for,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41428,the,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41429,potato,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41430,meal,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41431,(,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41432,94,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41433,+,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41434,/-,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41435,11,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41436,),O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41437,(,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41438,P,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41439,<,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41440,0.003,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41441,),O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41442,",",O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41443,as,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41444,were,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41445,the,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41446,postprandial,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41447,areas,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41448,under,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41449,the,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41450,insulin,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41451,concentration,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41452,time,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41453,curve,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41454,(,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41455,P,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41456,<,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41457,0.001,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41458,),O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41459,.,O,1420.0,"Glycemic indices for the rice ( 38 + /- 6 ) and almond meals ( 55 + /- 7 ) were less than for the potato meal ( 94 + /- 11 ) ( P < 0.003 ) , as were the postprandial areas under the insulin concentration time curve ( P < 0.001 ) ."
41634,Flavonoids,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41635,have,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41636,anti,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41637,-,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41638,inflammatory,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41639,and,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41640,antioxidative,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41641,effects,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41642,and,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41643,thus,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41644,may,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41645,protect,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41646,against,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41647,diabetes,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41648,.,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
42073,Higher,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42074,scores,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42075,of,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42076,the,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42077,meat,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42078,-,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42079,convenience,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42080,dietary,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42081,pattern,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42082,(,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42083,high,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42084,intake,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42085,of,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42086,deep,B-http://purl.bioontology.org/ontology/SNOMEDCT/819010002;http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42087,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/819010002;http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42088,fried,I-http://purl.bioontology.org/ontology/SNOMEDCT/819010002;http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42089,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/819010002;http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42090,processed,I-http://purl.bioontology.org/ontology/SNOMEDCT/819010002;http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42091,food,I-http://purl.bioontology.org/ontology/SNOMEDCT/819010002;http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42092,",",O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42093,sauces,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42094,",",O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42095,sugar,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42096,-,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42097,added,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42098,beverages,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42099,",",O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42100,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42101,and,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42102,organ,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42103,meats,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42104,",",O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42105,instant,B-http://purl.bioontology.org/ontology/SNOMEDCT/226735005,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42106,noodles,I-http://purl.bioontology.org/ontology/SNOMEDCT/226735005,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42107,",",O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42108,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42109,or,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42110,flour,B-http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42111,cooked,I-http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42112,in,I-http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42113,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42114,",",O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42115,and,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42116,eggs,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42117,),O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42118,had,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42119,no,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42120,association,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42121,with,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42122,components,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42123,of,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42124,dyslipidemia,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42125,and,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42126,abnormal,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42127,FPG,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
42128,.,O,1445.0,"Higher scores of the meat - convenience dietary pattern ( high intake of deep - fried and processed food , sauces , sugar - added beverages , meat and organ meats , instant noodles , rice or flour cooked in oil , and eggs ) had no association with components of dyslipidemia and abnormal FPG ."
43037,Red,B-http://purl.bioontology.org/ontology/SNOMEDCT/227563001,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43038,pepper,I-http://purl.bioontology.org/ontology/SNOMEDCT/227563001,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43039,had,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43040,the,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43041,highest,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43042,total,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43043,antioxidant,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43044,activity,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43045,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43046,followed,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43047,by,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43048,broccoli,B-http://purl.bioontology.org/ontology/SNOMEDCT/735123009,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43049,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43050,carrot,B-http://purl.bioontology.org/ontology/SNOMEDCT/256319004,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43051,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43052,spinach,B-http://purl.bioontology.org/ontology/SNOMEDCT/256329006,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43053,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43054,cabbage,B-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43055,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43056,yellow,B-http://purl.bioontology.org/ontology/SNOMEDCT/735047000,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43057,onion,I-http://purl.bioontology.org/ontology/SNOMEDCT/735047000,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43058,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43059,celery,B-http://purl.bioontology.org/ontology/SNOMEDCT/256326004,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43060,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43061,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43062,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43063,lettuce,B-http://purl.bioontology.org/ontology/SNOMEDCT/735042006,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43064,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43065,and,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43066,cucumber,B-http://purl.bioontology.org/ontology/SNOMEDCT/735213008,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43067,.,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43138,On,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43139,the,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43140,basis,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43141,of,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43142,these,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43143,results,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43144,",",O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43145,the,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43146,bioactivity,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43147,index,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43148,(,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43149,BI,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43150,),O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43151,for,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43152,dietary,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43153,cancer,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43154,prevention,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43155,is,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43156,proposed,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43157,to,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43158,provide,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43159,a,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43160,simple,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43161,reference,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43162,for,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43163,consumers,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43164,to,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43165,choose,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43166,vegetables,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43167,in,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43168,accordance,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43169,with,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43170,their,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43171,beneficial,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43172,activities,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43173,.,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43464,Methods,O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43465,and,O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43466,Results,O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43467,Between,O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43468,2000,O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43469,and,O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43470,2002,O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43471,",",O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43472,MESA,O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43473,(,O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43474,Multi,O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43475,-,O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43476,Ethnic,O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43477,Study,O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43478,of,O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43479,Atherosclerosis,O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43480,),O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43481,enrolled,O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43482,6814,O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43483,adults,O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43484,without,O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43485,clinical,O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43486,CVD,O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43487,.,O,1493.0,"Methods and Results Between 2000 and 2002 , MESA ( Multi - Ethnic Study of Atherosclerosis ) enrolled 6814 adults without clinical CVD ."
43578,Rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1496.0,Rice intake was assessed by food frequency questionnaire .
43579,intake,O,1496.0,Rice intake was assessed by food frequency questionnaire .
43580,was,O,1496.0,Rice intake was assessed by food frequency questionnaire .
43581,assessed,O,1496.0,Rice intake was assessed by food frequency questionnaire .
43582,by,O,1496.0,Rice intake was assessed by food frequency questionnaire .
43583,food,O,1496.0,Rice intake was assessed by food frequency questionnaire .
43584,frequency,O,1496.0,Rice intake was assessed by food frequency questionnaire .
43585,questionnaire,O,1496.0,Rice intake was assessed by food frequency questionnaire .
43586,.,O,1496.0,Rice intake was assessed by food frequency questionnaire .
43739,Understanding,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43740,the,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43741,role,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43742,of,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43743,low,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43744,-,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43745,level,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43746,arsenic,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43747,as,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43748,it,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43749,relates,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43750,to,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43751,subclinical,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43752,CVD,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43753,may,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43754,contribute,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43755,to,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43756,CVD,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43757,prevention,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43758,and,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43759,control,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43760,.,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43898,Walnuts,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43899,contain,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43900,more,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43901,than,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43902,20,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43903,mmol,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43904,antioxidants,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43905,per,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43906,100,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43907,g,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43908,",",O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43909,mostly,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43910,in,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43911,the,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43912,walnut,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43913,pellicles,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43914,.,O,1511.0,"Walnuts contain more than 20 mmol antioxidants per 100 g , mostly in the walnut pellicles ."
43915,Peanuts,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43916,(,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43917,a,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43918,legume,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43919,),O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43920,also,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43921,contribute,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43922,significantly,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43923,to,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43924,dietary,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43925,intake,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43926,of,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43927,antioxidants,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
43928,.,O,1512.0,Peanuts ( a legume ) also contribute significantly to dietary intake of antioxidants .
44283,The,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44284,commonest,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44285,foods,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44286,causing,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44287,reactions,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44288,were,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44289,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/412071004,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44290,(,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44291,78,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44292,%,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44293,),O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44294,",",O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44295,orange,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44296,(,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44297,65,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44298,%,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44299,),O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44300,",",O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44301,eggs,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44302,(,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44303,45,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44304,%,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44305,),O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44306,",",O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44307,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44308,and,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44309,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44310,(,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44311,40,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44312,%,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44313,each,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44314,),O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44315,",",O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44316,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44317,and,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44318,milk,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44319,(,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44320,37,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44321,%,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44322,),O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44323,each,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44324,),O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44325,",",O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44326,beef,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44327,(,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44328,35,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44329,%,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44330,),O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44331,",",O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44332,and,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44333,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/412357001,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44334,",",O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44335,cane,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44336,sugar,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44337,",",O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44338,and,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44339,yeast,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44340,(,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44341,33,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44342,%,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44343,each,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44344,),O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44345,.,O,1526.0,"The commonest foods causing reactions were wheat ( 78 % ) , orange ( 65 % ) , eggs ( 45 % ) , tea and coffee ( 40 % each ) , chocolate and milk ( 37 % ) each ) , beef ( 35 % ) , and corn , cane sugar , and yeast ( 33 % each ) ."
44400,Both,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44401,immunological,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44402,and,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44403,non,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44404,-,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44405,immunological,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44406,mechanisms,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44407,may,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44408,play,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44409,a,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44410,part,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44411,in,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44412,the,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44413,pathogenesis,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44414,of,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44415,migraine,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44416,caused,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44417,by,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44418,food,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44419,intolerance,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
44420,.,O,1530.0,Both immunological and non - immunological mechanisms may play a part in the pathogenesis of migraine caused by food intolerance .
45829,Therefore,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45830,",",O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45831,the,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45832,inhibition,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45833,of,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45834,pol,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45835,alpha,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45836,activity,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45837,by,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45838,SQDG,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45839,may,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45840,lead,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45841,to,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45842,cell,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45843,growth,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45844,suppression,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45845,.,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
46269,Comparisons,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46270,of,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46271,diets,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46272,and,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46273,disease,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46274,rates,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46275,between,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46276,Adventists,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46277,and,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46278,non,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46279,-,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46280,Adventists,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46281,",",O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46282,and,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46283,prospective,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46284,cohort,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46285,studies,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46286,among,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46287,Adventists,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46288,",",O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46289,have,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46290,contributed,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46291,greatly,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46292,to,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46293,our,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46294,general,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46295,understanding,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46296,of,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46297,nutrition,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46298,and,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46299,health,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46300,.,O,1599.0,"Comparisons of diets and disease rates between Adventists and non - Adventists , and prospective cohort studies among Adventists , have contributed greatly to our general understanding of nutrition and health ."
46416,One,O,1605.0,One topic that may be uniquely studied among an Adventist population is the effect of soy phytoestrogens in disease prevention .
46417,topic,O,1605.0,One topic that may be uniquely studied among an Adventist population is the effect of soy phytoestrogens in disease prevention .
46418,that,O,1605.0,One topic that may be uniquely studied among an Adventist population is the effect of soy phytoestrogens in disease prevention .
46419,may,O,1605.0,One topic that may be uniquely studied among an Adventist population is the effect of soy phytoestrogens in disease prevention .
46420,be,O,1605.0,One topic that may be uniquely studied among an Adventist population is the effect of soy phytoestrogens in disease prevention .
46421,uniquely,O,1605.0,One topic that may be uniquely studied among an Adventist population is the effect of soy phytoestrogens in disease prevention .
46422,studied,O,1605.0,One topic that may be uniquely studied among an Adventist population is the effect of soy phytoestrogens in disease prevention .
46423,among,O,1605.0,One topic that may be uniquely studied among an Adventist population is the effect of soy phytoestrogens in disease prevention .
46424,an,O,1605.0,One topic that may be uniquely studied among an Adventist population is the effect of soy phytoestrogens in disease prevention .
46425,Adventist,O,1605.0,One topic that may be uniquely studied among an Adventist population is the effect of soy phytoestrogens in disease prevention .
46426,population,O,1605.0,One topic that may be uniquely studied among an Adventist population is the effect of soy phytoestrogens in disease prevention .
46427,is,O,1605.0,One topic that may be uniquely studied among an Adventist population is the effect of soy phytoestrogens in disease prevention .
46428,the,O,1605.0,One topic that may be uniquely studied among an Adventist population is the effect of soy phytoestrogens in disease prevention .
46429,effect,O,1605.0,One topic that may be uniquely studied among an Adventist population is the effect of soy phytoestrogens in disease prevention .
46430,of,O,1605.0,One topic that may be uniquely studied among an Adventist population is the effect of soy phytoestrogens in disease prevention .
46431,soy,O,1605.0,One topic that may be uniquely studied among an Adventist population is the effect of soy phytoestrogens in disease prevention .
46432,phytoestrogens,O,1605.0,One topic that may be uniquely studied among an Adventist population is the effect of soy phytoestrogens in disease prevention .
46433,in,O,1605.0,One topic that may be uniquely studied among an Adventist population is the effect of soy phytoestrogens in disease prevention .
46434,disease,O,1605.0,One topic that may be uniquely studied among an Adventist population is the effect of soy phytoestrogens in disease prevention .
46435,prevention,O,1605.0,One topic that may be uniquely studied among an Adventist population is the effect of soy phytoestrogens in disease prevention .
46436,.,O,1605.0,One topic that may be uniquely studied among an Adventist population is the effect of soy phytoestrogens in disease prevention .
46934,Vegetarian,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46935,diets,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46936,may,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46937,contain,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46938,high,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46939,amounts,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46940,of,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46941,oxalate,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46942,when,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46943,whole,B-http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/412071004,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46944,grain,I-http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/412071004,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46945,wheat,I-http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/412071004,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46946,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/412071004,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46947,wheat,I-http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/412071004,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46948,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/412071004,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46949,are,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46950,ingested,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46951,.,O,1623.0,Vegetarian diets may contain high amounts of oxalate when whole grain wheat and wheat products are ingested .
46952,Recommendations,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46953,for,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46954,prevention,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46955,of,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46956,recurrence,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46957,of,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46958,calcium,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46959,oxalate,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46960,stone,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46961,disease,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46962,have,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46963,to,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46964,take,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46965,into,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46966,account,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46967,the,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46968,oxalate,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46969,content,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46970,of,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46971,these,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46972,foodstuffs,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
46973,.,O,1624.0,Recommendations for prevention of recurrence of calcium oxalate stone disease have to take into account the oxalate content of these foodstuffs .
47043,Nine,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47044,healthy,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47045,subjects,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47046,aged,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47047,between,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47048,26,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47049,and,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47050,59,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47051,(,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47052,one,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47053,male,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47054,and,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47055,eight,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47056,females,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47057,),O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47058,took,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47059,part,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47060,in,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47061,3,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47062,study,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47063,days,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47064,.,O,1629.0,Nine healthy subjects aged between 26 and 59 ( one male and eight females ) took part in 3 study days .
47259,Although,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47260,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47261,may,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47262,thus,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47263,represent,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47264,an,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47265,important,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47266,source,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47267,of,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47268,dietary,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47269,antioxidants,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47270,in,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47271,many,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47272,societies,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47273,",",O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47274,the,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47275,role,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47276,of,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47277,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47278,in,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47279,reducing,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47280,risk,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47281,of,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47282,major,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47283,disease,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47284,states,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47285,needs,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47286,to,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47287,be,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47288,investigated,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47289,in,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47290,more,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47291,detail,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47292,.,O,1636.0,"Although tea may thus represent an important source of dietary antioxidants in many societies , the role of tea in reducing risk of major disease states needs to be investigated in more detail ."
47544,Baseline,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47545,FFQ,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47546,data,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47547,were,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47548,used,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47549,to,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47550,generate,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47551,thirty,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47552,-,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47553,four,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47554,food,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47555,groups,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47556,.,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47870,Water,O,1654.0,Water was given as a control meal .
47871,was,O,1654.0,Water was given as a control meal .
47872,given,O,1654.0,Water was given as a control meal .
47873,as,O,1654.0,Water was given as a control meal .
47874,a,O,1654.0,Water was given as a control meal .
47875,control,O,1654.0,Water was given as a control meal .
47876,meal,O,1654.0,Water was given as a control meal .
47877,.,O,1654.0,Water was given as a control meal .
48623,For,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48624,puffed,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48625,rice,I-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48626,",",O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48627,consumers,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48628,liked,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48629,samples,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48630,with,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48631,attributes,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48632,of,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48633,crunchy,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48634,texture,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48635,",",O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48636,garlic,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48637,aftertaste,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48638,",",O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48639,and,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48640,savory,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48641,aftertaste,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48642,and,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48643,disliked,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48644,bitter,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48645,aftertaste,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48646,and,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48647,chili,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48648,powder,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48649,aroma,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48650,-,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48651,by,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48652,-,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48653,mouth,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48654,.,O,1681.0,"For puffed rice , consumers liked samples with attributes of crunchy texture , garlic aftertaste , and savory aftertaste and disliked bitter aftertaste and chili powder aroma - by - mouth ."
48884,Each,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48885,test,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48886,meal,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48887,provided,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48888,40,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48889,%,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48890,of,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48891,the,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48892,subjects,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48893,',O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48894,calculated,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48895,caloric,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48896,requirement,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48897,and,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48898,contained,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48899,15,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48900,%,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48901,of,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48902,total,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48903,calories,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48904,as,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48905,protein,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48906,",",O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48907,40,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48908,%,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48909,as,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48910,fat,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48911,",",O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48912,and,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48913,45,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48914,%,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48915,as,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48916,carbohydrate,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48917,.,O,1688.0,"Each test meal provided 40 % of the subjects ' calculated caloric requirement and contained 15 % of total calories as protein , 40 % as fat , and 45 % as carbohydrate ."
48928,The,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48929,results,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48930,indicated,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48931,that,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48932,plasma,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48933,glucose,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48934,concentrations,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48935,after,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48936,meals,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48937,containing,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48938,equal,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48939,amounts,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48940,of,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48941,carbohydrate,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48942,as,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48943,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48944,",",O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48945,spaghetti,B-http://purl.bioontology.org/ontology/SNOMEDCT/226744006,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48946,",",O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48947,or,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48948,lentil,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48949,were,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48950,similar,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48951,and,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48952,somewhat,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48953,lower,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48954,than,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48955,meals,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48956,containing,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48957,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48958,.,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
49048,Diet,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49049,plays,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49050,a,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49051,key,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49052,role,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49053,in,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49054,the,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49055,maintenance,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49056,and,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49057,optimal,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49058,functioning,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49059,of,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49060,immune,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49061,cells,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49062,.,O,1694.0,Diet plays a key role in the maintenance and optimal functioning of immune cells .
49220,In,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49221,the,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49222,present,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49223,paper,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49224,",",O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49225,we,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49226,summarize,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49227,the,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49228,current,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49229,knowledge,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49230,on,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49231,the,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49232,effect,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49233,of,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49234,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49235,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49236,per,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49237,se,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49238,and,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49239,MedDiets,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49240,generally,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49241,on,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49242,immune,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49243,-,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49244,mediated,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49245,and,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49246,inflammatory,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49247,diseases,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49248,",",O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49249,such,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49250,as,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49251,coronary,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49252,heart,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49253,disease,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49254,(,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49255,CHD)/cardiovascular,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49256,diseases,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49257,(,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49258,CVD,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49259,),O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49260,",",O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49261,obesity,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49262,",",O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49263,type-2,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49264,diabetes,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49265,",",O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49266,cancer,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49267,",",O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49268,asthma,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49269,",",O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49270,and,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49271,allergies,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49272,.,O,1700.0,"In the present paper , we summarize the current knowledge on the effect of olive oil per se and MedDiets generally on immune - mediated and inflammatory diseases , such as coronary heart disease ( CHD)/cardiovascular diseases ( CVD ) , obesity , type-2 diabetes , cancer , asthma , and allergies ."
49565,The,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49566,main,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49567,operators,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49568,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49569,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49570,olive,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49571,oil,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49572,sector,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49573,are,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49574,continuously,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49575,involved,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49576,in,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49577,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49578,development,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49579,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49580,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49581,olive,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49582,oil,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49583,mechanical,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49584,extraction,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49585,process,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49586,with,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49587,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49588,common,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49589,aim,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49590,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49591,increasing,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49592,both,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49593,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49594,quality,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49595,and,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49596,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49597,oil,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49598,extraction,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49599,yield,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49600,coupled,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49601,with,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49602,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49603,potential,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49604,enhancement,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49605,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49606,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49607,working,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49608,efficiency,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49609,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49610,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49611,olive,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49612,mill,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49613,.,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
50175,Adding,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50176,salt,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50177,is,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50178,indispensable,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50179,to,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50180,make,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50181,miso,B-http://purl.bioontology.org/ontology/SNOMEDCT/227354002,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50182,",",O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50183,and,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50184,therefore,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50185,",",O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50186,in,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50187,some,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50188,cases,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50189,",",O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50190,refraining,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50191,from,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50192,miso,B-http://purl.bioontology.org/ontology/SNOMEDCT/227354002;http://purl.bioontology.org/ontology/SNOMEDCT/227566009,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50193,soup,I-http://purl.bioontology.org/ontology/SNOMEDCT/227354002;http://purl.bioontology.org/ontology/SNOMEDCT/227566009,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50194,is,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50195,recommended,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50196,to,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50197,reduce,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50198,dietary,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50199,salt,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50200,intake,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50201,.,O,1731.0,"Adding salt is indispensable to make miso , and therefore , in some cases , refraining from miso soup is recommended to reduce dietary salt intake ."
50492,A,O,1741.0,A total of thirteen commonly consumed foods were examined .
50493,total,O,1741.0,A total of thirteen commonly consumed foods were examined .
50494,of,O,1741.0,A total of thirteen commonly consumed foods were examined .
50495,thirteen,O,1741.0,A total of thirteen commonly consumed foods were examined .
50496,commonly,O,1741.0,A total of thirteen commonly consumed foods were examined .
50497,consumed,O,1741.0,A total of thirteen commonly consumed foods were examined .
50498,foods,O,1741.0,A total of thirteen commonly consumed foods were examined .
50499,were,O,1741.0,A total of thirteen commonly consumed foods were examined .
50500,examined,O,1741.0,A total of thirteen commonly consumed foods were examined .
50501,.,O,1741.0,A total of thirteen commonly consumed foods were examined .
50720,We,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50721,assayed,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50722,the,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50723,capacity,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50724,of,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50725,extracts,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50726,of,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50727,these,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50728,fruits,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50729,and,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50730,vegetables,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50731,to,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50732,induce,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50733,NQO1,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50734,[,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50735,by,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50736,more,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50737,than,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50738,1.5,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50739,-,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50740,fold,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50741,:,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50742,ratio,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50743,of,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50744,induction,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50745,(,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50746,cells,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50747,treated,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50748,/,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50749,control,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50750,),O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50751,>,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50752,1.5,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50753,",",O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50754,8,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50755,-,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50756,mg,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50757,/,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50758,ml,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50759,dose,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50760,],O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50761,in,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50762,two,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50763,murine,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50764,hepatoma,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50765,cell,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50766,lines,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50767,:,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50768,Hepa,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50769,1c1c7,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50770,and,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50771,BPrC1,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50772,",",O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50773,a,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50774,modified,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50775,cell,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50776,line,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50777,that,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50778,possesses,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50779,a,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50780,nonfunctional,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50781,aryl,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50782,hydrocarbon,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50783,receptor,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50784,nuclear,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50785,translocator,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50786,system,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50787,and,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50788,is,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50789,thus,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50790,nonresponsive,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50791,to,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50792,bifunctional,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50793,inducers,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50794,.,O,1747.0,"We assayed the capacity of extracts of these fruits and vegetables to induce NQO1 [ by more than 1.5 - fold : ratio of induction ( cells treated / control ) > 1.5 , 8 - mg / ml dose ] in two murine hepatoma cell lines : Hepa 1c1c7 and BPrC1 , a modified cell line that possesses a nonfunctional aryl hydrocarbon receptor nuclear translocator system and is thus nonresponsive to bifunctional inducers ."
50931,Extracts,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50932,from,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50933,broccoli,B-http://purl.bioontology.org/ontology/SNOMEDCT/735123009,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50934,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50935,ratio=3.5,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50936,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50937,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50938,calcot,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50939,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50940,ratio=4.8,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50941,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50942,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50943,cauliflower,B-http://purl.bioontology.org/ontology/SNOMEDCT/735336002,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50944,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50945,ratio=4.2,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50946,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50947,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50948,cabbage,B-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50949,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50950,ratio=2.2,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50951,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50952,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50953,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/735047000,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50954,onion,I-http://purl.bioontology.org/ontology/SNOMEDCT/735047000,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50955,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50956,ratio=3.2,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50957,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50958,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50959,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/461801000124102;http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50960,cabbage,I-http://purl.bioontology.org/ontology/SNOMEDCT/461801000124102;http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50961,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50962,ratio=3.6,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50963,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50964,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50965,black,B-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50966,cabbage,I-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50967,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50968,ratio=4.5,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50969,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50970,",",O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50971,and,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50972,purple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50973,cabbage,I-http://purl.bioontology.org/ontology/SNOMEDCT/735108004,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50974,(,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50975,ratio=3.7,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50976,),O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50977,were,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50978,confirmed,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50979,to,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50980,contain,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50981,MIs,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50982,in,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50983,the,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50984,AREPE,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50985,cell,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50986,line,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
50987,.,O,1750.0,"Extracts from broccoli ( ratio=3.5 ) , calcot ( ratio=4.8 ) , cauliflower ( ratio=4.2 ) , cabbage ( ratio=2.2 ) , green onion ( ratio=3.2 ) , green cabbage ( ratio=3.6 ) , black cabbage ( ratio=4.5 ) , and purple cabbage ( ratio=3.7 ) were confirmed to contain MIs in the AREPE cell line ."
51417,Both,O,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51418,immunochemical,O,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51419,studies,O,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51420,and,O,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51421,in,O,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51422,vitro,O,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51423,and,O,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51424,in,O,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51425,vivo,O,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51426,challenge,O,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51427,of,O,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51428,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51429,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51430,free,I-http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51431,sorghum,I-http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51432,food,I-http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51433,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/255620007,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51434,support,O,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51435,this,O,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51436,conclusion,O,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51437,",",O,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51438,although,O,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51439,molecular,O,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51440,evidence,O,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51441,is,O,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51442,missing,O,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51443,.,O,1765.0,"Both immunochemical studies and in vitro and in vivo challenge of wheat - free sorghum food products support this conclusion , although molecular evidence is missing ."
51465,In,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51466,silico,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51467,analysis,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51468,of,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51469,the,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51470,recently,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51471,published,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51472,sorghum,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51473,genome,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51474,predicts,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51475,that,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51476,sorghum,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51477,does,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51478,not,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51479,contain,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51480,peptides,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51481,that,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51482,are,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51483,toxic,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51484,for,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51485,celiac,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51486,patients,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51487,.,O,1767.0,In silico analysis of the recently published sorghum genome predicts that sorghum does not contain peptides that are toxic for celiac patients .
51837,The,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51838,results,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51839,suggest,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51840,that,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51841,the,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51842,mechanism,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51843,for,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51844,the,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51845,hypocholesterolaemic,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51846,effect,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51847,does,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51848,not,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51849,involve,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51850,increased,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51851,hepatic,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51852,bile,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51853,acid,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51854,synthesis,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51855,and,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51856,thereby,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51857,increased,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51858,cholesterol,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51859,clearance,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51860,via,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51861,the,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51862,intestinal,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51863,route,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
51864,.,O,1778.0,The results suggest that the mechanism for the hypocholesterolaemic effect does not involve increased hepatic bile acid synthesis and thereby increased cholesterol clearance via the intestinal route .
52159,Fortification,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52160,of,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52161,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52162,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52163,substantially,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52164,improved,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52165,folate,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52166,status,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52167,in,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52168,a,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52169,population,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52170,of,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52171,women,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52172,of,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52173,reproductive,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52174,age,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52175,in,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52176,Chile,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52177,.,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52221,The,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52222,30,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52223,papers,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52224,examine,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52225,populations,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52226,in,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52227,12,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52228,countries,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52229,and,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52230,provide,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52231,data,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52232,on,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52233,consumption,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52234,of,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52235,both,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52236,black,B-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52237,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52238,green,I-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52239,tea,I-http://purl.bioontology.org/ontology/SNOMEDCT/412194001;http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52240,.,O,1791.0,The 30 papers examine populations in 12 countries and provide data on consumption of both black and green tea .
52375,There,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52376,is,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52377,no,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52378,consistent,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52379,adjustment,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52380,for,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52381,important,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52382,potential,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52383,confounders,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52384,of,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52385,any,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52386,tea,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52387,relationship,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52388,",",O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52389,such,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52390,as,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52391,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52392,and,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52393,alcohol,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52394,consumption,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52395,and,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52396,physical,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52397,activity,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52398,levels,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52399,.,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52619,The,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52620,obesity,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52621,risk,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52622,decreased,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52623,in,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52624,men,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52625,(,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52626,P,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52627,=,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52628,0.010,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52629,),O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52630,and,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52631,women,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52632,(,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52633,P,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52634,=,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52635,0.013,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52636,),O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52637,with,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52638,increasing,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52639,adherence,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52640,to,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52641,the,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52642,traditional,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52643,Mediterranean,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52644,dietary,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52645,pattern,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52646,.,O,1805.0,The obesity risk decreased in men ( P = 0.010 ) and women ( P = 0.013 ) with increasing adherence to the traditional Mediterranean dietary pattern .
52896,and,O,1816.0,and Lactobacillus spp .
52897,Lactobacillus,O,1816.0,and Lactobacillus spp .
52898,spp,O,1816.0,and Lactobacillus spp .
52899,.,O,1816.0,and Lactobacillus spp .
53029,Potatoes,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53030,",",O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53031,especially,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53032,mashed,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53033,potatoes,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53034,",",O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53035,are,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53036,known,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53037,to,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53038,result,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53039,in,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53040,high,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53041,glycaemic,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53042,and,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53043,insulinaemic,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53044,responses,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53045,.,O,1822.0,"Potatoes , especially mashed potatoes , are known to result in high glycaemic and insulinaemic responses ."
53282,In,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53283,conclusion,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53284,",",O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53285,the,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53286,protein,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53287,",",O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53288,fat,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53289,and,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53290,salad,B-http://purl.bioontology.org/ontology/SNOMEDCT/227927005,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53291,contents,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53292,of,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53293,a,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53294,meal,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53295,exert,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53296,considerable,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53297,influence,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53298,on,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53299,the,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53300,glycaemic,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53301,and,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53302,insulinaemic,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53303,responses,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53304,to,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53305,mashed,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53306,potatoes,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53307,.,O,1833.0,"In conclusion , the protein , fat and salad contents of a meal exert considerable influence on the glycaemic and insulinaemic responses to mashed potatoes ."
53511,Patients,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53512,with,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53513,more,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53514,aggressive,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53515,disease,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53516,presented,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53517,a,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53518,lower,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53519,adherence,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53520,to,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53521,MD,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53522,according,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53523,to,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53524,PREDIMED,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53525,categories,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53526,in,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53527,comparison,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53528,to,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53529,G1,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53530,",",O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53531,localized,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53532,and,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53533,free,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53534,/,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53535,stable,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53536,disease,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53537,status,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53538,.,O,1841.0,"Patients with more aggressive disease presented a lower adherence to MD according to PREDIMED categories in comparison to G1 , localized and free / stable disease status ."
53825,High,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53826,-,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53827,quality,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53828,clinical,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53829,trials,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53830,of,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53831,ketogenic,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53832,diets,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53833,will,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53834,be,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53835,needed,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53836,to,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53837,assess,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53838,important,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53839,questions,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53840,about,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53841,their,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53842,long,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53843,-,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53844,term,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53845,effects,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53846,and,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53847,full,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53848,potential,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53849,in,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53850,clinical,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53851,medicine,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
53852,.,O,1854.0,High - quality clinical trials of ketogenic diets will be needed to assess important questions about their long - term effects and full potential in clinical medicine .
54068,A,O,1864.0,A self - administered food - frequency questionnaire was used as a baseline survey .
54069,self,O,1864.0,A self - administered food - frequency questionnaire was used as a baseline survey .
54070,-,O,1864.0,A self - administered food - frequency questionnaire was used as a baseline survey .
54071,administered,O,1864.0,A self - administered food - frequency questionnaire was used as a baseline survey .
54072,food,O,1864.0,A self - administered food - frequency questionnaire was used as a baseline survey .
54073,-,O,1864.0,A self - administered food - frequency questionnaire was used as a baseline survey .
54074,frequency,O,1864.0,A self - administered food - frequency questionnaire was used as a baseline survey .
54075,questionnaire,O,1864.0,A self - administered food - frequency questionnaire was used as a baseline survey .
54076,was,O,1864.0,A self - administered food - frequency questionnaire was used as a baseline survey .
54077,used,O,1864.0,A self - administered food - frequency questionnaire was used as a baseline survey .
54078,as,O,1864.0,A self - administered food - frequency questionnaire was used as a baseline survey .
54079,a,O,1864.0,A self - administered food - frequency questionnaire was used as a baseline survey .
54080,baseline,O,1864.0,A self - administered food - frequency questionnaire was used as a baseline survey .
54081,survey,O,1864.0,A self - administered food - frequency questionnaire was used as a baseline survey .
54082,.,O,1864.0,A self - administered food - frequency questionnaire was used as a baseline survey .
54254,The,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54255,clinical,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54256,features,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54257,of,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54258,84,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54259,patients,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54260,with,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54261,rhinitis,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54262,",",O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54263,asthma,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54264,",",O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54265,urticaria,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54266,",",O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54267,and/or,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54268,anaphylaxis,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54269,whose,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54270,inhalant,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54271,allergy,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54272,was,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54273,exclusively,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54274,to,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54275,Artemisia,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54276,vulgaris,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54277,were,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54278,studied,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54279,and,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54280,compared,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54281,with,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54282,a,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54283,control,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54284,group,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54285,of,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54286,50,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54287,patients,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54288,monosensitized,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54289,to,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54290,grass,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54291,pollen,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
54292,.,O,1873.0,"The clinical features of 84 patients with rhinitis , asthma , urticaria , and/or anaphylaxis whose inhalant allergy was exclusively to Artemisia vulgaris were studied and compared with a control group of 50 patients monosensitized to grass pollen ."
55017,Positively,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55018,tested,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55019,edibles,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55020,were,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55021,staple,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55022,foods,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55023,such,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55024,as,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55025,maize,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55026,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55027,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55028,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55029,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55030,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55031,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55032,millet,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55033,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55034,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55035,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55036,and,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55037,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55038,and,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55039,also,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55040,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55041,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55042,popcorn,B-http://purl.bioontology.org/ontology/SNOMEDCT/226726003,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55043,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55044,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55045,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55046,carrot,B-http://purl.bioontology.org/ontology/SNOMEDCT/256319004,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55047,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55048,pineapple,B-http://purl.bioontology.org/ontology/SNOMEDCT/256313003,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55049,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55050,kiwi,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55051,",",O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55052,and,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55053,apples,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55054,.,O,1901.0,"Positively tested edibles were staple foods such as maize , rice , wheat flour , millet , potato , and milk and also cocoa , popcorn , tomato , carrot , pineapple , kiwi , and apples ."
55101,Therefore,O,1904.0,"Therefore , the role of dietary myosmine in esophageal adenocarcinoma should be further investigated ."
55102,",",O,1904.0,"Therefore , the role of dietary myosmine in esophageal adenocarcinoma should be further investigated ."
55103,the,O,1904.0,"Therefore , the role of dietary myosmine in esophageal adenocarcinoma should be further investigated ."
55104,role,O,1904.0,"Therefore , the role of dietary myosmine in esophageal adenocarcinoma should be further investigated ."
55105,of,O,1904.0,"Therefore , the role of dietary myosmine in esophageal adenocarcinoma should be further investigated ."
55106,dietary,O,1904.0,"Therefore , the role of dietary myosmine in esophageal adenocarcinoma should be further investigated ."
55107,myosmine,O,1904.0,"Therefore , the role of dietary myosmine in esophageal adenocarcinoma should be further investigated ."
55108,in,O,1904.0,"Therefore , the role of dietary myosmine in esophageal adenocarcinoma should be further investigated ."
55109,esophageal,O,1904.0,"Therefore , the role of dietary myosmine in esophageal adenocarcinoma should be further investigated ."
55110,adenocarcinoma,O,1904.0,"Therefore , the role of dietary myosmine in esophageal adenocarcinoma should be further investigated ."
55111,should,O,1904.0,"Therefore , the role of dietary myosmine in esophageal adenocarcinoma should be further investigated ."
55112,be,O,1904.0,"Therefore , the role of dietary myosmine in esophageal adenocarcinoma should be further investigated ."
55113,further,O,1904.0,"Therefore , the role of dietary myosmine in esophageal adenocarcinoma should be further investigated ."
55114,investigated,O,1904.0,"Therefore , the role of dietary myosmine in esophageal adenocarcinoma should be further investigated ."
55115,.,O,1904.0,"Therefore , the role of dietary myosmine in esophageal adenocarcinoma should be further investigated ."
55253,Besides,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55254,",",O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55255,anthocyanins,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55256,exhibited,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55257,anti,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55258,-,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55259,diabetic,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55260,properties,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55261,by,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55262,reducing,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55263,blood,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55264,glucose,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55265,and,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55266,HbA1c,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55267,levels,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55268,or,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55269,the,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55270,improvement,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55271,of,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55272,insulin,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55273,secretion,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55274,and,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55275,resistance,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55276,.,O,1910.0,"Besides , anthocyanins exhibited anti - diabetic properties by reducing blood glucose and HbA1c levels or the improvement of insulin secretion and resistance ."
55858,The,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55859,Eastern,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55860,Mediterranean,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55861,Region,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55862,(,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55863,EMR,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55864,),O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55865,has,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55866,witnessed,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55867,significant,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55868,social,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55869,and,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55870,economic,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55871,changes,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55872,that,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55873,may,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55874,have,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55875,influenced,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55876,the,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55877,diet,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55878,of,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55879,children,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55880,and,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55881,adolescents,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55882,",",O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55883,and,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55884,increased,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55885,the,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55886,risk,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55887,for,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55888,obesity,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55889,and,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55890,malnutrition,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55891,in,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55892,this,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55893,age,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55894,group,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55895,.,O,1931.0,"The Eastern Mediterranean Region ( EMR ) has witnessed significant social and economic changes that may have influenced the diet of children and adolescents , and increased the risk for obesity and malnutrition in this age group ."
55896,This,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55897,review,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55898,aims,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55899,to,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55900,characterize,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55901,and,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55902,assess,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55903,food,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55904,consumption,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55905,patterns,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55906,and,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55907,nutrient,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55908,intakes,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55909,amongst,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55910,school,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55911,-,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55912,aged,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55913,children,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55914,(,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55915,5,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55916,-,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55917,10,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55918,years,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55919,),O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55920,and,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55921,adolescents,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55922,(,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55923,10,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55924,-,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55925,19,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55926,years,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55927,),O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55928,in,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55929,countries,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55930,of,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55931,the,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55932,EMR,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
55933,.,O,1932.0,This review aims to characterize and assess food consumption patterns and nutrient intakes amongst school - aged children ( 5 - 10 years ) and adolescents ( 10 - 19 years ) in countries of the EMR .
56644,Processed,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56645,potato,I-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56646,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56647,are,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56648,typically,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56649,categorized,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56650,as,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56651,high,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56652,fat,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56653,and,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56654,sodium,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56655,foods,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56656,",",O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56657,as,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56658,well,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56659,as,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56660,being,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56661,classified,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56662,as,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56663,a,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56664,significant,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56665,source,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56666,of,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56667,carbohydrate,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56668,",",O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56669,in,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56670,the,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56671,form,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56672,of,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56673,starch,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
56674,.,O,1956.0,"Processed potato products are typically categorized as high fat and sodium foods , as well as being classified as a significant source of carbohydrate , in the form of starch ."
57018,The,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57019,aim,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57020,of,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57021,this,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57022,expert,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57023,opinion,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57024,recommendation,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57025,was,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57026,to,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57027,elucidate,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57028,the,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57029,different,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57030,impact,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57031,of,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57032,animal,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57033,vs,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57034,vegetable,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57035,protein,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57036,on,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57037,modifying,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57038,cardiometabolic,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57039,risk,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57040,factors,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57041,.,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57042,Many,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57043,observational,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57044,and,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57045,interventional,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57046,studies,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57047,confirmed,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57048,that,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57049,increasing,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57050,protein,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57051,intake,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57052,",",O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57053,especially,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57054,plant,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57055,-,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57056,based,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57057,proteins,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57058,and,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57059,certain,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57060,animal,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57061,-,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57062,based,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57063,proteins,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57064,(,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57065,poultry,B-http://purl.bioontology.org/ontology/SNOMEDCT/28230009,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57066,",",O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57067,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57068,",",O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57069,unprocessed,B-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57070,red,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57071,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57072,low,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57073,in,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57074,saturated,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57075,fats,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57076,and,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57077,low,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57078,-,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57079,fat,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57080,dairy,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57081,products,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57082,),O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57083,have,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57084,a,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57085,positive,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57086,effect,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57087,in,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57088,modifying,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57089,cardiometabolic,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57090,risk,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57091,factors,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57092,.,O,1970.0,"Many observational and interventional studies confirmed that increasing protein intake , especially plant - based proteins and certain animal - based proteins ( poultry , fish , unprocessed red meat low in saturated fats and low - fat dairy products ) have a positive effect in modifying cardiometabolic risk factors ."
57093,Red,B-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57094,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57095,intake,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57096,correlates,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57097,with,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57098,increased,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57099,CVD,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57100,risk,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57101,",",O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57102,mainly,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57103,because,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57104,of,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57105,its,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57106,non,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57107,-,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57108,protein,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57109,ingredients,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57110,(,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57111,saturated,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57112,fats,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57113,),O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57114,.,O,1971.0,"Red meat intake correlates with increased CVD risk , mainly because of its non - protein ingredients ( saturated fats ) ."
57334,One,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57335,hundred,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57336,forty,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57337,-,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57338,two,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57339,of,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57340,195,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57341,participants,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57342,(,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57343,73,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57344,%,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57345,),O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57346,completed,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57347,the,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57348,course,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57349,and,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57350,the,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57351,evaluation,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57352,.,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57378,The,O,1984.0,The food frequency results indicated that participants made some significant changes in their food practices .
57379,food,O,1984.0,The food frequency results indicated that participants made some significant changes in their food practices .
57380,frequency,O,1984.0,The food frequency results indicated that participants made some significant changes in their food practices .
57381,results,O,1984.0,The food frequency results indicated that participants made some significant changes in their food practices .
57382,indicated,O,1984.0,The food frequency results indicated that participants made some significant changes in their food practices .
57383,that,O,1984.0,The food frequency results indicated that participants made some significant changes in their food practices .
57384,participants,O,1984.0,The food frequency results indicated that participants made some significant changes in their food practices .
57385,made,O,1984.0,The food frequency results indicated that participants made some significant changes in their food practices .
57386,some,O,1984.0,The food frequency results indicated that participants made some significant changes in their food practices .
57387,significant,O,1984.0,The food frequency results indicated that participants made some significant changes in their food practices .
57388,changes,O,1984.0,The food frequency results indicated that participants made some significant changes in their food practices .
57389,in,O,1984.0,The food frequency results indicated that participants made some significant changes in their food practices .
57390,their,O,1984.0,The food frequency results indicated that participants made some significant changes in their food practices .
57391,food,O,1984.0,The food frequency results indicated that participants made some significant changes in their food practices .
57392,practices,O,1984.0,The food frequency results indicated that participants made some significant changes in their food practices .
57393,.,O,1984.0,The food frequency results indicated that participants made some significant changes in their food practices .
57394,They,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57395,decreased,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57396,the,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57397,number,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57398,of,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57399,times,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57400,they,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57401,selected,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57402,high,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57403,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57404,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57405,cheese,I-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57406,",",O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57407,regular,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57408,red,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57409,meats,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57410,",",O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57411,foods,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57412,from,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57413,the,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57414,saturated,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57415,fatty,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57416,acid,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57417,group,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57418,",",O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57419,desserts,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57420,",",O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57421,sodium,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57422,-,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57423,rich,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57424,products,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57425,",",O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57426,and,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57427,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57428,/,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57429,coffee,B-http://purl.bioontology.org/ontology/SNOMEDCT/29263009,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57430,(,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57431,p,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57432,less,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57433,than,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57434,.05,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57435,),O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57436,",",O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57437,and,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57438,they,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57439,increased,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57440,selection,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57441,of,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57442,low,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57443,-,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57444,fat,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57445,dairy,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57446,products,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57447,(,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57448,p,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57449,less,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57450,than,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57451,.05,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57452,),O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57453,.,O,1985.0,"They decreased the number of times they selected high - fat cheese , regular red meats , foods from the saturated fatty acid group , desserts , sodium - rich products , and tea / coffee ( p less than .05 ) , and they increased selection of low - fat dairy products ( p less than .05 ) ."
57526,Therefore,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57527,",",O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57528,we,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57529,investigated,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57530,the,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57531,dietary,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57532,habits,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57533,and,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57534,established,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57535,their,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57536,relationship,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57537,with,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57538,the,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57539,nutritional,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57540,status,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57541,and,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57542,glycemic,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57543,profile,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57544,of,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57545,such,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57546,women,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
57547,.,O,1990.0,"Therefore , we investigated the dietary habits and established their relationship with the nutritional status and glycemic profile of such women ."
58761,Most,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58762,of,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58763,the,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58764,claimed,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58765,physiological,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58766,properties,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58767,of,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58768,milk,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58769,bioactive,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58770,components,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58771,have,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58772,been,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58773,carried,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58774,out,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58775,in,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58776,vitro,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58777,or,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58778,in,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58779,animal,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58780,model,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58781,systems,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58782,",",O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58783,and,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58784,these,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58785,hypothesized,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58786,properties,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58787,remain,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58788,to,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58789,be,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58790,proven,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58791,in,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58792,humans,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58793,.,O,2031.0,"Most of the claimed physiological properties of milk bioactive components have been carried out in vitro or in animal model systems , and these hypothesized properties remain to be proven in humans ."
58876,However,O,2035.0,"However , few beers have been tested according to International Organization for Standardization ( ISO ) methodology ."
58877,",",O,2035.0,"However , few beers have been tested according to International Organization for Standardization ( ISO ) methodology ."
58878,few,O,2035.0,"However , few beers have been tested according to International Organization for Standardization ( ISO ) methodology ."
58879,beers,O,2035.0,"However , few beers have been tested according to International Organization for Standardization ( ISO ) methodology ."
58880,have,O,2035.0,"However , few beers have been tested according to International Organization for Standardization ( ISO ) methodology ."
58881,been,O,2035.0,"However , few beers have been tested according to International Organization for Standardization ( ISO ) methodology ."
58882,tested,O,2035.0,"However , few beers have been tested according to International Organization for Standardization ( ISO ) methodology ."
58883,according,O,2035.0,"However , few beers have been tested according to International Organization for Standardization ( ISO ) methodology ."
58884,to,O,2035.0,"However , few beers have been tested according to International Organization for Standardization ( ISO ) methodology ."
58885,International,O,2035.0,"However , few beers have been tested according to International Organization for Standardization ( ISO ) methodology ."
58886,Organization,O,2035.0,"However , few beers have been tested according to International Organization for Standardization ( ISO ) methodology ."
58887,for,O,2035.0,"However , few beers have been tested according to International Organization for Standardization ( ISO ) methodology ."
58888,Standardization,O,2035.0,"However , few beers have been tested according to International Organization for Standardization ( ISO ) methodology ."
58889,(,O,2035.0,"However , few beers have been tested according to International Organization for Standardization ( ISO ) methodology ."
58890,ISO,O,2035.0,"However , few beers have been tested according to International Organization for Standardization ( ISO ) methodology ."
58891,),O,2035.0,"However , few beers have been tested according to International Organization for Standardization ( ISO ) methodology ."
58892,methodology,O,2035.0,"However , few beers have been tested according to International Organization for Standardization ( ISO ) methodology ."
58893,.,O,2035.0,"However , few beers have been tested according to International Organization for Standardization ( ISO ) methodology ."
59355,A,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59356,decrease,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59357,in,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59358,D,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59359,-,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59360,ROMS,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59361,in,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59362,the,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59363,RD,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59364,and,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59365,an,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59366,increase,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59367,in,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59368,albumin,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59369,and,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59370,an,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59371,increased,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59372,tendency,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59373,in,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59374,cytotoxicity,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59375,in,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59376,the,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59377,TD,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59378,were,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59379,observed,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59380,.,O,2054.0,A decrease in D - ROMS in the RD and an increase in albumin and an increased tendency in cytotoxicity in the TD were observed .
59405,The,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59406,olive,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59407,tree,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59408,(,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59409,Olea,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59410,europaea,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59411,),O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59412,is,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59413,widely,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59414,cultivated,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59415,for,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59416,the,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59417,production,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59418,of,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59419,both,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59420,oil,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59421,and,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59422,table,B-http://purl.bioontology.org/ontology/SNOMEDCT/227436000,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59423,olives,I-http://purl.bioontology.org/ontology/SNOMEDCT/227436000,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59424,and,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59425,very,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59426,significant,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59427,because,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59428,of,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59429,its,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59430,economic,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59431,value,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59432,.,O,2056.0,The olive tree ( Olea europaea ) is widely cultivated for the production of both oil and table olives and very significant because of its economic value .
59628,With,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59629,increasing,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59630,content,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59631,of,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59632,iron,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59633,compounds,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59634,",",O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59635,up,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59636,to,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59637,25,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59638,-,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59639,fold,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59640,higher,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59641,concentrations,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59642,of,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59643,the,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59644,toxic,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59645,lipid,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59646,oxidation,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59647,products,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59648,malondialdehyde,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59649,",",O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59650,4,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59651,-,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59652,hydroxy-2,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59653,-,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59654,nonenal,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59655,",",O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59656,and,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59657,other,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59658,volatile,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59659,aldehydes,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59660,were,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59661,formed,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59662,during,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59663,digestion,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59664,",",O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59665,together,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59666,with,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59667,increased,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59668,protein,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59669,carbonyl,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59670,compounds,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59671,as,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59672,measurement,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59673,of,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59674,protein,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59675,oxidation,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59676,.,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
60531,However,O,2097.0,"However , red wine has been promoted as a beneficial part of a nutritious diet ."
60532,",",O,2097.0,"However , red wine has been promoted as a beneficial part of a nutritious diet ."
60533,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2097.0,"However , red wine has been promoted as a beneficial part of a nutritious diet ."
60534,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2097.0,"However , red wine has been promoted as a beneficial part of a nutritious diet ."
60535,has,O,2097.0,"However , red wine has been promoted as a beneficial part of a nutritious diet ."
60536,been,O,2097.0,"However , red wine has been promoted as a beneficial part of a nutritious diet ."
60537,promoted,O,2097.0,"However , red wine has been promoted as a beneficial part of a nutritious diet ."
60538,as,O,2097.0,"However , red wine has been promoted as a beneficial part of a nutritious diet ."
60539,a,O,2097.0,"However , red wine has been promoted as a beneficial part of a nutritious diet ."
60540,beneficial,O,2097.0,"However , red wine has been promoted as a beneficial part of a nutritious diet ."
60541,part,O,2097.0,"However , red wine has been promoted as a beneficial part of a nutritious diet ."
60542,of,O,2097.0,"However , red wine has been promoted as a beneficial part of a nutritious diet ."
60543,a,O,2097.0,"However , red wine has been promoted as a beneficial part of a nutritious diet ."
60544,nutritious,O,2097.0,"However , red wine has been promoted as a beneficial part of a nutritious diet ."
60545,diet,O,2097.0,"However , red wine has been promoted as a beneficial part of a nutritious diet ."
60546,.,O,2097.0,"However , red wine has been promoted as a beneficial part of a nutritious diet ."
60822,Milk,O,2110.0,"Milk production was measured , and colostrum , milk , and blood samples were analyzed during the experimental period ."
60823,production,O,2110.0,"Milk production was measured , and colostrum , milk , and blood samples were analyzed during the experimental period ."
60824,was,O,2110.0,"Milk production was measured , and colostrum , milk , and blood samples were analyzed during the experimental period ."
60825,measured,O,2110.0,"Milk production was measured , and colostrum , milk , and blood samples were analyzed during the experimental period ."
60826,",",O,2110.0,"Milk production was measured , and colostrum , milk , and blood samples were analyzed during the experimental period ."
60827,and,O,2110.0,"Milk production was measured , and colostrum , milk , and blood samples were analyzed during the experimental period ."
60828,colostrum,O,2110.0,"Milk production was measured , and colostrum , milk , and blood samples were analyzed during the experimental period ."
60829,",",O,2110.0,"Milk production was measured , and colostrum , milk , and blood samples were analyzed during the experimental period ."
60830,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2110.0,"Milk production was measured , and colostrum , milk , and blood samples were analyzed during the experimental period ."
60831,",",O,2110.0,"Milk production was measured , and colostrum , milk , and blood samples were analyzed during the experimental period ."
60832,and,O,2110.0,"Milk production was measured , and colostrum , milk , and blood samples were analyzed during the experimental period ."
60833,blood,O,2110.0,"Milk production was measured , and colostrum , milk , and blood samples were analyzed during the experimental period ."
60834,samples,O,2110.0,"Milk production was measured , and colostrum , milk , and blood samples were analyzed during the experimental period ."
60835,were,O,2110.0,"Milk production was measured , and colostrum , milk , and blood samples were analyzed during the experimental period ."
60836,analyzed,O,2110.0,"Milk production was measured , and colostrum , milk , and blood samples were analyzed during the experimental period ."
60837,during,O,2110.0,"Milk production was measured , and colostrum , milk , and blood samples were analyzed during the experimental period ."
60838,the,O,2110.0,"Milk production was measured , and colostrum , milk , and blood samples were analyzed during the experimental period ."
60839,experimental,O,2110.0,"Milk production was measured , and colostrum , milk , and blood samples were analyzed during the experimental period ."
60840,period,O,2110.0,"Milk production was measured , and colostrum , milk , and blood samples were analyzed during the experimental period ."
60841,.,O,2110.0,"Milk production was measured , and colostrum , milk , and blood samples were analyzed during the experimental period ."
60842,Treated,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60843,animals,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60844,showed,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60845,the,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60846,peak,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60847,of,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60848,milk,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60849,production,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60850,at,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60851,55,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60852,+,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60853,/-,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60854,1.85,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60855,d,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60856,after,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60857,calving,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60858,",",O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60859,1,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60860,wk,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60861,before,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60862,the,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60863,control,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60864,group,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60865,(,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60866,62,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60867,+,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60868,/-,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60869,3.27,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60870,d,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60871,),O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60872,;,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60873,the,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60874,average,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60875,peak,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60876,production,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60877,was,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60878,41.6,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60879,+,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60880,/-,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60881,1.05,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60882,kg,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60883,for,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60884,the,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60885,treated,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60886,group,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60887,vs.,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60888,39.1,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60889,+,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60890,/-,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60891,1.44,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60892,kg,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60893,for,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60894,the,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60895,control,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60896,;,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60897,the,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60898,treated,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60899,animals,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60900,maintained,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60901,a,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60902,greater,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60903,milk,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60904,production,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60905,than,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60906,control,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60907,cows,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60908,throughout,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60909,lactation,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60910,(,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60911,9922.1,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60912,+,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60913,/-,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60914,215.7,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60915,vs.,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60916,9597.8,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60917,+,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60918,/-,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60919,225.4,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60920,kg,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60921,),O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
60922,.,O,2111.0,"Treated animals showed the peak of milk production at 55 + /- 1.85 d after calving , 1 wk before the control group ( 62 + /- 3.27 d ) ; the average peak production was 41.6 + /- 1.05 kg for the treated group vs. 39.1 + /- 1.44 kg for the control ; the treated animals maintained a greater milk production than control cows throughout lactation ( 9922.1 + /- 215.7 vs. 9597.8 + /- 225.4 kg ) ."
61093,However,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61094,",",O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61095,the,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61096,molecular,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61097,mechanisms,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61098,responsible,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61099,for,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61100,this,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61101,preventive,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61102,activity,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61103,and,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61104,whether,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61105,cocoa,B-http://purl.bioontology.org/ontology/SNOMEDCT/901000161107,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61106,exerts,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61107,potential,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61108,beneficial,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61109,effects,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61110,on,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61111,the,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61112,insulin,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61113,signaling,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61114,pathway,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61115,in,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61116,the,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61117,liver,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61118,remain,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61119,largely,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61120,unknown,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
61121,.,O,2121.0,"However , the molecular mechanisms responsible for this preventive activity and whether cocoa exerts potential beneficial effects on the insulin signaling pathway in the liver remain largely unknown ."
62452,RAST,O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62453,inhibition,O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62454,experiments,O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62455,indicated,O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62456,in,O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62457,a,O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62458,more,O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62459,direct,O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62460,way,O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62461,the,O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62462,extent,O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62463,of,O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62464,cross,O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62465,-,O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62466,reactivity,O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62467,between,O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62468,grain,O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62469,extracts,O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62470,of,O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62471,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/412071004,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62472,",",O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62473,rye,B-http://purl.bioontology.org/ontology/SNOMEDCT/412068007,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62474,",",O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62475,barley,B-http://purl.bioontology.org/ontology/SNOMEDCT/735124003,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62476,and,O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62477,oats,O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62478,.,O,2166.0,"RAST inhibition experiments indicated in a more direct way the extent of cross - reactivity between grain extracts of wheat , rye , barley and oats ."
62716,Variation,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62717,of,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62718,extraction,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62719,conditions,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62720,had,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62721,little,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62722,effect,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62723,on,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62724,the,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62725,composition,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62726,and,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62727,activity,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62728,of,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62729,extracts,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62730,from,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62731,hazelnut,B-http://purl.bioontology.org/ontology/SNOMEDCT/256353000,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62732,.,O,2177.0,Variation of extraction conditions had little effect on the composition and activity of extracts from hazelnut .
62822,These,O,2181.0,These data indicated that new epitopes had been formed by the heating process .
62823,data,O,2181.0,These data indicated that new epitopes had been formed by the heating process .
62824,indicated,O,2181.0,These data indicated that new epitopes had been formed by the heating process .
62825,that,O,2181.0,These data indicated that new epitopes had been formed by the heating process .
62826,new,O,2181.0,These data indicated that new epitopes had been formed by the heating process .
62827,epitopes,O,2181.0,These data indicated that new epitopes had been formed by the heating process .
62828,had,O,2181.0,These data indicated that new epitopes had been formed by the heating process .
62829,been,O,2181.0,These data indicated that new epitopes had been formed by the heating process .
62830,formed,O,2181.0,These data indicated that new epitopes had been formed by the heating process .
62831,by,O,2181.0,These data indicated that new epitopes had been formed by the heating process .
62832,the,O,2181.0,These data indicated that new epitopes had been formed by the heating process .
62833,heating,O,2181.0,These data indicated that new epitopes had been formed by the heating process .
62834,process,O,2181.0,These data indicated that new epitopes had been formed by the heating process .
62835,.,O,2181.0,These data indicated that new epitopes had been formed by the heating process .
63099,When,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63100,proof,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63101,time,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63102,was,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63103,optimized,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63104,",",O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63105,a,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63106,specific,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63107,volume,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63108,of,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63109,~5.6,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63110,ml,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63111,/,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63112,g,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63113,and,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63114,crumb,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63115,hardness,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63116,value,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63117,of,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63118,~156,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63119,g,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63120,of,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63121,force,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63122,was,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63123,observed,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63124,.,O,2190.0,"When proof time was optimized , a specific volume of ~5.6 ml / g and crumb hardness value of ~156 g of force was observed ."
63125,Carob,B-http://purl.bioontology.org/ontology/SNOMEDCT/63766005,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63126,germ,I-http://purl.bioontology.org/ontology/SNOMEDCT/63766005,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63127,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/63766005,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63128,may,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63129,be,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63130,used,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63131,as,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63132,an,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63133,alternative,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63134,to,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63135,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63136,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63137,in,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63138,formulating,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63139,viscoelastic,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63140,dough,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63141,and,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63142,high,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63143,quality,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63144,gluten,B-http://purl.bioontology.org/ontology/SNOMEDCT/328664004;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63145,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/328664004;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63146,free,I-http://purl.bioontology.org/ontology/SNOMEDCT/328664004;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63147,bread,I-http://purl.bioontology.org/ontology/SNOMEDCT/328664004;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63148,.,O,2191.0,Carob germ flour may be used as an alternative to wheat flour in formulating viscoelastic dough and high quality gluten - free bread .
63592,The,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63593,rapidly,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63594,digestible,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63595,starch,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63596,(,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63597,RDS,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63598,),O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63599,content,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63600,and,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63601,estimated,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63602,glycemic,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63603,index,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63604,(,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63605,eGI,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63606,),O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63607,decreased,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63608,as,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63609,cooking,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63610,temperature,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63611,decreased,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63612,and,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63613,the,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63614,ratio,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63615,of,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63616,water,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63617,to,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63618,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63619,increased,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63620,.,O,2207.0,The rapidly digestible starch ( RDS ) content and estimated glycemic index ( eGI ) decreased as cooking temperature decreased and the ratio of water to rice increased .
63850,Dietary,O,2217.0,Dietary patterns were identified by principal component analysis .
63851,patterns,O,2217.0,Dietary patterns were identified by principal component analysis .
63852,were,O,2217.0,Dietary patterns were identified by principal component analysis .
63853,identified,O,2217.0,Dietary patterns were identified by principal component analysis .
63854,by,O,2217.0,Dietary patterns were identified by principal component analysis .
63855,principal,O,2217.0,Dietary patterns were identified by principal component analysis .
63856,component,O,2217.0,Dietary patterns were identified by principal component analysis .
63857,analysis,O,2217.0,Dietary patterns were identified by principal component analysis .
63858,.,O,2217.0,Dietary patterns were identified by principal component analysis .
63913,The,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63914,',O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63915,Traditional,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63916,',O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63917,pattern,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63918,was,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63919,characterised,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63920,by,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63921,high,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63922,loadings,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63923,(,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63924,>,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63925,or,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63926,=,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63927,0.40,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63928,),O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63929,on,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63930,paté,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63931,or,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63932,high,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63933,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63934,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63935,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63936,for,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63937,sandwiches,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63938,",",O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63939,mayonnaise,B-http://purl.bioontology.org/ontology/SNOMEDCT/227549007,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63940,salads,I-http://purl.bioontology.org/ontology/SNOMEDCT/227549007,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63941,",",O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63942,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63943,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63944,",",O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63945,potatoes,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63946,",",O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63947,butter,B-http://purl.bioontology.org/ontology/SNOMEDCT/226888007,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63948,and,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63949,lard,B-http://purl.bioontology.org/ontology/SNOMEDCT/226899009,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63950,",",O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63951,low,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63952,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63953,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63954,fish,I-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63955,",",O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63956,low,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63957,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63958,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63959,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63960,for,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63961,sandwiches,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63962,",",O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63963,and,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63964,sauces,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
63965,.,O,2221.0,"The ' Traditional ' pattern was characterised by high loadings ( > or = 0.40 ) on paté or high - fat meat for sandwiches , mayonnaise salads , red meat , potatoes , butter and lard , low - fat fish , low - fat meat for sandwiches , and sauces ."
64027,The,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64028,variation,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64029,observed,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64030,from,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64031,the,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64032,Bland,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64033,Altman,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64034,plots,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64035,of,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64036,factors,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64037,from,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64038,explorative,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64039,v.,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64040,confirmative,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64041,analyses,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64042,and,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64043,explorative,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64044,analyses,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64045,from,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64046,two,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64047,sub,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64048,-,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64049,samples,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64050,was,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64051,between,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64052,18.8,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64053,and,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64054,47.7,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64055,%,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64056,.,O,2225.0,The variation observed from the Bland Altman plots of factors from explorative v. confirmative analyses and explorative analyses from two sub - samples was between 18.8 and 47.7 % .
64079,We,O,2228.0,We conclude that the ' Traditional ' and ' Modern ' dietary patterns identified were reproducible .
64080,conclude,O,2228.0,We conclude that the ' Traditional ' and ' Modern ' dietary patterns identified were reproducible .
64081,that,O,2228.0,We conclude that the ' Traditional ' and ' Modern ' dietary patterns identified were reproducible .
64082,the,O,2228.0,We conclude that the ' Traditional ' and ' Modern ' dietary patterns identified were reproducible .
64083,',O,2228.0,We conclude that the ' Traditional ' and ' Modern ' dietary patterns identified were reproducible .
64084,Traditional,O,2228.0,We conclude that the ' Traditional ' and ' Modern ' dietary patterns identified were reproducible .
64085,',O,2228.0,We conclude that the ' Traditional ' and ' Modern ' dietary patterns identified were reproducible .
64086,and,O,2228.0,We conclude that the ' Traditional ' and ' Modern ' dietary patterns identified were reproducible .
64087,',O,2228.0,We conclude that the ' Traditional ' and ' Modern ' dietary patterns identified were reproducible .
64088,Modern,O,2228.0,We conclude that the ' Traditional ' and ' Modern ' dietary patterns identified were reproducible .
64089,',O,2228.0,We conclude that the ' Traditional ' and ' Modern ' dietary patterns identified were reproducible .
64090,dietary,O,2228.0,We conclude that the ' Traditional ' and ' Modern ' dietary patterns identified were reproducible .
64091,patterns,O,2228.0,We conclude that the ' Traditional ' and ' Modern ' dietary patterns identified were reproducible .
64092,identified,O,2228.0,We conclude that the ' Traditional ' and ' Modern ' dietary patterns identified were reproducible .
64093,were,O,2228.0,We conclude that the ' Traditional ' and ' Modern ' dietary patterns identified were reproducible .
64094,reproducible,O,2228.0,We conclude that the ' Traditional ' and ' Modern ' dietary patterns identified were reproducible .
64095,.,O,2228.0,We conclude that the ' Traditional ' and ' Modern ' dietary patterns identified were reproducible .
64604,No,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64605,behavioral,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64606,signs,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64607,of,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64608,pain,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64609,or,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64610,discomfort,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64611,were,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64612,observed,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64613,",",O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64614,but,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64615,shivering,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64616,was,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64617,noted,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64618,in,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64619,several,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64620,calves,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64621,drinking,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64622,8,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64623,°,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64624,C,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64625,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64626,.,O,2247.0,"No behavioral signs of pain or discomfort were observed , but shivering was noted in several calves drinking 8 ° C milk ."
64657,In,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64658,this,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64659,study,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64660,",",O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64661,pot,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64662,experiments,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64663,were,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64664,conducted,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64665,to,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64666,determine,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64667,the,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64668,effects,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64669,of,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64670,industrial,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64671,solid,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64672,wastes,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64673,(,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64674,ISWs,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64675,),O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64676,(,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64677,ceramic,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64678,",",O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64679,stone,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64680,",",O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64681,and,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64682,sugar,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64683,factory,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64684,wastes,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64685,),O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64686,and,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64687,organic,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64688,wastes,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64689,(,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64690,rice,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64691,husk,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64692,and,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64693,wheat,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64694,straw,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64695,),O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64696,on,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64697,growth,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64698,and,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64699,heavy,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64700,metals,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64701,uptake,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64702,by,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64703,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64704,(,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64705,Lycopersicum,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64706,esculentum,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64707,),O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64708,plants,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64709,.,O,2249.0,"In this study , pot experiments were conducted to determine the effects of industrial solid wastes ( ISWs ) ( ceramic , stone , and sugar factory wastes ) and organic wastes ( rice husk and wheat straw ) on growth and heavy metals uptake by tomato ( Lycopersicum esculentum ) plants ."
64710,The,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64711,soil,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64712,was,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64713,treated,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64714,with,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64715,10,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64716,%,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64717,of,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64718,ISWs,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64719,and,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64720,5,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64721,%,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64722,of,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64723,organic,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64724,wastes,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64725,.,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64740,It,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64741,was,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64742,observed,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64743,that,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64744,the,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64745,addition,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64746,of,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64747,ISWs,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64748,in,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64749,soil,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64750,increased,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64751,heavy,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64752,metal,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64753,contents,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64754,in,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64755,all,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64756,fractions,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
64757,.,O,2252.0,It was observed that the addition of ISWs in soil increased heavy metal contents in all fractions .
65899,Proteomic,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65900,analysis,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65901,of,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65902,the,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65903,liver,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65904,reveals,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65905,global,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65906,differences,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65907,in,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65908,hepatic,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65909,proteins,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65910,when,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65911,comparing,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65912,diets,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65913,rich,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65914,in,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65915,the,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65916,two,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65917,soybean,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65918,oils,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65919,",",O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65920,coconut,B-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65921,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/28942008;http://purl.bioontology.org/ontology/SNOMEDCT/735211005,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65922,",",O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65923,and,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65924,a,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65925,low,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65926,-,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65927,fat,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65928,diet,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
65929,.,O,2299.0,"Proteomic analysis of the liver reveals global differences in hepatic proteins when comparing diets rich in the two soybean oils , coconut oil , and a low - fat diet ."
66107,The,O,2306.0,The amount of alcohol given to red wine and ethanol groups was 1.4   g / kg / day .
66108,amount,O,2306.0,The amount of alcohol given to red wine and ethanol groups was 1.4   g / kg / day .
66109,of,O,2306.0,The amount of alcohol given to red wine and ethanol groups was 1.4   g / kg / day .
66110,alcohol,O,2306.0,The amount of alcohol given to red wine and ethanol groups was 1.4   g / kg / day .
66111,given,O,2306.0,The amount of alcohol given to red wine and ethanol groups was 1.4   g / kg / day .
66112,to,O,2306.0,The amount of alcohol given to red wine and ethanol groups was 1.4   g / kg / day .
66113,red,O,2306.0,The amount of alcohol given to red wine and ethanol groups was 1.4   g / kg / day .
66114,wine,O,2306.0,The amount of alcohol given to red wine and ethanol groups was 1.4   g / kg / day .
66115,and,O,2306.0,The amount of alcohol given to red wine and ethanol groups was 1.4   g / kg / day .
66116,ethanol,O,2306.0,The amount of alcohol given to red wine and ethanol groups was 1.4   g / kg / day .
66117,groups,O,2306.0,The amount of alcohol given to red wine and ethanol groups was 1.4   g / kg / day .
66118,was,O,2306.0,The amount of alcohol given to red wine and ethanol groups was 1.4   g / kg / day .
66119,1.4,O,2306.0,The amount of alcohol given to red wine and ethanol groups was 1.4   g / kg / day .
66120, ,O,2306.0,The amount of alcohol given to red wine and ethanol groups was 1.4   g / kg / day .
66121,g,O,2306.0,The amount of alcohol given to red wine and ethanol groups was 1.4   g / kg / day .
66122,/,O,2306.0,The amount of alcohol given to red wine and ethanol groups was 1.4   g / kg / day .
66123,kg,O,2306.0,The amount of alcohol given to red wine and ethanol groups was 1.4   g / kg / day .
66124,/,O,2306.0,The amount of alcohol given to red wine and ethanol groups was 1.4   g / kg / day .
66125,day,O,2306.0,The amount of alcohol given to red wine and ethanol groups was 1.4   g / kg / day .
66126,.,O,2306.0,The amount of alcohol given to red wine and ethanol groups was 1.4   g / kg / day .
66385,These,O,2317.0,These compounds in strawberries have potent antioxidant power .
66386,compounds,O,2317.0,These compounds in strawberries have potent antioxidant power .
66387,in,O,2317.0,These compounds in strawberries have potent antioxidant power .
66388,strawberries,B-http://purl.bioontology.org/ontology/SNOMEDCT/102261002,2317.0,These compounds in strawberries have potent antioxidant power .
66389,have,O,2317.0,These compounds in strawberries have potent antioxidant power .
66390,potent,O,2317.0,These compounds in strawberries have potent antioxidant power .
66391,antioxidant,O,2317.0,These compounds in strawberries have potent antioxidant power .
66392,power,O,2317.0,These compounds in strawberries have potent antioxidant power .
66393,.,O,2317.0,These compounds in strawberries have potent antioxidant power .
66721,Although,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66722,some,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66723,studies,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66724,have,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66725,found,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66726,that,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66727,heavy,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66728,alcohol,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66729,consumption,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66730,is,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66731,associated,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66732,with,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66733,increased,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66734,risk,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66735,",",O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66736,a,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66737,recent,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66738,study,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66739,reported,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66740,that,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66741,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66742,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66743,consumption,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66744,is,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66745,associated,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66746,with,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66747,reduced,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66748,risk,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
66749,.,O,2330.0,"Although some studies have found that heavy alcohol consumption is associated with increased risk , a recent study reported that red wine consumption is associated with reduced risk ."
67591,Tomatoes,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67592,are,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67593,the,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67594,fourth,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67595,most,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67596,commonly,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67597,consumed,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67598,fresh,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67599,vegetable,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67600,and,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67601,the,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67602,most,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67603,frequently,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67604,consumed,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67605,canned,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67606,vegetable,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67607,in,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67608,the,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67609,American,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67610,diet,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67611,.,O,2361.0,Tomatoes are the fourth most commonly consumed fresh vegetable and the most frequently consumed canned vegetable in the American diet .
67664,Recent,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67665,animal,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67666,studies,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67667,have,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67668,investigated,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67669,tomatoes,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67670,",",O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67671,lycopene,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67672,",",O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67673,and,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67674,prostate,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67675,cancer,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67676,using,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67677,the,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67678,N,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67679,-,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67680,methyl,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67681,-,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67682,N,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67683,-,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67684,nitrosourea,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67685,and,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67686,Dunning,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67687,rat,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67688,models,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
67689,.,O,2364.0,"Recent animal studies have investigated tomatoes , lycopene , and prostate cancer using the N - methyl - N - nitrosourea and Dunning rat models ."
68087,Wheat,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68088,gluten,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68089,has,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68090,an,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68091,immense,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68092,impact,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68093,on,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68094,human,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68095,nutrition,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68096,as,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68097,it,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68098,largely,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68099,determines,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68100,the,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68101,processing,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68102,properties,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68103,of,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68104,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68105,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68106,",",O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68107,and,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68108,in,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68109,particular,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68110,the,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68111,ability,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68112,to,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68113,make,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68114,leavened,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68115,breads,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68116,",",O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68117,other,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68118,baked,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68119,products,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68120,",",O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68121,pasta,B-http://purl.bioontology.org/ontology/SNOMEDCT/226740002,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68122,and,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68123,noodles,B-http://purl.bioontology.org/ontology/SNOMEDCT/226735005,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68124,.,O,2378.0,"Wheat gluten has an immense impact on human nutrition as it largely determines the processing properties of wheat flour , and in particular the ability to make leavened breads , other baked products , pasta and noodles ."
68383,Over,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68384,14,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68385,years,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68386,of,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68387,follow,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68388,-,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68389,up,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68390,",",O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68391,1803,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68392,incident,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68393,diabetes,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68394,cases,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68395,were,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68396,identified,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68397,through,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68398,self,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68399,-,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68400,reports,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68401,",",O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68402,supplementary,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68403,questionnaires,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68404,and,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68405,drug,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68406,reimbursement,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68407,information,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68408,.,O,2387.0,"Over 14 years of follow - up , 1803 incident diabetes cases were identified through self - reports , supplementary questionnaires and drug reimbursement information ."
68469,When,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68470,comparing,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68471,women,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68472,who,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68473,consumed,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68474,at,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68475,least,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68476,five,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68477,eggs,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68478,per,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68479,week,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68480,with,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68481,non,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68482,-,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68483,consumers,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68484,",",O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68485,the,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68486,multivariable,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68487,hazard,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68488,ratio,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68489,(,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68490,HR,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68491,),O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68492,was,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68493,found,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68494,to,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68495,be,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68496,1·00,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68497,(,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68498,95,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68499,%,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68500,CI,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68501,0·78,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68502,",",O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68503,1·29,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68504,;,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68505,across,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68506,categories,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68507,",",O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68508,P,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68509,trend=0·11,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68510,),O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68511,.,O,2390.0,"When comparing women who consumed at least five eggs per week with non - consumers , the multivariable hazard ratio ( HR ) was found to be 1·00 ( 95 % CI 0·78 , 1·29 ; across categories , P trend=0·11 ) ."
68638,Over,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68639,one,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68640,third,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68641,of,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68642,Australians,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68643,',O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68644,daily,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68645,energy,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68646,intake,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68647,is,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68648,from,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68649,discretionary,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68650,foods,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68651,and,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68652,drinks,B-http://purl.bioontology.org/ontology/SNOMEDCT/226465004,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68653,.,O,2395.0,Over one third of Australians ' daily energy intake is from discretionary foods and drinks .
68841,A,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68842,reduction,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68843,of,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68844,one,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68845,serving,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68846,of,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68847,SSBs,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68848,(,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68849,375,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68850,mL,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68851,),O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68852,had,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68853,the,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68854,greatest,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68855,potential,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68856,impact,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68857,in,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68858,terms,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68859,of,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68860,weight,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68861,reduction,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68862,",",O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68863,particularly,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68864,in,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68865,ages,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68866,19,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68867,-,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68868,24,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68869,years,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68870,(,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68871,mean,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68872,0.31,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68873,kg,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68874,",",O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68875,95,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68876,%,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68877,UI,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68878,:,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68879,0.23,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68880,kg,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68881,to,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68882,0.37,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68883,kg,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68884,),O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68885,and,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68886,overall,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68887,healthcare,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68888,cost,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68889,savings,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68890,of,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68891,AUD,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68892,793.4,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68893,million,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68894,(,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68895,95,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68896,%,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68897,UI,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68898,:,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68899,589.1,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68900,M,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68901,to,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68902,976.1,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68903,M,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68904,),O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
68905,.,O,2401.0,"A reduction of one serving of SSBs ( 375 mL ) had the greatest potential impact in terms of weight reduction , particularly in ages 19 - 24 years ( mean 0.31 kg , 95 % UI : 0.23 kg to 0.37 kg ) and overall healthcare cost savings of AUD 793.4 million ( 95 % UI : 589.1 M to 976.1 M ) ."
69558,Meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2424.0,Meat is sometimes added .
69559,is,O,2424.0,Meat is sometimes added .
69560,sometimes,O,2424.0,Meat is sometimes added .
69561,added,O,2424.0,Meat is sometimes added .
69562,.,O,2424.0,Meat is sometimes added .
70484,Dietary,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70485,EW,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70486,also,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70487,increased,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70488,the,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70489,fecal,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70490,excretion,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70491,of,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70492,triacylglycerol,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70493,",",O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70494,cholesterol,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70495,and,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70496,total,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70497,bile,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70498,acids,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70499,",",O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70500,and,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70501,decreased,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70502,the,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70503,serum,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70504,levels,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70505,of,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70506,triacylglycerol,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70507,and,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70508,leptin,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70509,.,O,2456.0,"Dietary EW also increased the fecal excretion of triacylglycerol , cholesterol and total bile acids , and decreased the serum levels of triacylglycerol and leptin ."
70529,These,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70530,findings,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70531,indicate,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70532,that,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70533,EW,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70534,and,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70535,EWH,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70536,",",O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70537,especially,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70538,EW,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70539,",",O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70540,are,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70541,effective,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70542,in,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70543,reducing,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70544,body,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70545,fat,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70546,accumulation,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70547,by,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70548,regulating,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70549,hepatic,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70550,and,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70551,muscular,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70552,SCD,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70553,indices,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70554,.,O,2458.0,"These findings indicate that EW and EWH , especially EW , are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices ."
70725,Among,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70726,persons,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70727,who,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70728,reported,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70729,drinking,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70730,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70731,regularly,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70732,",",O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70733,persons,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70734,reporting,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70735,drinking,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70736,only,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70737,whole,B-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70738,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/226767008;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70739,were,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70740,at,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70741,increased,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70742,risk,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70743,(,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70744,relative,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70745,risk,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70746,=,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70747,2.6,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70748,",",O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70749,95,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70750,%,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70751,CI,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70752,1.7,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70753,-,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70754,4.0,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70755,),O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70756,relative,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70757,to,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70758,persons,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70759,who,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70760,drank,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70761,only,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70762,skim,B-http://purl.bioontology.org/ontology/SNOMEDCT/25743006;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70763,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/25743006;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70764,or,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70765,2,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70766,%,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70767,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70768,.,O,2465.0,"Among persons who reported drinking milk regularly , persons reporting drinking only whole milk were at increased risk ( relative risk = 2.6 , 95 % CI 1.7 - 4.0 ) relative to persons who drank only skim milk or 2 % milk ."
70899,During,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70900,8,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70901,years,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70902,of,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70903,follow,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70904,-,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70905,up,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70906,",",O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70907,we,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70908,documented,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70909,710,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70910,cases,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70911,of,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70912,invasive,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70913,breast,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70914,cancer,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
70915,.,O,2471.0,"During 8 years of follow - up , we documented 710 cases of invasive breast cancer ."
71018,Among,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71019,the,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71020,major,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71021,food,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71022,sources,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71023,of,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71024,flavonols,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71025,",",O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71026,we,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71027,found,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71028,a,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71029,significant,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71030,inverse,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71031,association,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71032,with,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71033,intake,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71034,of,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71035,beans,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71036,or,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71037,lentils,B-http://purl.bioontology.org/ontology/SNOMEDCT/227350006,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71038,but,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71039,not,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71040,with,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71041,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71042,",",O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71043,onions,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71044,",",O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71045,apples,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71046,",",O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71047,string,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71048,beans,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71049,",",O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71050,broccoli,B-http://purl.bioontology.org/ontology/SNOMEDCT/735123009,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71051,",",O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71052,green,B-http://purl.bioontology.org/ontology/SNOMEDCT/227563001,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71053,pepper,I-http://purl.bioontology.org/ontology/SNOMEDCT/227563001,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71054,and,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71055,blueberries,B-http://purl.bioontology.org/ontology/SNOMEDCT/412061001,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71056,.,O,2474.0,"Among the major food sources of flavonols , we found a significant inverse association with intake of beans or lentils but not with tea , onions , apples , string beans , broccoli , green pepper and blueberries ."
71524,In,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71525,contrast,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71526,",",O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71527,pattern,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71528,2,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71529,(,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71530,',O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71531,Western,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71532,pattern,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71533,',O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71534,),O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71535,was,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71536,characterised,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71537,by,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71538,high,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71539,levels,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71540,of,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71541,processed,B-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71542,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71543,red,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71544,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71545,",",O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71546,snacks,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71547,",",O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71548,takeaway,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71549,foods,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71550,",",O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71551,jam,B-http://purl.bioontology.org/ontology/SNOMEDCT/227601008,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71552,",",O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71553,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71554,",",O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71555,soft,B-http://purl.bioontology.org/ontology/SNOMEDCT/226465004,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71556,drinks,I-http://purl.bioontology.org/ontology/SNOMEDCT/226465004,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71557,",",O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71558,white,B-http://purl.bioontology.org/ontology/SNOMEDCT/226590000;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71559,bread,I-http://purl.bioontology.org/ontology/SNOMEDCT/226590000;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71560,",",O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71561,poultry,B-http://purl.bioontology.org/ontology/SNOMEDCT/28230009,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71562,",",O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71563,potato,B-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71564,with,I-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71565,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/735053000,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71566,",",O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71567,high,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71568,-,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71569,fat,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71570,dairy,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71571,products,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71572,and,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71573,eggs,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
71574,.,O,2489.0,"In contrast , pattern 2 ( ' Western pattern ' ) was characterised by high levels of processed and red meat , snacks , takeaway foods , jam , beer , soft drinks , white bread , poultry , potato with fat , high - fat dairy products and eggs ."
72289,Principal,O,2514.0,Principal component analysis was used to identify dietary patterns .
72290,component,O,2514.0,Principal component analysis was used to identify dietary patterns .
72291,analysis,O,2514.0,Principal component analysis was used to identify dietary patterns .
72292,was,O,2514.0,Principal component analysis was used to identify dietary patterns .
72293,used,O,2514.0,Principal component analysis was used to identify dietary patterns .
72294,to,O,2514.0,Principal component analysis was used to identify dietary patterns .
72295,identify,O,2514.0,Principal component analysis was used to identify dietary patterns .
72296,dietary,O,2514.0,Principal component analysis was used to identify dietary patterns .
72297,patterns,O,2514.0,Principal component analysis was used to identify dietary patterns .
72298,.,O,2514.0,Principal component analysis was used to identify dietary patterns .
72313,We,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72314,identified,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72315,four,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72316,major,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72317,dietary,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72318,patterns,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72319,:,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72320,"""",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72321,Western,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72322,"""",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72323,dietary,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72324,pattern,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72325,characterized,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72326,by,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72327,high,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72328,consumption,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72329,of,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72330,potatoes,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72331,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72332,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/227031001;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72333,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/227031001;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72334,processed,I-http://purl.bioontology.org/ontology/SNOMEDCT/227031001;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72335,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/227031001;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72336,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72337,poultry,B-http://purl.bioontology.org/ontology/SNOMEDCT/28230009,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72338,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72339,and,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72340,cakes,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72341,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72342,"""",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72343,fruit&vegetable,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72344,"""",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72345,pattern,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72346,:,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72347,high,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72348,intake,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72349,of,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72350,vegetables,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72351,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72352,fruits,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72353,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72354,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72355,oils,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72356,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72357,and,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72358,soy,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72359,products,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72360,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72361,"""",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72362,bread&butter,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72363,"""",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72364,pattern,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72365,:,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72366,high,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72367,intake,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72368,of,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72369,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72370,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72371,butter,B-http://purl.bioontology.org/ontology/SNOMEDCT/226888007,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72372,and,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72373,margarine,B-http://purl.bioontology.org/ontology/SNOMEDCT/226890008,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72374,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72375,and,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72376,"""",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72377,high,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72378,-,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72379,carb,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72380,"""",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72381,pattern,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72382,:,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72383,high,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72384,consumption,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72385,of,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72386,pasta,B-http://purl.bioontology.org/ontology/SNOMEDCT/226740002,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72387,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72388,grains,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72389,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72390,nonalcoholic,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72391,beverages,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72392,",",O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72393,sauces,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72394,and,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72395,condiments,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
72396,.,O,2516.0,"We identified four major dietary patterns : "" Western "" dietary pattern characterized by high consumption of potatoes , red and processed meat , poultry , and cakes , "" fruit&vegetable "" pattern : high intake of vegetables , fruits , vegetable oils , and soy products , "" bread&butter "" pattern : high intake of bread , butter and margarine , and "" high - carb "" pattern : high consumption of pasta , grains , nonalcoholic beverages , sauces and condiments ."
73388,Diet,O,2549.0,Diet was assessed with an FFQ .
73389,was,O,2549.0,Diet was assessed with an FFQ .
73390,assessed,O,2549.0,Diet was assessed with an FFQ .
73391,with,O,2549.0,Diet was assessed with an FFQ .
73392,an,O,2549.0,Diet was assessed with an FFQ .
73393,FFQ,O,2549.0,Diet was assessed with an FFQ .
73394,.,O,2549.0,Diet was assessed with an FFQ .
73620,The,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73621,purpose,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73622,of,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73623,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73624,study,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73625,was,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73626,to,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73627,1,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73628,),O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73629,systematically,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73630,study,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73631,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73632,insulin,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73633,response,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73634,to,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73635,several,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73636,different,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73637,high,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73638,-,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73639,starch,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73640,foods,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73641,",",O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73642,2,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73643,),O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73644,determine,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73645,whether,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73646,this,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73647,insulin,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73648,response,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73649,could,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73650,be,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73651,predicted,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73652,by,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73653,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73654,glucose,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73655,response,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73656,",",O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73657,and,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73658,3,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73659,),O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73660,determine,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73661,whether,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73662,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73663,glucose,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73664,response,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73665,could,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73666,be,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73667,predicted,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73668,by,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73669,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73670,physical,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73671,structure,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73672,and,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73673,digestibility,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73674,of,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73675,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73676,ingested,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73677,carbohydrate,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73678,.,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73722,Bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73723,",",O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73724,oatmeal,B-http://purl.bioontology.org/ontology/SNOMEDCT/226725004,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73725,",",O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73726,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73727,",",O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73728,lentils,B-http://purl.bioontology.org/ontology/SNOMEDCT/227350006,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73729,",",O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73730,kidney,B-http://purl.bioontology.org/ontology/SNOMEDCT/227362005,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73731,beans,I-http://purl.bioontology.org/ontology/SNOMEDCT/227362005,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73732,",",O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73733,and,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73734,high,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73735,-,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73736,amylose,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73737,corn,B-http://purl.bioontology.org/ontology/SNOMEDCT/412357001,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73738,muffins,I-http://purl.bioontology.org/ontology/SNOMEDCT/412357001,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73739,resulted,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73740,in,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73741,a,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73742,significantly,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73743,lower,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73744,glucose,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73745,area,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73746,than,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73747,50,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73748,g,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73749,glucose,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73750,",",O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73751,and,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73752,the,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73753,glucose,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73754,response,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73755,generally,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73756,could,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73757,be,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73758,predicted,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73759,by,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73760,the,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73761,physical,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73762,structure,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73763,and,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73764,the,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73765,known,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73766,digestibility,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73767,of,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73768,the,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73769,ingested,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73770,carbohydrate,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
73771,.,O,2561.0,"Bread , oatmeal , rice , lentils , kidney beans , and high - amylose corn muffins resulted in a significantly lower glucose area than 50 g glucose , and the glucose response generally could be predicted by the physical structure and the known digestibility of the ingested carbohydrate ."
74163,Nutrition,O,2574.0,Nutrition before pregnancy is associated with perinatal outcomes .
74164,before,O,2574.0,Nutrition before pregnancy is associated with perinatal outcomes .
74165,pregnancy,O,2574.0,Nutrition before pregnancy is associated with perinatal outcomes .
74166,is,O,2574.0,Nutrition before pregnancy is associated with perinatal outcomes .
74167,associated,O,2574.0,Nutrition before pregnancy is associated with perinatal outcomes .
74168,with,O,2574.0,Nutrition before pregnancy is associated with perinatal outcomes .
74169,perinatal,O,2574.0,Nutrition before pregnancy is associated with perinatal outcomes .
74170,outcomes,O,2574.0,Nutrition before pregnancy is associated with perinatal outcomes .
74171,.,O,2574.0,Nutrition before pregnancy is associated with perinatal outcomes .
74628,The,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74629,natural,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74630,history,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74631,of,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74632,the,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74633,positive,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74634,-,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74635,latex,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74636,-,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74637,SPT,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74638,children,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74639,without,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74640,clinical,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74641,reactions,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74642,to,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74643,latex,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74644,exposure,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74645,and,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74646,the,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74647,clinical,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74648,significance,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74649,of,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74650,the,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74651,association,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74652,of,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74653,latex,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74654,and,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74655,fruit,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74656,sensitivity,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74657,require,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74658,further,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74659,studies,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74660,.,O,2593.0,The natural history of the positive - latex - SPT children without clinical reactions to latex exposure and the clinical significance of the association of latex and fruit sensitivity require further studies .
74661,Pyrrolizidine,O,2594.0,Pyrrolizidine alkaloids ( PAs ) are secondary metabolites of plants .
74662,alkaloids,O,2594.0,Pyrrolizidine alkaloids ( PAs ) are secondary metabolites of plants .
74663,(,O,2594.0,Pyrrolizidine alkaloids ( PAs ) are secondary metabolites of plants .
74664,PAs,O,2594.0,Pyrrolizidine alkaloids ( PAs ) are secondary metabolites of plants .
74665,),O,2594.0,Pyrrolizidine alkaloids ( PAs ) are secondary metabolites of plants .
74666,are,O,2594.0,Pyrrolizidine alkaloids ( PAs ) are secondary metabolites of plants .
74667,secondary,O,2594.0,Pyrrolizidine alkaloids ( PAs ) are secondary metabolites of plants .
74668,metabolites,O,2594.0,Pyrrolizidine alkaloids ( PAs ) are secondary metabolites of plants .
74669,of,O,2594.0,Pyrrolizidine alkaloids ( PAs ) are secondary metabolites of plants .
74670,plants,O,2594.0,Pyrrolizidine alkaloids ( PAs ) are secondary metabolites of plants .
74671,.,O,2594.0,Pyrrolizidine alkaloids ( PAs ) are secondary metabolites of plants .
74957,The,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74958,mean,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74959,amount,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74960,of,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74961,folic,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74962,acid,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74963,found,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74964,in,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74965,white,B-http://purl.bioontology.org/ontology/SNOMEDCT/226590000;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74966,bread,I-http://purl.bioontology.org/ontology/SNOMEDCT/226590000;http://purl.bioontology.org/ontology/SNOMEDCT/226559002,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74967,was,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74968,200,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74969, ,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74970,μg/100,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74971, ,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74972,g,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74973,which,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74974,demonstrated,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74975,that,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74976,folic,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74977,-,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74978,acid,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74979,-,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74980,fortified,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74981,wheat,B-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74982,flour,I-http://purl.bioontology.org/ontology/SNOMEDCT/229944000;http://purl.bioontology.org/ontology/SNOMEDCT/412071004;http://purl.bioontology.org/ontology/SNOMEDCT/63766005,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74983,was,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74984,used,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74985,to,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74986,bake,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74987,the,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74988,bread,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74989,.,O,2605.0,The mean amount of folic acid found in white bread was 200   μg/100   g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
75130,The,O,2611.0,The results showed that the amount of protein - bound carbonyls increased after Maillard reaction ( MR ) .
75131,results,O,2611.0,The results showed that the amount of protein - bound carbonyls increased after Maillard reaction ( MR ) .
75132,showed,O,2611.0,The results showed that the amount of protein - bound carbonyls increased after Maillard reaction ( MR ) .
75133,that,O,2611.0,The results showed that the amount of protein - bound carbonyls increased after Maillard reaction ( MR ) .
75134,the,O,2611.0,The results showed that the amount of protein - bound carbonyls increased after Maillard reaction ( MR ) .
75135,amount,O,2611.0,The results showed that the amount of protein - bound carbonyls increased after Maillard reaction ( MR ) .
75136,of,O,2611.0,The results showed that the amount of protein - bound carbonyls increased after Maillard reaction ( MR ) .
75137,protein,O,2611.0,The results showed that the amount of protein - bound carbonyls increased after Maillard reaction ( MR ) .
75138,-,O,2611.0,The results showed that the amount of protein - bound carbonyls increased after Maillard reaction ( MR ) .
75139,bound,O,2611.0,The results showed that the amount of protein - bound carbonyls increased after Maillard reaction ( MR ) .
75140,carbonyls,O,2611.0,The results showed that the amount of protein - bound carbonyls increased after Maillard reaction ( MR ) .
75141,increased,O,2611.0,The results showed that the amount of protein - bound carbonyls increased after Maillard reaction ( MR ) .
75142,after,O,2611.0,The results showed that the amount of protein - bound carbonyls increased after Maillard reaction ( MR ) .
75143,Maillard,O,2611.0,The results showed that the amount of protein - bound carbonyls increased after Maillard reaction ( MR ) .
75144,reaction,O,2611.0,The results showed that the amount of protein - bound carbonyls increased after Maillard reaction ( MR ) .
75145,(,O,2611.0,The results showed that the amount of protein - bound carbonyls increased after Maillard reaction ( MR ) .
75146,MR,O,2611.0,The results showed that the amount of protein - bound carbonyls increased after Maillard reaction ( MR ) .
75147,),O,2611.0,The results showed that the amount of protein - bound carbonyls increased after Maillard reaction ( MR ) .
75148,.,O,2611.0,The results showed that the amount of protein - bound carbonyls increased after Maillard reaction ( MR ) .
75441,Some,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75442,weeks,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75443,later,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75444,",",O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75445,approximately,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75446,200,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75447,infants,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75448,(,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75449,fed,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75450,exclusively,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75451,with,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75452,formula,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75453,milks,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75454,with,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75455,a,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75456,chloride,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75457,content,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75458,of,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75459,only,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75460,2,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75461,-,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75462,4,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75463,mmol,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75464,/,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75465,L,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75466,),O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75467,",",O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75468,were,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75469,admitted,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75470,with,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75471,failure,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75472,to,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75473,thrive,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75474,",",O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75475,constipation,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75476,",",O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75477,food,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75478,refusal,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75479,",",O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75480,muscular,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75481,weakness,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75482,",",O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75483,and,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75484,delayed,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75485,psychomotor,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75486,development,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75487,.,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75584,We,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75585,review,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75586,and,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75587,compare,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75588,trends,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75589,in,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75590,coronary,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75591,heart,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75592,disease,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75593,(,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75594,CHD,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75595,),O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75596,and,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75597,stroke,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75598,mortality,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75599,in,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75600,Spain,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75601,from,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75602,1966,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75603,to,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75604,1990,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75605,and,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75606,changes,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75607,in,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75608,food,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75609,consumption,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75610,at,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75611,national,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75612,and,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75613,regional,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75614,levels,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
75615,.,O,2628.0,We review and compare trends in coronary heart disease ( CHD ) and stroke mortality in Spain from 1966 to 1990 and changes in food consumption at national and regional levels .
76624,By,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76625,December,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76626,31,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76627,",",O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76628,2001,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76629,",",O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76630,238,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76631,cases,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76632,had,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76633,occurred,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76634,in,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76635,which,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76636,HER-2,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76637,status,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76638,was,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76639,known,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76640,.,O,2663.0,"By December 31 , 2001 , 238 cases had occurred in which HER-2 status was known ."
76854,A,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76855,total,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76856,of,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76857,"1,501",O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76858,individuals,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76859,",",O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76860,in,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76861,197,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76862,households,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76863,",",O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76864,from,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76865,35,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76866,villages,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76867,in,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76868,different,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76869,regions,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76870,were,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76871,studied,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
76872,.,O,2670.0,"A total of 1,501 individuals , in 197 households , from 35 villages in different regions were studied ."
77260,Usage,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77261,of,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77262,these,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77263,reproductive,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77264,drugs,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77265,in,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77266,humans,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77267,is,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77268,increased,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77269,manifold,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77270,to,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77271,manage,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77272,reproductive,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77273,problems,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77274,and/or,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77275,for,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77276,birth,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77277,control,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77278,with,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77279,changing,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77280,lifestyles,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77281,.,O,2682.0,Usage of these reproductive drugs in humans is increased manifold to manage reproductive problems and/or for birth control with changing lifestyles .
77512,Mortality,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77513,rates,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77514,for,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77515,these,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77516,diseases,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77517,subsequently,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77518,decreased,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77519,significantly,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77520,while,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77521,the,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77522,already,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77523,low,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77524,rates,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77525,for,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77526,ischemic,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77527,heart,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77528,disease,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77529,and,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77530,cancer,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77531,also,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77532,decreased,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77533,",",O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77534,resulting,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77535,in,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77536,Japanese,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77537,life,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77538,expectancy,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77539,becoming,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77540,the,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77541,longest,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77542,.,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77672,The,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77673,typical,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77674,Japanese,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77675,diet,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77676,as,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77677,characterized,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77678,by,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77679,plant,B-http://purl.bioontology.org/ontology/SNOMEDCT/255620007,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77680,food,I-http://purl.bioontology.org/ontology/SNOMEDCT/255620007,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77681,and,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77682,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77683,as,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77684,well,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77685,as,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77686,modest,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77687,Westernized,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77688,diet,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77689,such,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77690,as,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77691,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77692,",",O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77693,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77694,and,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77695,dairy,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77696,products,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77697,might,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77698,be,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77699,associated,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77700,with,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77701,longevity,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77702,in,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77703,Japan,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77704,.,O,2695.0,"The typical Japanese diet as characterized by plant food and fish as well as modest Westernized diet such as meat , milk and dairy products might be associated with longevity in Japan ."
77790,During,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77791,a,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77792,mean,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77793,follow,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77794,-,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77795,up,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77796,of,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77797,11.1,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77798,years,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77799,",",O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77800,339,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77801,participants,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77802,developed,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77803,EC,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77804,",",O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77805,of,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77806,which,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77807,142,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77808,were,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77809,esophageal,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77810,adenocarcinoma,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77811,(,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77812,EAC,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77813,),O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77814,and,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77815,174,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77816,were,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77817,esophageal,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77818,squamous,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77819,cell,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77820,carcinoma,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77821,(,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77822,ESCC,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77823,),O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77824,.,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77944,However,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77945,",",O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77946,no,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77947,statistically,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77948,significant,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77949,findings,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77950,were,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77951,observed,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77952,using,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77953,the,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77954,continuous,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77955,variable,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77956,(,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77957,per,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77958,100,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77959,mL,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77960,/,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77961,d,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77962,),O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
77963,.,O,2704.0,"However , no statistically significant findings were observed using the continuous variable ( per 100 mL / d ) ."
78137,A,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78138,protective,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78139,effect,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78140,on,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78141,risk,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78142,of,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78143,EOC,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78144,for,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78145,whole,B-http://purl.bioontology.org/ontology/SNOMEDCT/255620007,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78146,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/255620007,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78147,grain,I-http://purl.bioontology.org/ontology/SNOMEDCT/255620007,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78148,food,I-http://purl.bioontology.org/ontology/SNOMEDCT/255620007,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78149,consumption,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78150,as,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78151,well,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78152,as,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78153,for,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78154,consumption,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78155,of,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78156,low,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78157,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78158,fat,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78159,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78160,is,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78161,suggested,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78162,by,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78163,the,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78164,results,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78165,of,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78166,the,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78167,studies,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78168,.,O,2710.0,A protective effect on risk of EOC for whole - grain food consumption as well as for consumption of low - fat milk is suggested by the results of the studies .
78169,However,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78170,",",O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78171,evidence,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78172,for,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78173,associations,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78174,of,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78175,foods,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78176,such,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78177,as,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78178,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78179,",",O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78180,grains,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78181,",",O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78182,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78183,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78184,",",O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78185,and,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78186,fats,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78187,and,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78188,oils,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78189,with,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78190,EOC,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78191,risk,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78192,is,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78193,limited,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78194,and,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78195,inconsistent,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78196,",",O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78197,and,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78198,further,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78199,examination,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78200,of,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78201,these,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78202,dietary,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78203,determinants,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78204,of,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78205,EOC,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78206,are,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78207,warranted,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78208,.,O,2711.0,"However , evidence for associations of foods such as fish , grains , milk products , and fats and oils with EOC risk is limited and inconsistent , and further examination of these dietary determinants of EOC are warranted ."
78427,Additionally,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78428,",",O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78429,intake,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78430,of,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78431,animal,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78432,fat,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78433,",",O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78434,eggs,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78435,",",O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78436,and,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78437,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78438,was,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78439,positively,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78440,associated,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78441,with,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78442,the,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78443,risk,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78444,of,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78445,TNBC,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78446,",",O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78447,but,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78448,intake,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78449,of,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78450,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78451,fats,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78452,",",O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78453,nuts,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78454,",",O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78455,and,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78456,vegetables,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78457,showed,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78458,a,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78459,negative,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78460,association,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78461,.,O,2720.0,"Additionally , intake of animal fat , eggs , and meat was positively associated with the risk of TNBC , but intake of vegetable fats , nuts , and vegetables showed a negative association ."
78613,At,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78614,the,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78615,follow,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78616,-,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78617,up,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78618,survey,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78619,in,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78620,2002,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78621,",",O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78622,the,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78623,development,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78624,of,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78625,diabetes,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78626,and,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78627,the,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78628,time,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78629,of,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78630,diagnosis,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78631,were,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78632,reported,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
78633,.,O,2727.0,"At the follow - up survey in 2002 , the development of diabetes and the time of diagnosis were reported ."
79293,Overall,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79294,",",O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79295,incorporating,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79296,an,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79297,80,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79298,-,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79299,90,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79300,g,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79301,portion,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79302,of,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79303,raisins,B-http://purl.bioontology.org/ontology/SNOMEDCT/227463004,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79304,(,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79305,half,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79306,a,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79307,cup,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79308,),O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79309,into,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79310,the,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79311,daily,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79312,diet,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79313,may,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79314,be,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79315,favorable,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79316,for,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79317,human,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79318,health,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79319,.,O,2748.0,"Overall , incorporating an 80 - 90 g portion of raisins ( half a cup ) into the daily diet may be favorable for human health ."
79402,PD,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79403,cases,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79404,were,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79405,identified,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79406,through,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79407,linkage,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79408,with,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79409,the,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79410,Swedish,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79411,National,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79412,Patient,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79413,and,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79414,Cause,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79415,of,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79416,Death,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79417,Registers,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79418,.,O,2752.0,PD cases were identified through linkage with the Swedish National Patient and Cause of Death Registers .
79930,Red,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79931,foods,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79932,contain,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79933,lycopene,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79934,",",O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79935,the,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79936,pigment,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79937,in,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79938,tomatoes,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79939,",",O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79940,which,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79941,is,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79942,localized,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79943,in,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79944,the,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79945,prostate,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79946,gland,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79947,and,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79948,may,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79949,be,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79950,involved,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79951,in,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79952,maintaining,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79953,prostate,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79954,health,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
79955,.,O,2768.0,"Red foods contain lycopene , the pigment in tomatoes , which is localized in the prostate gland and may be involved in maintaining prostate health ."
80108,The,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80109,color,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80110,code,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80111,provides,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80112,simplification,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80113,",",O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80114,but,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80115,it,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80116,is,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80117,also,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80118,important,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80119,as,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80120,a,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80121,way,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80122,to,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80123,help,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80124,consumers,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80125,to,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80126,find,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80127,common,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80128,fruits,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80129,and,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80130,vegetables,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80131,easily,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80132,while,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80133,traveling,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80134,",",O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80135,eating,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80136,in,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80137,restaurants,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80138,or,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80139,working,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80140,.,O,2776.0,"The color code provides simplification , but it is also important as a way to help consumers to find common fruits and vegetables easily while traveling , eating in restaurants or working ."
80401,At,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80402,the,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80403,top,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80404,of,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80405,the,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80406,pyramid,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80407,",",O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80408,there,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80409,are,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80410,two,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80411,pennants,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80412,:,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80413,one,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80414,green,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80415,means,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80416,that,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80417,subjects,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80418,with,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80419,RA,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80420,need,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80421,some,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80422,personalized,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80423,supplementation,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80424,(,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80425,vitamin,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80426,D,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80427,and,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80428,omega,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80429,3,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80430,),O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80431,and,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80432,one,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80433,red,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80434,means,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80435,that,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80436,there,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80437,are,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80438,some,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80439,foods,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80440,that,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80441,are,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80442,banned,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80443,(,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80444,salt,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80445,and,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80446,sugar,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80447,),O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80448,.,O,2783.0,"At the top of the pyramid , there are two pennants : one green means that subjects with RA need some personalized supplementation ( vitamin D and omega 3 ) and one red means that there are some foods that are banned ( salt and sugar ) ."
80877,Primary,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80878,outcomes,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80879,were,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80880,particle,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80881,size,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80882,and,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80883,lipid,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80884,release,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80885,at,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80886,each,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80887,phase,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80888,of,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80889,digestion,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80890,.,O,2800.0,Primary outcomes were particle size and lipid release at each phase of digestion .
80891,Walnuts,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80892,produced,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80893,a,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80894,significantly,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80895,larger,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80896,particle,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80897,size,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80898,post,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80899,-,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80900,mastication,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80901,compared,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80902,with,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80903,almonds,B-http://purl.bioontology.org/ontology/SNOMEDCT/256350002,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80904,.,O,2801.0,Walnuts produced a significantly larger particle size post - mastication compared with almonds .
80929,However,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80930,",",O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80931,the,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80932,masticated,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80933,and,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80934,digesta,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80935,particle,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80936,sizes,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80937,were,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80938,not,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80939,related,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80940,to,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80941,the,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80942,integrity,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80943,of,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80944,cell,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80945,walls,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80946,or,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80947,lipid,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80948,release,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
80949,.,O,2803.0,"However , the masticated and digesta particle sizes were not related to the integrity of cell walls or lipid release ."
82149,Features,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82150,of,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82151,a,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82152,vegetarian,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82153,diet,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82154,that,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82155,may,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82156,reduce,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82157,risk,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82158,of,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82159,chronic,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82160,disease,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82161,include,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82162,lower,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82163,intakes,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82164,of,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82165,saturated,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82166,fat,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82167,and,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82168,cholesterol,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82169,and,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82170,higher,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82171,intakes,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82172,of,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82173,fruits,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82174,",",O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82175,vegetables,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82176,",",O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82177,whole,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82178,grains,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82179,",",O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82180,nuts,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82181,",",O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82182,soy,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82183,products,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82184,",",O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82185,fiber,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82186,",",O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82187,and,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82188,phytochemicals,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82189,.,O,2848.0,"Features of a vegetarian diet that may reduce risk of chronic disease include lower intakes of saturated fat and cholesterol and higher intakes of fruits , vegetables , whole grains , nuts , soy products , fiber , and phytochemicals ."
82969,Nonheme,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82970,iron,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82971,was,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82972,better,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82973,absorbed,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82974,than,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82975,heme,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82976,iron,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82977,regardless,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82978,of,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82979,other,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82980,dietary,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82981,factors,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82982,.,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
83092,The,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83093,monitoring,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83094,of,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83095,heavy,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83096,metals,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83097,in,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83098,industrialized,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83099,areas,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83100,to,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83101,study,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83102,their,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83103,association,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83104,with,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83105,different,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83106,occupational,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83107,and,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83108,environmental,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83109,factors,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83110,is,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83111,carried,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83112,out,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83113,in,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83114,different,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83115,ways,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83116,.,O,2879.0,The monitoring of heavy metals in industrialized areas to study their association with different occupational and environmental factors is carried out in different ways .
83532,These,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83533,studies,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83534,indicate,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83535,that,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83536,ginger,B-http://purl.bioontology.org/ontology/SNOMEDCT/227400003,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83537,has,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83538,very,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83539,good,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83540,potential,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83541,for,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83542,α,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83543,-,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83544,glucosidase,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83545,and,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83546,α,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83547,-,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83548,amylase,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83549,inhibition,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83550,relevant,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83551,for,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83552,type,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83553,2,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83554,diabetes,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83555,management,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83556,and,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83557,cyclooxygenase,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83558,inhibition,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83559,for,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83560,inflammation,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83561,.,O,2896.0,These studies indicate that ginger has very good potential for α - glucosidase and α - amylase inhibition relevant for type 2 diabetes management and cyclooxygenase inhibition for inflammation .
83670,Nonsensory,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83671,factors,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83672,such,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83673,as,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83674,demographic,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83675,profile,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83676,",",O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83677,innovativeness,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83678,",",O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83679,social,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83680,representation,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83681,",",O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83682,sensation,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83683,-,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83684,seeking,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83685,",",O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83686,and,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83687,personality,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83688,traits,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83689,were,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83690,also,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83691,assessed,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83692,.,O,2901.0,"Nonsensory factors such as demographic profile , innovativeness , social representation , sensation - seeking , and personality traits were also assessed ."
83832,However,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83833,",",O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83834,the,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83835,removal,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83836,of,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83837,fat,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83838,often,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83839,impairs,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83840,the,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83841,sensory,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83842,and,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83843,textural,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83844,properties,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83845,of,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83846,foods,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83847,",",O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83848,leading,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83849,to,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83850,low,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83851,consumer,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83852,acceptance,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83853,.,O,2907.0,"However , the removal of fat often impairs the sensory and textural properties of foods , leading to low consumer acceptance ."
83962,A,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83963,similar,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83964,effect,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83965,was,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83966,also,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83967,shown,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83968,for,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83969,rennet,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83970,casein,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83971,",",O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83972,whereas,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83973,inulin,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83974,and,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83975,polydextrose,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83976,had,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83977,little,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83978,or,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83979,no,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83980,effect,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83981,on,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83982,these,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83983,rheological,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83984,parameters,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
83985,.,O,2911.0,"A similar effect was also shown for rennet casein , whereas inulin and polydextrose had little or no effect on these rheological parameters ."
84593,In,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84594,summary,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84595,",",O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84596,in,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84597,the,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84598,present,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84599,study,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84600,",",O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84601,2,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84602,-,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84603,week,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84604,interventions,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84605,with,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84606,carotenoid,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84607,-,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84608,rich,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84609,juices,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84610,led,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84611,only,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84612,to,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84613,minor,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84614,changes,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84615,in,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84616,investigated,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84617,luminal,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84618,biomarkers,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84619,relevant,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84620,to,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84621,colon,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84622,carcinogenesis,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84623,.,O,2936.0,"In summary , in the present study , 2 - week interventions with carotenoid - rich juices led only to minor changes in investigated luminal biomarkers relevant to colon carcinogenesis ."
84850,The,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84851,"""",O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84852,healthy,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84853,/,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84854,Mediterranean,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84855,"""",O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84856,pattern,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84857,was,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84858,negatively,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84859,associated,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84860,with,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84861,breast,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84862,cancer,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84863,risk,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84864,(,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84865,hazard,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84866,ratio,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84867,=,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84868,0.85,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84869,",",O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84870,95,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84871,%,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84872,CI,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84873,:,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84874,0.75,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84875,",",O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84876,0.95,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84877,;,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84878,P,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84879,=,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84880,0.003,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84881,for,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84882,linear,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84883,trend,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84884,),O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84885,",",O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84886,especially,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84887,when,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84888,tumors,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84889,were,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84890,estrogen,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84891,receptor,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84892,-,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84893,positive,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84894,/,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84895,progesterone,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84896,receptor,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84897,-,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84898,negative,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
84899,.,O,2942.0,"The "" healthy / Mediterranean "" pattern was negatively associated with breast cancer risk ( hazard ratio = 0.85 , 95 % CI : 0.75 , 0.95 ; P = 0.003 for linear trend ) , especially when tumors were estrogen receptor - positive / progesterone receptor - negative ."
85072,By,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85073,combining,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85074,the,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85075,two,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85076,data,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85077,sets,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85078,",",O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85079,correlation,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85080,coefficients,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85081,were,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85082,calculated,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85083,for,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85084,per,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85085,capita,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85086,consumption,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85087,patterns,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85088,of,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85089,eight,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85090,foods,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85091,(,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85092,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85093,",",O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85094,pork,B-http://purl.bioontology.org/ontology/SNOMEDCT/226934003,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85095,",",O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85096,beef,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85097,",",O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85098,poultry,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85099,",",O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85100,saltwater,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85101,fish,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85102,",",O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85103,freshwater,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85104,fish,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85105,",",O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85106,fresh,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85107,vegetables,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85108,",",O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85109,and,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85110,eggs,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85111,),O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85112,and,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85113,cancer,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85114,incidence,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85115,data,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85116,of,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85117,the,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85118,same,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85119,year,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85120,or,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85121,10,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85122,years,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85123,later,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85124,.,O,2948.0,"By combining the two data sets , correlation coefficients were calculated for per capita consumption patterns of eight foods ( rice , pork , beef , poultry , saltwater fish , freshwater fish , fresh vegetables , and eggs ) and cancer incidence data of the same year or 10 years later ."
85125,Higher,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85126,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85127,intakes,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85128,were,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85129,significantly,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85130,and,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85131,positively,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85132,correlated,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85133,with,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85134,cancers,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85135,of,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85136,the,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85137,colon,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85138,",",O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85139,rectum,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85140,",",O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85141,prostate,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85142,",",O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85143,and,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85144,female,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85145,breast,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85146,.,O,2949.0,"Higher meat intakes were significantly and positively correlated with cancers of the colon , rectum , prostate , and female breast ."
85322,Finally,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85323,",",O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85324,children,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85325,and,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85326,parents,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85327,should,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85328,be,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85329,taught,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85330,how,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85331,to,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85332,count,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85333,carbohydrates,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85334,",",O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85335,which,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85336,would,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85337,help,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85338,them,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85339,manage,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85340,exceptions,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85341,in,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85342,their,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85343,daily,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85344,meal,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85345,plan,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85346,.,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85434,In,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85435,the,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85436,case,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85437,of,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85438,very,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85439,young,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85440,children,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85441,",",O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85442,new,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85443,behavioural,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85444,-,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85445,based,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85446,intervention,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85447,strategies,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85448,to,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85449,help,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85450,parents,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85451,improve,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85452,mealtimes,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85453,could,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85454,be,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85455,useful,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85456,in,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85457,teaching,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85458,diabetic,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85459,children,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85460,to,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85461,learn,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85462,to,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85463,follow,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85464,a,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85465,structured,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85466,eating,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85467,schedule,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85468,",",O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85469,which,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85470,is,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85471,desirable,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85472,for,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85473,long,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85474,-,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85475,lasting,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85476,efficacy,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85477,in,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85478,diabetes,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85479,care,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85480,.,O,2960.0,"In the case of very young children , new behavioural - based intervention strategies to help parents improve mealtimes could be useful in teaching diabetic children to learn to follow a structured eating schedule , which is desirable for long - lasting efficacy in diabetes care ."
85539,The,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85540,medicinal,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85541,use,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85542,of,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85543,cacao,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85544,",",O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85545,or,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85546,chocolate,B-http://purl.bioontology.org/ontology/SNOMEDCT/102262009,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85547,",",O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85548,both,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85549,as,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85550,a,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85551,primary,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85552,remedy,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85553,and,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85554,as,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85555,a,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85556,vehicle,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85557,to,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85558,deliver,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85559,other,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85560,medicines,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85561,",",O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85562,originated,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85563,in,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85564,the,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85565,New,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85566,World,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85567,and,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85568,diffused,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85569,to,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85570,Europe,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85571,in,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85572,the,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85573,mid,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85574,1500s,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
85575,.,O,2964.0,"The medicinal use of cacao , or chocolate , both as a primary remedy and as a vehicle to deliver other medicines , originated in the New World and diffused to Europe in the mid 1500s ."
86235,Seventeen,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86236,type,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86237,II,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86238,(,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86239,non,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86240,-,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86241,insulin,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86242,-,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86243,dependent,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86244,),O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86245,untreated,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86246,diabetic,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86247,subjects,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86248,were,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86249,given,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86250,single,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86251,breakfast,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86252,meals,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86253,consisting,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86254,of,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86255,50,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86256,g,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86257,glucose,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86258,",",O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86259,or,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86260,50,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86261,g,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86262,glucose,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86263,plus,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86264,25,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86265,g,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86266,protein,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86267,in,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86268,the,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86269,form,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86270,of,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86271,lean,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86272,beef,I-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86273,",",O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86274,turkey,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86275,",",O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86276,gelatin,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86277,",",O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86278,egg,B-http://purl.bioontology.org/ontology/SNOMEDCT/256443002,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86279,white,I-http://purl.bioontology.org/ontology/SNOMEDCT/256443002,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86280,",",O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86281,cottage,B-http://purl.bioontology.org/ontology/SNOMEDCT/226814003;http://purl.bioontology.org/ontology/SNOMEDCT/102264005,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86282,cheese,I-http://purl.bioontology.org/ontology/SNOMEDCT/226814003;http://purl.bioontology.org/ontology/SNOMEDCT/102264005,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86283,",",O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86284,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86285,",",O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86286,or,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86287,soy,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86288,.,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86407,The,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86408,peripheral,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86409,glucagon,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86410,concentration,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86411,was,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86412,decreased,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86413,following,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86414,ingestion,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86415,of,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86416,glucose,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86417,alone,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86418,and,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86419,increased,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86420,following,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86421,all,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86422,the,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86423,meals,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86424,containing,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86425,protein,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86426,.,O,2993.0,The peripheral glucagon concentration was decreased following ingestion of glucose alone and increased following all the meals containing protein .
86427,The,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86428,alpha,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86429,amino,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86430,nitrogen,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86431,concentration,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86432,varied,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86433,considerably,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86434,.,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86568,After,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86569,adjusting,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86570,for,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86571,these,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86572,effects,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86573,",",O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86574,case,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86575,-,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86576,control,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86577,differences,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86578,were,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86579,found,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86580,for,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86581,several,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86582,dietary,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86583,variables,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86584,",",O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86585,assessed,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86586,by,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86587,asking,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86588,about,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86589,the,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86590,usual,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86591,frequency,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86592,of,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86593,consumption,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86594,of,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86595,146,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86596,food,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86597,items,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86598,and,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86599,beverages,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86600,.,O,2999.0,"After adjusting for these effects , case - control differences were found for several dietary variables , assessed by asking about the usual frequency of consumption of 146 food items and beverages ."
86691,Lowered,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86692,risk,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86693,was,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86694,also,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86695,related,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86696,to,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86697,consumption,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86698,of,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86699,spices,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86700,",",O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86701,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86702,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86703,and,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86704,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86705,.,O,3003.0,"Lowered risk was also related to consumption of spices , olive oil and garlic ."
86839,We,O,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86840,have,O,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86841,previously,O,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86842,described,O,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86843,the,O,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86844,hypoglycemic,O,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86845,",",O,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86846,hypolipidemic,O,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86847,",",O,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86848,and,O,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86849,anticoagulant,O,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86850,activity,O,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86851,of,O,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86852,orally,O,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86853,administered,O,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86854,camel,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86855,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86856,in,O,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86857,streptozotocin,O,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86858,-,O,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86859,induced,O,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86860,diabetic,O,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86861,rats,O,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86862,.,O,3009.0,"We have previously described the hypoglycemic , hypolipidemic , and anticoagulant activity of orally administered camel milk in streptozotocin - induced diabetic rats ."
86863,In,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86864,the,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86865,present,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86866,study,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86867,in,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86868,the,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86869,same,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86870,animal,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86871,model,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86872,",",O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86873,we,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86874,extended,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86875,these,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86876,observations,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86877,by,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86878,comparing,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86879,camel,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86880,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86881,and,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86882,the,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86883,more,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86884,available,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86885,and,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86886,widely,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86887,consumed,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86888,bovine,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86889,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86890,with,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86891,respect,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86892,to,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86893,their,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86894,antidiabetic,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86895,and,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86896,antithrombotic,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86897,actions,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86898,.,O,3010.0,"In the present study in the same animal model , we extended these observations by comparing camel milk and the more available and widely consumed bovine milk with respect to their antidiabetic and antithrombotic actions ."
86899,Rats,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86900,were,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86901,rendered,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86902,diabetic,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86903,by,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86904,intraperitoneal,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86905,streptozotocin,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86906,(,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86907,65,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86908,mg,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86909,/,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86910,kg,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86911,),O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86912,",",O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86913,and,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86914,then,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86915,camel,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86916,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86917,or,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86918,bovine,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86919,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86920,was,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86921,administered,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86922,orally,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86923,for,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86924,8,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86925,wk,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86926,.,O,3011.0,"Rats were rendered diabetic by intraperitoneal streptozotocin ( 65 mg / kg ) , and then camel milk or bovine milk was administered orally for 8 wk ."
86993,Treatment,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86994,with,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86995,camel,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86996,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86997,or,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86998,bovine,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
86999,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87000,reversed,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87001,these,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87002,abnormalities,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87003,",",O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87004,resulting,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87005,in,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87006,weight,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87007,gain,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87008,",",O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87009,decreased,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87010,blood,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87011,glucose,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87012,levels,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87013,",",O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87014,and,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87015,improved,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87016,glucose,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87017,tolerance,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87018,.,O,3014.0,"Treatment with camel milk or bovine milk reversed these abnormalities , resulting in weight gain , decreased blood glucose levels , and improved glucose tolerance ."
87399,We,O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87400,conclude,O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87401,that,O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87402,butter,B-http://purl.bioontology.org/ontology/SNOMEDCT/226888007,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87403,increases,O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87404,the,O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87405,insulin,O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87406,response,O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87407,more,O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87408,than,O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87409,does,O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87410,olive,B-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87411,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/41834005,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87412,",",O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87413,and,O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87414,large,O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87415,amounts,O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87416,of,O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87417,butter,B-http://purl.bioontology.org/ontology/SNOMEDCT/226888007,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87418,also,O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87419,increase,O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87420,fatty,O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87421,acid,O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87422,and,O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87423,triacylglycerol,O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87424,concentrations,O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87425,.,O,3025.0,"We conclude that butter increases the insulin response more than does olive oil , and large amounts of butter also increase fatty acid and triacylglycerol concentrations ."
87814,The,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87815,same,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87816,laboratory,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87817,analyzed,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87818,all,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87819,serum,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87820,samples,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87821,for,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87822,IGF,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87823,-,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87824,I,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87825,and,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87826,IGF,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87827,binding,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87828,protein,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87829,(,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87830,IGFBP)-3,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87831,by,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87832,enzyme,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87833,-,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87834,linked,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87835,immunosorbent,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87836,assay,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
87837,.,O,3040.0,The same laboratory analyzed all serum samples for IGF - I and IGF binding protein ( IGFBP)-3 by enzyme - linked immunosorbent assay .
88393,Milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88394,",",O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88395,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88396,",",O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88397,and,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88398,grains,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88399,supplied,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88400,an,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88401,appreciable,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88402,proportion,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88403,of,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88404,each,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88405,vitamin,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88406,except,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88407,vitamin,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88408,A,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88409,",",O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88410,which,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88411,was,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88412,found,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88413,primarily,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88414,in,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88415,the,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88416,two,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88417,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88418,groups,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88419,.,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
89338,use,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89339,of,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89340,a,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89341,refrigerator,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89342,at,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89343,home,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89344,for,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89345,30,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89346,and,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89347,more,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89348,years,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89349,compared,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89350,to,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89351,24,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89352,years,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89353,or,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89354,less,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89355,showed,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89356,an,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89357,inverse,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89358,relationship,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89359,",",O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89360,whereas,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89361,salt,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89362,intake,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89363,estimated,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89364,by,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89365,questionnaire,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89366,showed,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89367,no,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89368,relationship,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89369,to,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89370,stomach,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89371,cancer,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89372,risk,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89373,.,O,3091.0,"use of a refrigerator at home for 30 and more years compared to 24 years or less showed an inverse relationship , whereas salt intake estimated by questionnaire showed no relationship to stomach cancer risk ."
89464,Increased,O,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89465,consumption,O,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89466,of,O,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89467,processed,B-http://purl.bioontology.org/ontology/SNOMEDCT/227031001;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89468,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/227031001;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89469,and,O,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89470,of,O,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89471,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89472,showed,O,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89473,a,O,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89474,positive,O,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89475,association,O,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89476,with,O,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89477,risk,O,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89478,whereas,O,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89479,increased,O,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89480,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89481,and,O,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89482,liquor,O,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89483,consumption,O,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89484,showed,O,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89485,a,O,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89486,significant,O,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89487,negative,O,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89488,association,O,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89489,.,O,3097.0,Increased consumption of processed meat and of beer showed a positive association with risk whereas increased wine and liquor consumption showed a significant negative association .
89519,Among,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89520,these,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89521,",",O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89522,chlorogenic,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89523,acids,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89524,(,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89525,CGAs,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89526,),O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89527,received,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89528,considerable,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89529,attention,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89530,for,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89531,their,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89532,wide,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89533,distribution,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89534,and,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89535,part,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89536,of,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89537,human,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89538,diet,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89539,with,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89540,potential,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89541,biological,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89542,effects,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89543,.,O,3100.0,"Among these , chlorogenic acids ( CGAs ) received considerable attention for their wide distribution and part of human diet with potential biological effects ."
89544,CGAs,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89545,(,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89546,71,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89547,compounds,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89548,),O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89549,",",O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89550,being,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89551,esters,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89552,of,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89553,derivatives,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89554,of,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89555,cinnamic,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89556,acids,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89557,with,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89558,quinic,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89559,acid,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89560,are,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89561,widely,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89562,distributed,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89563,in,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89564,plant,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89565,materials,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89566,.,O,3101.0,"CGAs ( 71 compounds ) , being esters of derivatives of cinnamic acids with quinic acid are widely distributed in plant materials ."
89678,Recent,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89679,technological,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89680,advancements,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89681,in,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89682,the,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89683,separation,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89684,and,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89685,purification,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89686,of,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89687,CGAs,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89688,such,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89689,as,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89690,molecular,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89691,-,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89692,imprinted,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89693,polymer,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89694,technique,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89695,;,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89696,microwave,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89697,-,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89698,assisted,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89699,extraction,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89700,;,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89701,pH,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89702,gradient,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89703,counter,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89704,current,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89705,chromatography,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89706,has,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89707,also,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89708,been,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89709,described,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
89710,.,O,3107.0,Recent technological advancements in the separation and purification of CGAs such as molecular - imprinted polymer technique ; microwave - assisted extraction ; pH gradient counter current chromatography has also been described .
90546,The,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90547,samples,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90548,were,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90549,prepared,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90550,using,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90551,3,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90552,%,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90553,(,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90554,w,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90555,/,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90556,w,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90557,),O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90558,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90559,starch,I-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90560,",",O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90561,with,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90562,10,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90563,%,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90564,or,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90565,30,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90566,%,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90567,(,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90568,w,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90569,/,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90570,w,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90571,),O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90572,sugar,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90573,(,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90574,trehalose,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90575,or,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90576,allose,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90577,),O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90578,added,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90579,and,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90580,10,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90581,%,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90582,or,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90583,30,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90584,%,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90585,(,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90586,w,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90587,/,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90588,w,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90589,),O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90590,oil,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90591,(,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90592,canola,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90593,or,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90594,coconut,B-http://purl.bioontology.org/ontology/SNOMEDCT/735211005,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90595,),O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
90596,.,O,3137.0,"The samples were prepared using 3 % ( w / w ) rice starch , with 10 % or 30 % ( w / w ) sugar ( trehalose or allose ) added and 10 % or 30 % ( w / w ) oil ( canola or coconut ) ."
91269,Five,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91270,participants,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91271,ate,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91272,polyunsaturated,B-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91273,beef,I-http://purl.bioontology.org/ontology/SNOMEDCT/226916002,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91274,and,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91275,dairy,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91276,products,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91277,during,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91278,the,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91279,first,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91280,experimental,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91281,period,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91282,and,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91283,their,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91284,saturated,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91285,counterparts,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91286,in,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91287,the,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91288,second,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91289,;,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91290,six,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91291,participants,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91292,ate,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91293,saturated,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91294,products,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91295,first,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91296,",",O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91297,then,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91298,polyunsaturated,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91299,.,O,3165.0,"Five participants ate polyunsaturated beef and dairy products during the first experimental period and their saturated counterparts in the second ; six participants ate saturated products first , then polyunsaturated ."
91315,Serum,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91316,cholesterol,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91317,levels,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91318,in,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91319,five,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91320,participants,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91321,who,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91322,had,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91323,not,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91324,previously,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91325,followed,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91326,a,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91327,fat,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91328,-,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91329,modified,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91330,diet,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91331,were,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91332,reduced,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91333,by,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91334,18,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91335,per,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91336,cent,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91337,with,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91338,polyunsaturated,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91339,animal,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91340,products,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91341,and,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91342,11,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91343,per,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91344,cent,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91345,with,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91346,saturated,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91347,products,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91348,.,O,3167.0,Serum cholesterol levels in five participants who had not previously followed a fat - modified diet were reduced by 18 per cent with polyunsaturated animal products and 11 per cent with saturated products .
91761,Overall,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91762,psychosocial,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91763,function,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91764,score,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91765,and,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91766,parental,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91767,educational,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91768,level,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91769,were,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91770,associated,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91771,with,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91772,lower,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91773,fat,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91774,intake,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91775,in,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91776,multivariate,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91777,analysis,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91778,",",O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91779,explaining,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91780,11,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91781,%,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91782,of,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91783,the,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91784,variance,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91785,in,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91786,fat,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91787,intake,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91788,.,O,3180.0,"Overall psychosocial function score and parental educational level were associated with lower fat intake in multivariate analysis , explaining 11 % of the variance in fat intake ."
91849,Numerous,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91850,sensors,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91851,that,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91852,gather,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91853,this,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91854,information,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91855,are,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91856,either,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91857,currently,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91858,available,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91859,or,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91860,in,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91861,development,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
91862,.,O,3183.0,Numerous sensors that gather this information are either currently available or in development .
92266,However,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92267,",",O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92268,additional,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92269,pharmacological,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92270,studies,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92271,and,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92272,clinical,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92273,trials,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92274,are,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92275,needed,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92276,to,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92277,elucidate,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92278,their,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92279,molecular,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92280,and,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92281,cellular,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92282,mechanisms,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92283,of,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92284,actions,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92285,",",O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92286,frequency,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92287,",",O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92288,and,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92289,amount,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92290,of,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92291,consumption,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92292,",",O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92293,possible,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92294,adverse,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92295,effects,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92296,",",O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92297,and,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92298,optimum,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92299,preparation,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92300,methods,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92301,.,O,3198.0,"However , additional pharmacological studies and clinical trials are needed to elucidate their molecular and cellular mechanisms of actions , frequency , and amount of consumption , possible adverse effects , and optimum preparation methods ."
92354,Skin,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92355,reactions,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92356,among,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92357,other,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92358,atopics,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92359,were,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92360,rare,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92361,",",O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92362,and,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92363,non,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92364,-,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92365,atopic,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92366,patients,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92367,showed,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92368,no,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92369,reactions,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92370,to,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92371,fresh,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92372,fruits,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92373,and,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92374,vegetables,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92375,.,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92479,Yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92480,is,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92481,a,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92482,nutrient,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92483,-,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92484,dense,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92485,food,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92486,that,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92487,may,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92488,benefit,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92489,individuals,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92490,with,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92491,lactose,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92492,intolerance,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92493,",",O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92494,constipation,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92495,and,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92496,diarrheal,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92497,diseases,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92498,",",O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92499,hypertension,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92500,",",O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92501,cardiovascular,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92502,diseases,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92503,",",O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92504,diabetes,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92505,",",O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92506,and,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92507,certain,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92508,types,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92509,of,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92510,cancer,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92511,.,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92720,Accumulating,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92721,evidence,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92722,shows,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92723,that,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92724,consuming,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92725,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92726,or,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92727,dairy,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92728,products,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92729,may,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92730,contribute,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92731,to,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92732,the,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92733,risk,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92734,of,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92735,prostate,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92736,and,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92737,ovarian,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92738,cancers,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92739,",",O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92740,autoimmune,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92741,diseases,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92742,",",O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92743,and,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92744,some,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92745,childhood,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92746,ailments,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
92747,.,O,3217.0,"Accumulating evidence shows that consuming milk or dairy products may contribute to the risk of prostate and ovarian cancers , autoimmune diseases , and some childhood ailments ."
105908,Lifestyle,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105909,factors,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105910,",",O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105911,including,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105912,nutrition,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105913,",",O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105914,play,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105915,an,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105916,important,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105917,role,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105918,in,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105919,the,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105920,etiology,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105921,of,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105922,Cardiovascular,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105923,Disease,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105924,(,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105925,CVD,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105926,),O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105927,.,O,3683.0,"Lifestyle factors , including nutrition , play an important role in the etiology of Cardiovascular Disease ( CVD ) ."
105928,This,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105929,position,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105930,paper,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105931,",",O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105932,written,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105933,by,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105934,collaboration,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105935,between,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105936,the,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105937,Israel,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105938,Heart,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105939,Association,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105940,and,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105941,the,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105942,Israel,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105943,Dietetic,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105944,Association,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105945,",",O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105946,summarizes,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105947,the,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105948,current,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105949,",",O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105950,preferably,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105951,latest,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105952,",",O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105953,literature,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105954,on,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105955,the,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105956,association,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105957,of,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105958,nutrition,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105959,and,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105960,CVD,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105961,with,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105962,emphasis,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105963,on,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105964,the,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105965,level,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105966,of,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105967,evidence,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105968,and,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105969,practical,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105970,recommendations,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105971,.,O,3684.0,"This position paper , written by collaboration between the Israel Heart Association and the Israel Dietetic Association , summarizes the current , preferably latest , literature on the association of nutrition and CVD with emphasis on the level of evidence and practical recommendations ."
105972,The,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105973,nutritional,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105974,information,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105975,is,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105976,divided,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105977,into,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105978,three,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105979,main,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105980,sections,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105981,:,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105982,dietary,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105983,patterns,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105984,",",O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105985,individual,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105986,food,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105987,items,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105988,",",O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105989,and,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105990,nutritional,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105991,supplements,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
105992,.,O,3685.0,"The nutritional information is divided into three main sections : dietary patterns , individual food items , and nutritional supplements ."
106363,Dairy,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106364,and,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106365,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106366,meat,I-http://purl.bioontology.org/ontology/SNOMEDCT/226915003;http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106367,were,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106368,more,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106369,consumed,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106370,in,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106371,summer,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106372,and,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106373,winter,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106374,",",O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106375,respectively,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106376,.,O,3699.0,"Dairy and red meat were more consumed in summer and winter , respectively ."
106887,Consumption,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106888,of,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106889,a,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106890,diet,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106891,rich,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106892,in,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106893,fruits,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106894,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106895,vegetables,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106896,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106897,folate,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106898,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106899,K,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106900,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106901,Ca,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106902,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106903,Mg,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106904,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106905,dietary,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106906,fibre,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106907,",",O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106908,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106909,and,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106910,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106911,may,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106912,protect,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106913,against,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106914,stroke,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
106915,.,O,3716.0,"Consumption of a diet rich in fruits , vegetables , folate , K , Ca , Mg , dietary fibre , fish and milk may protect against stroke ."
107036,Nutrition,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107037,is,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107038,far,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107039,more,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107040,important,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107041,in,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107042,stroke,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107043,risk,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107044,than,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107045,most,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107046,physcians,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107047,suppose,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107048,.,O,3721.0,Nutrition is far more important in stroke risk than most physcians suppose .
107490,A,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107491,major,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107492,determinant,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107493,of,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107494,the,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107495,postmeal,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107496,glucose,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107497,rise,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107498,in,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107499,IDDM,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107500,patients,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107501,seems,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107502,to,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107503,be,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107504,dependent,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107505,on,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107506,the,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107507,kind,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107508,of,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107509,carbohydrate,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107510,in,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107511,the,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107512,meal,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107513,.,O,3737.0,A major determinant of the postmeal glucose rise in IDDM patients seems to be dependent on the kind of carbohydrate in the meal .
107844,Age-,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107845,",",O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107846,gender-,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107847,",",O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107848,education-,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107849,and,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107850,total,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107851,energy,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107852,intake,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107853,-,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107854,adjusted,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107855,odds,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107856,ratios,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107857,(,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107858,OR,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107859,),O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107860,were,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107861,computed,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107862,.,O,3751.0,"Age- , gender- , education- and total energy intake - adjusted odds ratios ( OR ) were computed ."
107983,The,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107984,association,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107985,was,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107986,similar,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107987,for,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107988,cardia,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107989,and,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107990,non,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107991,-,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107992,cardia,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107993,gastric,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107994,cancer,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107995,",",O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107996,but,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107997,for,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107998,tumors,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
107999,of,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108000,the,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108001,diffuse,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108002,Laurén,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108003,histological,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108004,type,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108005,",",O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108006,the,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108007,association,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108008,was,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108009,weaker,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108010,for,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108011,pattern,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108012,II,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108013,vs.,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108014,I,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108015,(,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108016,OR,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108017,=,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108018,1.32,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108019,",",O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108020,95,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108021,%,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108022,CI,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108023,:,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108024,0.83,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108025,-,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108026,2.08,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108027,),O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108028,and,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108029,a,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108030,protective,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108031,effect,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108032,was,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108033,observed,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108034,for,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108035,pattern,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108036,III,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108037,vs.,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108038,I,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108039,(,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108040,OR,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108041,=,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108042,0.43,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108043,",",O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108044,95,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108045,%,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108046,CI,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108047,:,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108048,0.22,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108049,-,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108050,0.87,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108051,),O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108052,.,O,3754.0,"The association was similar for cardia and non - cardia gastric cancer , but for tumors of the diffuse Laurén histological type , the association was weaker for pattern II vs. I ( OR = 1.32 , 95 % CI : 0.83 - 2.08 ) and a protective effect was observed for pattern III vs. I ( OR = 0.43 , 95 % CI : 0.22 - 0.87 ) ."
108053,Our,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108054,results,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108055,confirm,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108056,the,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108057,protective,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108058,effect,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108059,of,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108060,high,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108061,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108062,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108063,vegetables,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108064,intake,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108065,",",O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108066,and,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108067,show,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108068,a,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108069,differential,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108070,association,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108071,according,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108072,to,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108073,histological,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108074,type,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108075,.,O,3755.0,"Our results confirm the protective effect of high fruit and vegetables intake , and show a differential association according to histological type ."
108644,Intake,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108645,of,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108646,vegetables,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108647,is,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108648,recommended,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108649,for,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108650,the,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108651,prevention,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108652,of,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108653,myocardial,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108654,infarction,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108655,(,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108656,MI,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108657,),O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108658,.,O,3775.0,Intake of vegetables is recommended for the prevention of myocardial infarction ( MI ) .
108718,We,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108719,followed,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108720,"29,142",O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108721,women,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108722,and,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108723,"26,029",O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108724,men,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108725,aged,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108726,50,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108727,-,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108728,64,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108729,years,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108730,in,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108731,the,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108732,Danish,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108733,Diet,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108734,",",O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108735,Cancer,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108736,and,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108737,Health,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108738,cohort,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108739,.,O,3779.0,"We followed 29,142 women and 26,029 men aged 50 - 64 years in the Danish Diet , Cancer and Health cohort ."
108791,Among,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108792,women,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108793,",",O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108794,the,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108795,adjusted,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108796,HR,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108797,for,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108798,MI,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108799,was,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108800,1.02,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108801,(,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108802,95,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108803,%,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108804,CI,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108805,:,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108806,0.93,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108807,",",O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108808,1.13,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108809,),O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108810,per,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108811,500,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108812,g,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108813,/,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108814,week,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108815,replacement,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108816,of,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108817,potatoes,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108818,with,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108819,other,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108820,vegetables,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108821,.,O,3783.0,"Among women , the adjusted HR for MI was 1.02 ( 95 % CI : 0.93 , 1.13 ) per 500 g / week replacement of potatoes with other vegetables ."
108949,Scientists,O,3790.0,Scientists have been studying cranberries ' beneficial effects on urinary tract health since the 20th century .
108950,have,O,3790.0,Scientists have been studying cranberries ' beneficial effects on urinary tract health since the 20th century .
108951,been,O,3790.0,Scientists have been studying cranberries ' beneficial effects on urinary tract health since the 20th century .
108952,studying,O,3790.0,Scientists have been studying cranberries ' beneficial effects on urinary tract health since the 20th century .
108953,cranberries,B-http://purl.bioontology.org/ontology/SNOMEDCT/227421003,3790.0,Scientists have been studying cranberries ' beneficial effects on urinary tract health since the 20th century .
108954,',O,3790.0,Scientists have been studying cranberries ' beneficial effects on urinary tract health since the 20th century .
108955,beneficial,O,3790.0,Scientists have been studying cranberries ' beneficial effects on urinary tract health since the 20th century .
108956,effects,O,3790.0,Scientists have been studying cranberries ' beneficial effects on urinary tract health since the 20th century .
108957,on,O,3790.0,Scientists have been studying cranberries ' beneficial effects on urinary tract health since the 20th century .
108958,urinary,O,3790.0,Scientists have been studying cranberries ' beneficial effects on urinary tract health since the 20th century .
108959,tract,O,3790.0,Scientists have been studying cranberries ' beneficial effects on urinary tract health since the 20th century .
108960,health,O,3790.0,Scientists have been studying cranberries ' beneficial effects on urinary tract health since the 20th century .
108961,since,O,3790.0,Scientists have been studying cranberries ' beneficial effects on urinary tract health since the 20th century .
108962,the,O,3790.0,Scientists have been studying cranberries ' beneficial effects on urinary tract health since the 20th century .
108963,20th,O,3790.0,Scientists have been studying cranberries ' beneficial effects on urinary tract health since the 20th century .
108964,century,O,3790.0,Scientists have been studying cranberries ' beneficial effects on urinary tract health since the 20th century .
108965,.,O,3790.0,Scientists have been studying cranberries ' beneficial effects on urinary tract health since the 20th century .
109008,The,O,3793.0,The cardiometabolic effects of cranberries have been investigated in several clinical trials .
109009,cardiometabolic,O,3793.0,The cardiometabolic effects of cranberries have been investigated in several clinical trials .
109010,effects,O,3793.0,The cardiometabolic effects of cranberries have been investigated in several clinical trials .
109011,of,O,3793.0,The cardiometabolic effects of cranberries have been investigated in several clinical trials .
109012,cranberries,B-http://purl.bioontology.org/ontology/SNOMEDCT/227421003,3793.0,The cardiometabolic effects of cranberries have been investigated in several clinical trials .
109013,have,O,3793.0,The cardiometabolic effects of cranberries have been investigated in several clinical trials .
109014,been,O,3793.0,The cardiometabolic effects of cranberries have been investigated in several clinical trials .
109015,investigated,O,3793.0,The cardiometabolic effects of cranberries have been investigated in several clinical trials .
109016,in,O,3793.0,The cardiometabolic effects of cranberries have been investigated in several clinical trials .
109017,several,O,3793.0,The cardiometabolic effects of cranberries have been investigated in several clinical trials .
109018,clinical,O,3793.0,The cardiometabolic effects of cranberries have been investigated in several clinical trials .
109019,trials,O,3793.0,The cardiometabolic effects of cranberries have been investigated in several clinical trials .
109020,.,O,3793.0,The cardiometabolic effects of cranberries have been investigated in several clinical trials .
109472,The,O,3814.0,The aim of the study was to investigate the relationship between dietary habits and thyroid cancer .
109473,aim,O,3814.0,The aim of the study was to investigate the relationship between dietary habits and thyroid cancer .
109474,of,O,3814.0,The aim of the study was to investigate the relationship between dietary habits and thyroid cancer .
109475,the,O,3814.0,The aim of the study was to investigate the relationship between dietary habits and thyroid cancer .
109476,study,O,3814.0,The aim of the study was to investigate the relationship between dietary habits and thyroid cancer .
109477,was,O,3814.0,The aim of the study was to investigate the relationship between dietary habits and thyroid cancer .
109478,to,O,3814.0,The aim of the study was to investigate the relationship between dietary habits and thyroid cancer .
109479,investigate,O,3814.0,The aim of the study was to investigate the relationship between dietary habits and thyroid cancer .
109480,the,O,3814.0,The aim of the study was to investigate the relationship between dietary habits and thyroid cancer .
109481,relationship,O,3814.0,The aim of the study was to investigate the relationship between dietary habits and thyroid cancer .
109482,between,O,3814.0,The aim of the study was to investigate the relationship between dietary habits and thyroid cancer .
109483,dietary,O,3814.0,The aim of the study was to investigate the relationship between dietary habits and thyroid cancer .
109484,habits,O,3814.0,The aim of the study was to investigate the relationship between dietary habits and thyroid cancer .
109485,and,O,3814.0,The aim of the study was to investigate the relationship between dietary habits and thyroid cancer .
109486,thyroid,O,3814.0,The aim of the study was to investigate the relationship between dietary habits and thyroid cancer .
109487,cancer,O,3814.0,The aim of the study was to investigate the relationship between dietary habits and thyroid cancer .
109488,.,O,3814.0,The aim of the study was to investigate the relationship between dietary habits and thyroid cancer .
109724,An,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109725,increased,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109726,risk,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109727,was,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109728,observed,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109729,for,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109730,consumption,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109731,of,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109732,iodized,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109733,salts,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109734,(,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109735,OR,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109736,2.06,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109737,",",O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109738,95,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109739,%,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109740,CI,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109741,1.21,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109742,-,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109743,3.51,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109744,),O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109745,",",O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109746,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109747,(,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109748,OR,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109749, ,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109750,=,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109751, ,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109752,1.42,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109753,",",O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109754,95,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109755,%,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109756,CI,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109757,0.84,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109758,-,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109759,2.41,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109760,),O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109761,and,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109762,coca,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109763,-,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109764,cola,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109765,(,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109766,OR,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109767, ,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109768,=,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109769, ,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109770,3.08,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109771,",",O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109772,95,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109773,%,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109774,CI,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109775,1.53,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109776,-,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109777,6.20,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109778,),O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109779,.,O,3821.0,"An increased risk was observed for consumption of iodized salts ( OR 2.06 , 95 % CI 1.21 - 3.51 ) , tea ( OR   =   1.42 , 95 % CI 0.84 - 2.41 ) and coca - cola ( OR   =   3.08 , 95 % CI 1.53 - 6.20 ) ."
109925,Legislation,O,3827.0,Legislation requires labeling of foods containing allergenic ingredients .
109926,requires,O,3827.0,Legislation requires labeling of foods containing allergenic ingredients .
109927,labeling,O,3827.0,Legislation requires labeling of foods containing allergenic ingredients .
109928,of,O,3827.0,Legislation requires labeling of foods containing allergenic ingredients .
109929,foods,O,3827.0,Legislation requires labeling of foods containing allergenic ingredients .
109930,containing,O,3827.0,Legislation requires labeling of foods containing allergenic ingredients .
109931,allergenic,O,3827.0,Legislation requires labeling of foods containing allergenic ingredients .
109932,ingredients,O,3827.0,Legislation requires labeling of foods containing allergenic ingredients .
109933,.,O,3827.0,Legislation requires labeling of foods containing allergenic ingredients .
110638,In,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110639,recent,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110640,history,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110641,",",O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110642,some,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110643,dietary,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110644,recommendations,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110645,have,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110646,treated,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110647,dairy,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110648,fat,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110649,as,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110650,an,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110651,unnecessary,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110652,source,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110653,of,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110654,calories,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110655,and,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110656,saturated,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110657,fat,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110658,in,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110659,the,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110660,human,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110661,diet,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110662,.,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110779,This,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110780,synopsis,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110781,of,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110782,these,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110783,symposia,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110784,describes,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110785,the,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110786,complexity,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110787,of,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110788,dairy,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110789,fat,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110790,and,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110791,the,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110792,effects,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110793,regular,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110794,-,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110795,fat,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110796,dairy,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110797,foods,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110798,have,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110799,on,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110800,human,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110801,health,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110802,.,O,3858.0,This synopsis of these symposia describes the complexity of dairy fat and the effects regular - fat dairy foods have on human health .
110908,A,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110909,low,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110910,incidence,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110911,for,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110912,both,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110913,cancers,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110914,has,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110915,been,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110916,recorded,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110917,in,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110918,Mongolia,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110919,and,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110920,Bolivia,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
110921,.,O,3863.0,A low incidence for both cancers has been recorded in Mongolia and Bolivia .
111184,As,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111185,part,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111186,of,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111187,a,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111188,survey,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111189,conducted,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111190,by,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111191,the,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111192,Central,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111193,Agricultural,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111194,Office,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111195,of,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111196,Hungary,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111197,",",O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111198,67,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111199,food,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111200,samples,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111201,including,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111202,beverages,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111203,were,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111204,taken,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111205,from,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111206,57,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111207,food,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111208,industrial,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111209,and,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111210,catering,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111211,companies,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111212,",",O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111213,75,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111214,%,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111215,of,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111216,them,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111217,being,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111218,small,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111219,and,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111220,medium,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111221,-,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111222,sized,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111223,enterprises,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111224,(,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111225,SMEs,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111226,),O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111227,.,O,3874.0,"As part of a survey conducted by the Central Agricultural Office of Hungary , 67 food samples including beverages were taken from 57 food industrial and catering companies , 75 % of them being small and medium - sized enterprises ( SMEs ) ."
111248,The,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111249,arsenic,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111250,(,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111251,As,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111252,),O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111253,content,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111254,of,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111255,solid,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111256,food,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111257,stuff,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111258,was,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111259,determined,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111260,by,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111261,hydride,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111262,generation,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111263,atomic,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111264,absorption,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111265,spectrometry,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111266,after,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111267,dry,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111268,ashing,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111269,.,O,3877.0,The arsenic ( As ) content of solid food stuff was determined by hydride generation atomic absorption spectrometry after dry ashing .
111288,The,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111289,As,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111290,concentration,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111291,exceeded,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111292,10,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111293,μg,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111294,/,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111295,L,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111296,in,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111297,74,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111298,%,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111299,of,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111300,the,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111301,water,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111302,samples,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111303,taken,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111304,from,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111305,SMEs,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111306,.,O,3879.0,The As concentration exceeded 10 μg / L in 74 % of the water samples taken from SMEs .
111368,Five,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111369,settlements,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111370,had,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111371,higher,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111372,As,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111373,intake,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111374,than,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111375,the,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111376,BMDL0.5,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111377,.,O,3882.0,Five settlements had higher As intake than the BMDL0.5 .
111528,Total,O,3890.0,Total vegetable and fruit intake was found to be inversely associated with breast cancer risk .
111529,vegetable,B-http://purl.bioontology.org/ontology/SNOMEDCT/22836000;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3890.0,Total vegetable and fruit intake was found to be inversely associated with breast cancer risk .
111530,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3890.0,Total vegetable and fruit intake was found to be inversely associated with breast cancer risk .
111531,fruit,I-http://purl.bioontology.org/ontology/SNOMEDCT/22836000;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3890.0,Total vegetable and fruit intake was found to be inversely associated with breast cancer risk .
111532,intake,O,3890.0,Total vegetable and fruit intake was found to be inversely associated with breast cancer risk .
111533,was,O,3890.0,Total vegetable and fruit intake was found to be inversely associated with breast cancer risk .
111534,found,O,3890.0,Total vegetable and fruit intake was found to be inversely associated with breast cancer risk .
111535,to,O,3890.0,Total vegetable and fruit intake was found to be inversely associated with breast cancer risk .
111536,be,O,3890.0,Total vegetable and fruit intake was found to be inversely associated with breast cancer risk .
111537,inversely,O,3890.0,Total vegetable and fruit intake was found to be inversely associated with breast cancer risk .
111538,associated,O,3890.0,Total vegetable and fruit intake was found to be inversely associated with breast cancer risk .
111539,with,O,3890.0,Total vegetable and fruit intake was found to be inversely associated with breast cancer risk .
111540,breast,O,3890.0,Total vegetable and fruit intake was found to be inversely associated with breast cancer risk .
111541,cancer,O,3890.0,Total vegetable and fruit intake was found to be inversely associated with breast cancer risk .
111542,risk,O,3890.0,Total vegetable and fruit intake was found to be inversely associated with breast cancer risk .
111543,.,O,3890.0,Total vegetable and fruit intake was found to be inversely associated with breast cancer risk .
111859,Histopathological,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111860,analysis,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111861,in,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111862,rat,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111863,femur,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111864,revealed,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111865,extensive,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111866,bone,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111867,loss,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111868,in,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111869,rats,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111870,intoxicated,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111871,with,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111872,cadmium,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
111873,.,O,3905.0,Histopathological analysis in rat femur revealed extensive bone loss in rats intoxicated with cadmium .
112314,Wine,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112315,treatments,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112316,also,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112317,reduced,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112318,the,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112319,frequency,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112320,of,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112321,hepatocellular,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112322,adenomas,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112323,compared,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112324,with,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112325,those,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112326,of,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112327,other,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112328,treatment,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112329,groups,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112330,",",O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112331,and,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112332,no,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112333,hepatocellular,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112334,carcinomas,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112335,developed,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112336,in,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112337,any,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112338,of,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112339,the,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112340,groups,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112341,given,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112342,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112343,",",O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112344,even,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112345,with,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112346,the,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112347,20,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112348,-,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112349,mg,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112350,/,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112351,kg,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112352,ethyl,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112353,carbamate,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112354,dose,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112355,.,O,3921.0,"Wine treatments also reduced the frequency of hepatocellular adenomas compared with those of other treatment groups , and no hepatocellular carcinomas developed in any of the groups given wine , even with the 20 - mg / kg ethyl carbamate dose ."
112390,The,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112391,mean,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112392,weight,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112393,gains,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112394,of,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112395,mice,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112396,on,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112397,all,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112398,the,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112399,wine,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112400,treatments,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112401,were,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112402,lower,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112403,than,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112404,those,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112405,of,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112406,water,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112407,-,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112408,treated,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112409,mice,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112410,and,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112411,this,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112412,may,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112413,have,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112414,been,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112415,a,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112416,factor,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112417,in,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112418,tumour,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112419,inhibition,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112420,;,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112421,however,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112422,",",O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112423,it,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112424,is,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112425,also,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112426,possible,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112427,that,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112428,wine,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112429,components,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112430,other,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112431,than,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112432,ethanol,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112433,may,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112434,play,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112435,a,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112436,role,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112437,in,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112438,the,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112439,inhibition,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112440,of,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112441,tumour,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112442,development,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112443,.,O,3923.0,"The mean weight gains of mice on all the wine treatments were lower than those of water - treated mice and this may have been a factor in tumour inhibition ; however , it is also possible that wine components other than ethanol may play a role in the inhibition of tumour development ."
112472,Therefore,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112473,",",O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112474,we,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112475,aimed,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112476,to,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112477,evaluate,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112478,the,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112479,association,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112480,of,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112481,FPS,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112482,with,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112483,excess,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112484,body,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112485,weight,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112486,(,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112487,EBW,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112488,),O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112489,",",O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112490,and,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112491,to,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112492,monitor,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112493,differences,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112494,in,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112495,the,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112496,population,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112497,from,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112498,São,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112499,Paulo,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112500,",",O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112501,Brazil,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112502,",",O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112503,from,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112504,2003,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112505,to,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112506,2015,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112507,.,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112533,Dietary,O,3927.0,Dietary data were obtained from 24 - h recalls .
112534,data,O,3927.0,Dietary data were obtained from 24 - h recalls .
112535,were,O,3927.0,Dietary data were obtained from 24 - h recalls .
112536,obtained,O,3927.0,Dietary data were obtained from 24 - h recalls .
112537,from,O,3927.0,Dietary data were obtained from 24 - h recalls .
112538,24,O,3927.0,Dietary data were obtained from 24 - h recalls .
112539,-,O,3927.0,Dietary data were obtained from 24 - h recalls .
112540,h,O,3927.0,Dietary data were obtained from 24 - h recalls .
112541,recalls,O,3927.0,Dietary data were obtained from 24 - h recalls .
112542,.,O,3927.0,Dietary data were obtained from 24 - h recalls .
112822,When,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112823,compared,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112824,with,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112825,data,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112826,from,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112827,non,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112828,-,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112829,drinkers,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112830,",",O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112831,the,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112832,cumulative,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112833,lifetime,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112834,consumption,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112835,of,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112836,all,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112837,types,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112838,of,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112839,alcohol,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112840,in,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112841,grams,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112842,of,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112843,ethanol,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112844,(,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112845,ORs,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112846,1.00,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112847,",",O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112848,0.97,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112849,",",O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112850,0.93,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112851,",",O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112852,1.25,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112853,",",O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112854,p,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112855,trend,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112856,0.55,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112857,),O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112858,",",O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112859,beer,B-http://purl.bioontology.org/ontology/SNOMEDCT/53410008,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112860,",",O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112861,spirits,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112862,",",O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112863,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112864,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112865,and,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112866,fortified,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112867,wine,B-http://purl.bioontology.org/ontology/SNOMEDCT/35748005,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112868,was,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112869,not,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112870,related,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112871,to,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112872,risk,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
112873,.,O,3936.0,"When compared with data from non - drinkers , the cumulative lifetime consumption of all types of alcohol in grams of ethanol ( ORs 1.00 , 0.97 , 0.93 , 1.25 , p trend 0.55 ) , beer , spirits , red wine and fortified wine was not related to risk ."
113044,There,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113045,is,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113046,growing,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113047,evidence,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113048,that,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113049,intakes,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113050,of,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113051,high,B-http://purl.bioontology.org/ontology/SNOMEDCT/412064009;http://purl.bioontology.org/ontology/SNOMEDCT/412357001;http://purl.bioontology.org/ontology/SNOMEDCT/229862008,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113052,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/412064009;http://purl.bioontology.org/ontology/SNOMEDCT/412357001;http://purl.bioontology.org/ontology/SNOMEDCT/229862008,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113053,fructose,I-http://purl.bioontology.org/ontology/SNOMEDCT/412064009;http://purl.bioontology.org/ontology/SNOMEDCT/412357001;http://purl.bioontology.org/ontology/SNOMEDCT/229862008,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113054,corn,I-http://purl.bioontology.org/ontology/SNOMEDCT/412064009;http://purl.bioontology.org/ontology/SNOMEDCT/412357001;http://purl.bioontology.org/ontology/SNOMEDCT/229862008,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113055,syrup,I-http://purl.bioontology.org/ontology/SNOMEDCT/412064009;http://purl.bioontology.org/ontology/SNOMEDCT/412357001;http://purl.bioontology.org/ontology/SNOMEDCT/229862008,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113056,(,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113057,HFCS,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113058,),O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113059,",",O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113060,HFCS,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113061,-,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113062,sweetened,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113063,soda,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113064,",",O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113065,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/226465004,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113066,drinks,I-http://purl.bioontology.org/ontology/SNOMEDCT/72511004;http://purl.bioontology.org/ontology/SNOMEDCT/226465004,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113067,and,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113068,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/226491003;http://purl.bioontology.org/ontology/SNOMEDCT/735215001;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113069,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/226491003;http://purl.bioontology.org/ontology/SNOMEDCT/735215001;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113070,-,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113071,a,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113072,high,B-http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113073,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113074,fructose,I-http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113075,100,I-http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113076,%,I-http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113077,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113078,-,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113079,are,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113080,associated,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113081,with,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113082,asthma,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113083,",",O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113084,possibly,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113085,because,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113086,of,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113087,the,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113088,high,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113089,fructose,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113090,:,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113091,glucose,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113092,ratios,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113093,and,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113094,underlying,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113095,fructose,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113096,malabsorption,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113097,",",O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113098,which,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113099,may,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113100,contribute,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113101,to,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113102,enteral,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113103,formation,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113104,of,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113105,pro,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113106,-,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113107,inflammatory,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113108,advanced,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113109,glycation,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113110,end,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113111,products,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113112,",",O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113113,which,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113114,bind,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113115,receptors,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113116,that,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113117,are,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113118,mediators,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113119,of,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113120,asthma,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113121,.,O,3942.0,"There is growing evidence that intakes of high - fructose corn syrup ( HFCS ) , HFCS - sweetened soda , fruit drinks and apple juice - a high - fructose 100 % juice - are associated with asthma , possibly because of the high fructose : glucose ratios and underlying fructose malabsorption , which may contribute to enteral formation of pro - inflammatory advanced glycation end products , which bind receptors that are mediators of asthma ."
113285,There,O,3947.0,There were no associations with diet soda / orange juice .
113286,were,O,3947.0,There were no associations with diet soda / orange juice .
113287,no,O,3947.0,There were no associations with diet soda / orange juice .
113288,associations,O,3947.0,There were no associations with diet soda / orange juice .
113289,with,O,3947.0,There were no associations with diet soda / orange juice .
113290,diet,O,3947.0,There were no associations with diet soda / orange juice .
113291,soda,O,3947.0,There were no associations with diet soda / orange juice .
113292,/,O,3947.0,There were no associations with diet soda / orange juice .
113293,orange,B-http://purl.bioontology.org/ontology/SNOMEDCT/226496008;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3947.0,There were no associations with diet soda / orange juice .
113294,juice,I-http://purl.bioontology.org/ontology/SNOMEDCT/226496008;http://purl.bioontology.org/ontology/SNOMEDCT/129559002,3947.0,There were no associations with diet soda / orange juice .
113295,.,O,3947.0,There were no associations with diet soda / orange juice .
113463,It,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113464,should,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113465,however,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113466,be,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113467,noted,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113468,that,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113469,these,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113470,bioactive,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113471,factors,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113472,can,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113473,be,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113474,significantly,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113475,affected,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113476,by,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113477,differences,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113478,in,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113479,strawberry,B-http://purl.bioontology.org/ontology/SNOMEDCT/102261002,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113480,cultivars,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113481,",",O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113482,agricultural,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113483,practices,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113484,",",O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113485,storage,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113486,",",O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113487,and,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113488,processing,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113489,methods,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113490,:,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113491,freezing,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113492,versus,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113493,dry,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113494,heat,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113495,has,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113496,been,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113497,associated,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113498,with,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113499,maximum,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113500,retention,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113501,of,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113502,strawberry,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113503,bioactives,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113504,in,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113505,several,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113506,studies,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113507,.,O,3954.0,"It should however be noted that these bioactive factors can be significantly affected by differences in strawberry cultivars , agricultural practices , storage , and processing methods : freezing versus dry heat has been associated with maximum retention of strawberry bioactives in several studies ."
113838,We,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113839,measured,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113840,the,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113841,PTHrP,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113842,concentrations,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113843,in,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113844,normal,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113845,liquid,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113846,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113847,",",O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113848,processed,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113849,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113850,",",O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113851,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002;http://purl.bioontology.org/ontology/SNOMEDCT/226465004,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113852,drinks,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002;http://purl.bioontology.org/ontology/SNOMEDCT/226465004,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113853,",",O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113854,formulated,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113855,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113856,powders,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113857,",",O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113858,and,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113859,skim,B-http://purl.bioontology.org/ontology/SNOMEDCT/25743006;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113860,milk,I-http://purl.bioontology.org/ontology/SNOMEDCT/25743006;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113861,powder,I-http://purl.bioontology.org/ontology/SNOMEDCT/25743006;http://purl.bioontology.org/ontology/SNOMEDCT/70813002,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113862,by,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113863,using,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113864,the,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113865,appropriate,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113866,combination,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113867,of,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113868,pretreatment,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113869,(,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113870,acidification,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113871,),O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113872,and,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113873,diluent,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113874,(,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113875,plasma,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113876,treated,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113877,with,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113878,protease,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113879,inhibitors,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113880,),O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113881,.,O,3966.0,"We measured the PTHrP concentrations in normal liquid milk , processed milk , milk drinks , formulated milk powders , and skim milk powder by using the appropriate combination of pretreatment ( acidification ) and diluent ( plasma treated with protease inhibitors ) ."
113994,Although,O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
113995,the,O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
113996,designation,O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
113997,of,O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
113998,the,O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
113999,diet,O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
114000,as,O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
114001,glutenfree,O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
114002,may,O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
114003,imply,O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
114004,that,O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
114005,the,O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
114006,diet,O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
114007,contains,O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
114008,zero,O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
114009,gluten,O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
114010,",",O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
114011,this,O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
114012,is,O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
114013,not,O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
114014,necessarily,O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
114015,true,O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
114016,.,O,3971.0,"Although the designation of the diet as glutenfree may imply that the diet contains zero gluten , this is not necessarily true ."
114093,The,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114094,discrepancy,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114095,in,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114096,the,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114097,use,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114098,of,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114099,foods,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114100,rendered,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114101,gluten,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114102,free,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114103,exists,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114104,because,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114105,the,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114106,amount,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114107,of,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114108,toxic,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114109,prolamins,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114110,that,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114111,individuals,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114112,with,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114113,celiac,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114114,disease,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114115,may,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114116,consume,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114117,without,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114118,damaging,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114119,the,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114120,mucosa,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114121,of,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114122,the,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114123,small,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114124,intestine,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114125,is,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114126,unknown,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114127,.,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114232,Until,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114233,this,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114234,research,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114235,is,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114236,conducted,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114237,",",O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114238,dietitians,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114239,in,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114240,the,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114241,United,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114242,States,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114243,should,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114244,continue,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114245,to,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114246,advise,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114247,their,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114248,patients,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114249,against,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114250,the,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114251,use,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114252,of,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114253,wheat,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114254,starch,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114255,and,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114256,other,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114257,foods,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114258,rendered,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114259,gluten,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114260,free,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114261,.,O,3978.0,"Until this research is conducted , dietitians in the United States should continue to advise their patients against the use of wheat starch and other foods rendered gluten free ."
114262,Milk,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114263,",",O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114264,cheese,B-http://purl.bioontology.org/ontology/SNOMEDCT/102264005,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114265,",",O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114266,yogurt,B-http://purl.bioontology.org/ontology/SNOMEDCT/226863004,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114267,",",O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114268,and,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114269,other,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114270,dairy,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114271,products,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114272,have,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114273,long,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114274,been,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114275,known,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114276,to,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114277,provide,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114278,good,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114279,nutrition,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114280,.,O,3979.0,"Milk , cheese , yogurt , and other dairy products have long been known to provide good nutrition ."
114508,We,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114509,defined,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114510,Med,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114511,-,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114512,style,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114513,diet,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114514,as,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114515,a,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114516,high,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114517,consumption,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114518,of,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114519,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114520,",",O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114521,vegetables,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114522,",",O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114523,legumes,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114524,",",O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114525,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114526,",",O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114527,cereal,B-http://purl.bioontology.org/ontology/SNOMEDCT/23182003,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114528,and,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114529,low,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114530,consumption,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114531,of,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114532,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114533,",",O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114534,dairy,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114535,products,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114536,",",O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114537,fat,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114538,and,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114539,alcohol,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114540,categorising,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114541,participants,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114542,into,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114543,Med,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114544,-,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114545,style,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114546,diet,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114547,tertiles,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114548,(,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114549,low,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114550,:,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114551,0,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114552,-,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114553,3,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114554,",",O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114555,moderate,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114556,:,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114557,4,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114558,-,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114559,5,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114560,",",O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114561,high,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114562,:,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114563,6,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114564,-,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114565,9,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114566,),O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114567,.,O,3989.0,"We defined Med - style diet as a high consumption of fruit , vegetables , legumes , fish , cereal and low consumption of meat , dairy products , fat and alcohol categorising participants into Med - style diet tertiles ( low : 0 - 3 , moderate : 4 - 5 , high : 6 - 9 ) ."
114661,There,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114662,were,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114663,1109,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114664,(,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114665,5·2,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114666,%,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114667,),O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114668,first,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114669,sepsis,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114670,events,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114671,.,O,3994.0,There were 1109 ( 5·2 % ) first sepsis events .
114728,High,O,3996.0,High Med - style diet adherence is associated with lower risk of sepsis .
114729,Med,O,3996.0,High Med - style diet adherence is associated with lower risk of sepsis .
114730,-,O,3996.0,High Med - style diet adherence is associated with lower risk of sepsis .
114731,style,O,3996.0,High Med - style diet adherence is associated with lower risk of sepsis .
114732,diet,O,3996.0,High Med - style diet adherence is associated with lower risk of sepsis .
114733,adherence,O,3996.0,High Med - style diet adherence is associated with lower risk of sepsis .
114734,is,O,3996.0,High Med - style diet adherence is associated with lower risk of sepsis .
114735,associated,O,3996.0,High Med - style diet adherence is associated with lower risk of sepsis .
114736,with,O,3996.0,High Med - style diet adherence is associated with lower risk of sepsis .
114737,lower,O,3996.0,High Med - style diet adherence is associated with lower risk of sepsis .
114738,risk,O,3996.0,High Med - style diet adherence is associated with lower risk of sepsis .
114739,of,O,3996.0,High Med - style diet adherence is associated with lower risk of sepsis .
114740,sepsis,O,3996.0,High Med - style diet adherence is associated with lower risk of sepsis .
114741,.,O,3996.0,High Med - style diet adherence is associated with lower risk of sepsis .
115169,Typically,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115170,",",O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115171,hydroxytyrosol,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115172,is,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115173,a,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115174,superior,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115175,antioxidant,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115176,and,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115177,radical,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115178,scavenger,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115179,to,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115180,oleuropein,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115181,and,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115182,tyrosol,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115183,.,O,4013.0,"Typically , hydroxytyrosol is a superior antioxidant and radical scavenger to oleuropein and tyrosol ."
115577,Additional,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115578,recommended,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115579,practices,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115580,include,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115581,using,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115582,fermented,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115583,soy,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115584,foods,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115585,and,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115586,sprouting,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115587,at,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115588,least,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115589,some,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115590,of,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115591,the,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115592,legumes,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115593,consumed,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115594,.,O,4026.0,Additional recommended practices include using fermented soy foods and sprouting at least some of the legumes consumed .
115800,Additional,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115801,control,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115802,for,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115803,established,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115804,CHD,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115805,risk,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115806,factors,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115807,",",O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115808,multivitamin,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115809,use,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115810,",",O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115811,and,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115812,intakes,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115813,of,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115814,saturated,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115815,fat,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115816,",",O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115817,monounsaturated,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115818,fat,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115819,",",O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115820,and,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115821,linoleic,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115822,acid,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115823,",",O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115824,dietary,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115825,cholesterol,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115826,",",O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115827,vitamins,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115828,E,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115829,or,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115830,C,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115831,",",O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115832,carotene,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115833,",",O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115834,or,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115835,fibre,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115836,did,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115837,not,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115838,change,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115839,the,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115840,relative,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115841,risk,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115842,substantially,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115843,.,O,4034.0,"Additional control for established CHD risk factors , multivitamin use , and intakes of saturated fat , monounsaturated fat , and linoleic acid , dietary cholesterol , vitamins E or C , carotene , or fibre did not change the relative risk substantially ."
115962,This,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115963,study,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115964,examined,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115965,two,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115966,low,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115967,-,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115968,calorie,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115969,sweeteners,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115970,",",O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115971,tagatose,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115972,and,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115973,stevia,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115974,",",O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115975,in,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115976,comparison,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115977,to,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115978,sugar,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115979,in,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115980,dark,B-http://purl.bioontology.org/ontology/SNOMEDCT/443931000124105;http://purl.bioontology.org/ontology/SNOMEDCT/102262009,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115981,chocolate,I-http://purl.bioontology.org/ontology/SNOMEDCT/443931000124105;http://purl.bioontology.org/ontology/SNOMEDCT/102262009,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115982,.,O,4040.0,"This study examined two low - calorie sweeteners , tagatose and stevia , in comparison to sugar in dark chocolate ."
115983,A,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115984,total,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115985,of,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115986,219,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115987,consumers,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115988,participated,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115989,in,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115990,this,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115991,study,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115992,and,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115993,rated,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115994,overall,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115995,liking,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115996,and,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115997,sensory,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115998,attributes,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
115999,.,O,4041.0,A total of 219 consumers participated in this study and rated overall liking and sensory attributes .
116167,But,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116168,is,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116169,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116170,an,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116171,alternative,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116172,to,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116173,established,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116174,methods,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116175,of,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116176,disease,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116177,prevention,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116178,or,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116179,treatment,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116180,?,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116181,Scientists,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116182,from,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116183,around,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116184,the,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116185,world,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116186,have,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116187,identified,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116188,a,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116189,number,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116190,of,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116191,bioactive,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116192,substances,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116193,in,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116194,garlic,B-http://purl.bioontology.org/ontology/SNOMEDCT/735030001,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116195,that,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116196,are,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116197,water,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116198,soluble,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116199,(,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116200,e.g.,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116201,",",O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116202,S,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116203,-,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116204,allyl,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116205,methylcysteine,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116206,),O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116207,",",O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116208,and,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116209,fat,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116210,soluble,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116211,(,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116212,e.g.,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116213,",",O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116214,diallyldisulfide,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116215,),O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116216,.,O,4049.0,"But is garlic an alternative to established methods of disease prevention or treatment ? Scientists from around the world have identified a number of bioactive substances in garlic that are water soluble ( e.g. , S - allyl methylcysteine ) , and fat soluble ( e.g. , diallyldisulfide ) ."
116619,The,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116620,development,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116621,of,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116622,this,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116623,disease,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116624,is,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116625,influenced,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116626,by,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116627,genetic,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116628,and,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116629,environmental,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116630,factors,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116631,.,O,4067.0,The development of this disease is influenced by genetic and environmental factors .
116632,The,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116633,results,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116634,of,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116635,many,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116636,studies,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116637,have,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116638,linked,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116639,increased,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116640,consumption,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116641,of,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116642,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116643,and,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116644,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116645,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116646,with,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116647,lower,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116648,blood,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116649,pressure,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116650,and,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116651,reduced,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116652,risk,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116653,of,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116654,hypertension,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116655,.,O,4068.0,The results of many studies have linked increased consumption of milk and milk products with lower blood pressure and reduced risk of hypertension .
116779,But,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116780,there,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116781,are,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116782,several,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116783,studies,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116784,indicating,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116785,that,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116786,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116787,and,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116788,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116789,products,I-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116790,may,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116791,not,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116792,affect,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116793,adversely,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116794,blood,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116795,lipids,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116796,as,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116797,would,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116798,be,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116799,predicted,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116800,from,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116801,its,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116802,fat,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116803,content,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116804,and,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116805,fat,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116806,composition,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
116807,.,O,4074.0,But there are several studies indicating that milk and milk products may not affect adversely blood lipids as would be predicted from its fat content and fat composition .
117249,Pasta,B-http://purl.bioontology.org/ontology/SNOMEDCT/226740002,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117250,and,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117251,rice,B-http://purl.bioontology.org/ontology/SNOMEDCT/67324005,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117252,(,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117253,the,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117254,major,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117255,sources,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117256,of,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117257,starch,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117258,),O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117259,",",O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117260,polenta,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117261,(,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117262,a,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117263,porridge,B-http://purl.bioontology.org/ontology/SNOMEDCT/226617008,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117264,made,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117265,of,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117266,maize,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117267,),O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117268,and,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117269,ham,B-http://purl.bioontology.org/ontology/SNOMEDCT/442861000124104,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117270,were,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117271,positively,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117272,related,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117273,with,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117274,gastric,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117275,cancer,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117276,risk,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117277,",",O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117278,whereas,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117279,green,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117280,vegetables,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117281,and,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117282,fresh,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117283,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117284,as,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117285,a,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117286,whole,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117287,(,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117288,and,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117289,specifically,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117290,citrus,B-http://purl.bioontology.org/ontology/SNOMEDCT/102259006;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117291,fruit,I-http://purl.bioontology.org/ontology/SNOMEDCT/102259006;http://purl.bioontology.org/ontology/SNOMEDCT/72511004,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117292,),O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117293,and,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117294,selected,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117295,fibre,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117296,-,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117297,rich,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117298,aliments,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117299,(,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117300,such,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117301,as,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117302,whole,B-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117303,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117304,grain,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117305,bread,I-http://purl.bioontology.org/ontology/SNOMEDCT/226559002,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117306,or,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117307,pasta,B-http://purl.bioontology.org/ontology/SNOMEDCT/226740002,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117308,),O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117309,showed,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117310,protective,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117311,effects,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117312,on,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117313,gastric,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117314,cancer,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117315,risk,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117316,.,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117517,Synergistic,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117518,action,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117519,of,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117520,these,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117521,and,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117522,other,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117523,compounds,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117524,",",O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117525,which,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117526,are,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117527,also,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117528,present,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117529,in,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117530,dried,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117531,plums,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117532,in,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117533,less,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117534,conspicuous,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117535,amounts,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117536,",",O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117537,may,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117538,have,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117539,beneficial,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117540,health,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117541,effects,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117542,when,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117543,dried,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117544,plums,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117545,are,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117546,regularly,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117547,consumed,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117548,.,O,4098.0,"Synergistic action of these and other compounds , which are also present in dried plums in less conspicuous amounts , may have beneficial health effects when dried plums are regularly consumed ."
117576,Despite,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117577,their,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117578,sweet,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117579,taste,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117580,",",O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117581,dried,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117582,plums,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117583,do,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117584,not,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117585,cause,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117586,large,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117587,postprandial,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117588,rise,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117589,in,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117590,blood,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117591,glucose,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117592,and,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117593,insulin,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117594,.,O,4100.0,"Despite their sweet taste , dried plums do not cause large postprandial rise in blood glucose and insulin ."
117774,Dose,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117775,-,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117776,dependent,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117777,HR,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117778,(,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117779,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117780,peel,I-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117781,=,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117782,apple,B-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117783,pulp,I-http://purl.bioontology.org/ontology/SNOMEDCT/735215001,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117784,>,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117785,peach,B-http://purl.bioontology.org/ontology/SNOMEDCT/735049002,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117786,=,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117787,cherry,B-http://purl.bioontology.org/ontology/SNOMEDCT/735248001,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117788,),O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117789,was,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117790,demonstrated,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117791,in,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117792,both,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117793,allergic,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117794,groups,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117795,",",O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117796,but,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117797,to,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117798,a,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117799,higher,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117800,extent,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117801,in,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117802,patients,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117803,with,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117804,fruit,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117805,allergy,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117806,(,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117807,P,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117808,<,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117809,0.01,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117810,),O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
117811,.,O,4107.0,"Dose - dependent HR ( apple peel = apple pulp > peach = cherry ) was demonstrated in both allergic groups , but to a higher extent in patients with fruit allergy ( P < 0.01 ) ."
118246,Curcumin,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118247,directly,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118248,interacts,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118249,with,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118250,adipocytes,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118251,",",O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118252,pancreatic,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118253,cells,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118254,",",O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118255,hepatic,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118256,stellate,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118257,cells,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118258,",",O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118259,macrophages,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118260,",",O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118261,and,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118262,muscle,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118263,cells,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
118264,.,O,4125.0,"Curcumin directly interacts with adipocytes , pancreatic cells , hepatic stellate cells , macrophages , and muscle cells ."
119196,Weighed,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119197,/,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119198,semi,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119199,-,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119200,weighed,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119201,food,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119202,records,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119203,from,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119204,three,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119205,cross,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119206,-,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119207,sectional,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119208,surveys,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119209,(,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119210,the,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119211,National,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119212,Children,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119213,'s,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119214,Food,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119215,Survey,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119216,",",O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119217,the,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119218,National,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119219,Teens,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119220,',O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119221,Food,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119222,Survey,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119223,and,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119224,the,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119225,National,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119226,Adult,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119227,Nutrition,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119228,Survey,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119229,),O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119230,were,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119231,collated,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119232,to,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119233,estimate,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119234,habitual,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119235,dietary,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119236,intakes,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119237,for,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119238,a,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119239,nationally,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119240,representative,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119241,sample,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119242,of,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119243,the,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119244,Irish,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119245,population,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119246,",",O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119247,aged,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119248,5,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119249,-,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119250,90,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119251,years,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119252,(,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119253,n,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119254,2535,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119255,),O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119256,.,O,4157.0,"Weighed / semi - weighed food records from three cross - sectional surveys ( the National Children 's Food Survey , the National Teens ' Food Survey and the National Adult Nutrition Survey ) were collated to estimate habitual dietary intakes for a nationally representative sample of the Irish population , aged 5 - 90 years ( n 2535 ) ."
119530,To,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119531,obtain,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119532,an,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119533,average,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119534,plasma,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119535,cholesterol,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119536,concentration,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119537,of,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119538,20,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119539,mmol,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119540,/,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119541,l,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119542,in,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119543,each,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119544,rabbit,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119545,during,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119546,the,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119547,13,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119548,-,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119549,week,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119550,cholesterol,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119551,-,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119552,feeding,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119553,period,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119554,",",O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119555,dietary,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119556,cholesterol,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119557,was,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119558,adjusted,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119559,weekly,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119560,.,O,4167.0,"To obtain an average plasma cholesterol concentration of 20 mmol / l in each rabbit during the 13 - week cholesterol - feeding period , dietary cholesterol was adjusted weekly ."
119838,Cases,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119839,(,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119840,N,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119841,=,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119842,148,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119843,),O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119844,were,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119845,married,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119846,men,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119847,ages,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119848,20,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119849,through,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119850,74,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119851,years,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119852,diagnosed,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119853,with,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119854,pancreatic,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119855,cancer,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119856,from,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119857,July,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119858,1982,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119859,through,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119860,June,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119861,1986,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119862,.,O,4175.0,Cases ( N = 148 ) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986 .
119941,This,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119942,excess,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119943,risk,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119944,was,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119945,confined,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119946,to,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119947,current,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119948,smokers,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119949,",",O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119950,in,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119951,whom,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119952,the,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119953,odds,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119954,ratio,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119955,was,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119956,3.2,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119957,(,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119958,95,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119959,%,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119960,CI,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119961,1.8,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119962,-,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119963,5.7,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119964,),O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119965,;,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119966,the,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119967,risk,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119968,among,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119969,former,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119970,smokers,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119971,resembled,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119972,that,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119973,in,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119974,those,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119975,who,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119976,had,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119977,never,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119978,smoked,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
119979,.,O,4180.0,"This excess risk was confined to current smokers , in whom the odds ratio was 3.2 ( 95 % CI 1.8 - 5.7 ) ; the risk among former smokers resembled that in those who had never smoked ."
120123,The,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120124,glucose,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120125,oxidation,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120126,enhancing,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120127,bioactivity,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120128,was,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120129,lost,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120130,from,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120131,cinnamon,B-http://purl.bioontology.org/ontology/SNOMEDCT/227388008,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120132,",",O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120133,tea,B-http://purl.bioontology.org/ontology/SNOMEDCT/16313001,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120134,",",O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120135,witch,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120136,hazel,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120137,",",O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120138,cloves,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120139,",",O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120140,bay,B-http://purl.bioontology.org/ontology/SNOMEDCT/227379004,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120141,leaf,I-http://purl.bioontology.org/ontology/SNOMEDCT/227379004,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120142,and,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120143,allspice,B-http://purl.bioontology.org/ontology/SNOMEDCT/227375005,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120144,by,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120145,poly(vinylpyrrolidone,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120146,),O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120147,(,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120148,PVP,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120149,),O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120150,treatment,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120151,",",O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120152,indicating,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120153,that,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120154,the,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120155,active,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120156,phytochemicals,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120157,are,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120158,likely,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120159,to,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120160,be,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120161,phenolic,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120162,in,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120163,nature,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120164,.,O,4185.0,"The glucose oxidation enhancing bioactivity was lost from cinnamon , tea , witch hazel , cloves , bay leaf and allspice by poly(vinylpyrrolidone ) ( PVP ) treatment , indicating that the active phytochemicals are likely to be phenolic in nature ."
120288,Dairy,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120289,products,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120290,have,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120291,an,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120292,important,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120293,role,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120294,in,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120295,a,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120296,healthy,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120297,diet,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120298,due,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120299,to,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120300,their,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120301,high,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120302,-,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120303,quality,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120304,protein,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120305,and,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120306,rich,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120307,micronutrients,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
120308,.,O,4190.0,Dairy products have an important role in a healthy diet due to their high - quality protein and rich micronutrients .
121128,Milk,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121129,sEV,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121130,were,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121131,isolated,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121132,from,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121133,three,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121134,BLV,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121135,-,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121136,infected,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121137,and,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121138,three,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121139,uninfected,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121140,cattle,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121141,.,O,4222.0,Milk sEV were isolated from three BLV - infected and three uninfected cattle .
121355,A,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121356,random,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121357,sample,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121358,of,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121359,1153,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121360,individuals,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121361,",",O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121362,aged,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121363,18,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121364,-,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121365,69,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121366,years,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121367,",",O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121368,was,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121369,recruited,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121370,to,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121371,participate,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121372,in,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121373,the,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121374,cross,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121375,-,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121376,sectional,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121377,Observation,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121378,of,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121379,Cardiovascular,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121380,Risk,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121381,Factors,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121382,in,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121383,Luxembourg,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121384,study,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121385,.,O,4230.0,"A random sample of 1153 individuals , aged 18 - 69 years , was recruited to participate in the cross - sectional Observation of Cardiovascular Risk Factors in Luxembourg study ."
121952,Hamsters,O,4248.0,Hamsters ( n = 32 ) were divided into 4 groups of 8 and fed an atherogenic diet for 8 wk .
121953,(,O,4248.0,Hamsters ( n = 32 ) were divided into 4 groups of 8 and fed an atherogenic diet for 8 wk .
121954,n,O,4248.0,Hamsters ( n = 32 ) were divided into 4 groups of 8 and fed an atherogenic diet for 8 wk .
121955,=,O,4248.0,Hamsters ( n = 32 ) were divided into 4 groups of 8 and fed an atherogenic diet for 8 wk .
121956,32,O,4248.0,Hamsters ( n = 32 ) were divided into 4 groups of 8 and fed an atherogenic diet for 8 wk .
121957,),O,4248.0,Hamsters ( n = 32 ) were divided into 4 groups of 8 and fed an atherogenic diet for 8 wk .
121958,were,O,4248.0,Hamsters ( n = 32 ) were divided into 4 groups of 8 and fed an atherogenic diet for 8 wk .
121959,divided,O,4248.0,Hamsters ( n = 32 ) were divided into 4 groups of 8 and fed an atherogenic diet for 8 wk .
121960,into,O,4248.0,Hamsters ( n = 32 ) were divided into 4 groups of 8 and fed an atherogenic diet for 8 wk .
121961,4,O,4248.0,Hamsters ( n = 32 ) were divided into 4 groups of 8 and fed an atherogenic diet for 8 wk .
121962,groups,O,4248.0,Hamsters ( n = 32 ) were divided into 4 groups of 8 and fed an atherogenic diet for 8 wk .
121963,of,O,4248.0,Hamsters ( n = 32 ) were divided into 4 groups of 8 and fed an atherogenic diet for 8 wk .
121964,8,O,4248.0,Hamsters ( n = 32 ) were divided into 4 groups of 8 and fed an atherogenic diet for 8 wk .
121965,and,O,4248.0,Hamsters ( n = 32 ) were divided into 4 groups of 8 and fed an atherogenic diet for 8 wk .
121966,fed,O,4248.0,Hamsters ( n = 32 ) were divided into 4 groups of 8 and fed an atherogenic diet for 8 wk .
121967,an,O,4248.0,Hamsters ( n = 32 ) were divided into 4 groups of 8 and fed an atherogenic diet for 8 wk .
121968,atherogenic,O,4248.0,Hamsters ( n = 32 ) were divided into 4 groups of 8 and fed an atherogenic diet for 8 wk .
121969,diet,O,4248.0,Hamsters ( n = 32 ) were divided into 4 groups of 8 and fed an atherogenic diet for 8 wk .
121970,for,O,4248.0,Hamsters ( n = 32 ) were divided into 4 groups of 8 and fed an atherogenic diet for 8 wk .
121971,8,O,4248.0,Hamsters ( n = 32 ) were divided into 4 groups of 8 and fed an atherogenic diet for 8 wk .
121972,wk,O,4248.0,Hamsters ( n = 32 ) were divided into 4 groups of 8 and fed an atherogenic diet for 8 wk .
121973,.,O,4248.0,Hamsters ( n = 32 ) were divided into 4 groups of 8 and fed an atherogenic diet for 8 wk .
121982,d,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
121983,),O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
121984,PE,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
121985,in,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
121986,2.6,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
121987,mol,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
121988,/,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
121989,L,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
121990,ethanol,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
121991,(,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
121992,E,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
121993,+,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
121994,PE,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
121995,),O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
121996,or,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
121997,PE,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
121998,in,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
121999,water,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122000,(,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122001,W,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122002,+,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122003,PE,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122004,),O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122005,",",O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122006,mimicking,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122007,a,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122008,moderate,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122009,consumption,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122010,of,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122011,red,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122012,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122013,or,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122014,alcohol,B-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122015,-,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122016,free,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122017,red,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122018,wine,I-http://purl.bioontology.org/ontology/SNOMEDCT/58732000;http://purl.bioontology.org/ontology/SNOMEDCT/35748005,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122019,[,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122020,30.4,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122021,mg/(kg,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122022,.,O,4250.0,"d ) PE in 2.6 mol / L ethanol ( E + PE ) or PE in water ( W + PE ) , mimicking a moderate consumption of red wine or alcohol - free red wine [ 30.4 mg/(kg ."
122222,Ethanol,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122223,significantly,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122224,reduced,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122225,AFSA,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122226,by,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122227,60,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122228,%,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122229,(,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122230,Group,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122231,E,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122232,-,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122233,PE,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122234,vs.,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122235,Group,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122236,W,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122237,-,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122238,PE,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122239,),O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122240,or,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122241,62,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122242,%,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122243,(,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122244,Group,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122245,E,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122246,+,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122247,PE,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122248,vs.,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122249,Group,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122250,W,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122251,+,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122252,PE,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122253,),O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122254,.,O,4258.0,Ethanol significantly reduced AFSA by 60 % ( Group E - PE vs. Group W - PE ) or 62 % ( Group E + PE vs. Group W + PE ) .
122529,Results,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122530,from,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122531,this,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122532,study,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122533,suggest,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122534,that,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122535,types,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122536,of,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122537,fluids,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122538,consumed,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122539,may,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122540,play,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122541,a,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122542,role,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122543,in,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122544,the,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122545,development,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122546,of,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122547,bladder,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122548,cancer,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
122549,.,O,4269.0,Results from this study suggest that types of fluids consumed may play a role in the development of bladder cancer .
123170,From,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123171,that,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123172,study,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123173,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123174,we,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123175,now,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123176,report,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123177,measures,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123178,of,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123179,circulating,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123180,factors,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123181,that,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123182,may,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123183,influence,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123184,CRC,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123185,initiation,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123186,or,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123187,progression,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123188,including,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123189,malondialdehyde,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123190,(,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123191,MDA,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123192,),O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123193,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123194,leptin,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123195,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123196,insulin,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123197,-,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123198,like,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123199,growth,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123200,factor,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123201,-,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123202,I,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123203,(,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123204,IGF,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123205,-,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123206,I,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123207,),O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123208,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123209,insulin,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123210,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123211,matrix,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123212,metalloproteinase-2,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123213,(,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123214,MMP-2,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123215,),O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123216,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123217,tissue,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123218,inhibitor,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123219,of,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123220,MMP-2,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123221,(,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123222,TIMP-2,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123223,),O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123224,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123225,interleukins,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123226,(,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123227,IL,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123228,),O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123229,",",O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123230,and,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123231,short,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123232,chain,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123233,fatty,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123234,acids,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123235,.,O,4291.0,"From that study , we now report measures of circulating factors that may influence CRC initiation or progression including malondialdehyde ( MDA ) , leptin , insulin - like growth factor - I ( IGF - I ) , insulin , matrix metalloproteinase-2 ( MMP-2 ) , tissue inhibitor of MMP-2 ( TIMP-2 ) , interleukins ( IL ) , and short chain fatty acids ."
123374,MMP-2,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123375,and,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123376,TIMP-2,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123377,positively,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123378,correlated,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123379,with,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123380,hepatic,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123381,portal,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123382,butyrate,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123383,levels,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123384,but,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123385,leptin,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123386,concentrations,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123387,correlated,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123388,negatively,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123389,.,O,4300.0,MMP-2 and TIMP-2 positively correlated with hepatic portal butyrate levels but leptin concentrations correlated negatively .
123870,There,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123871,was,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123872,also,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123873,a,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123874,clue,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123875,that,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123876,the,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123877,unfavorable,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123878,influence,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123879,of,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123880,frequent,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123881,intake,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123882,of,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123883,a,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123884,few,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123885,food,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123886,items,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123887,(,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123888,i.e.,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123889,meat,B-http://purl.bioontology.org/ontology/SNOMEDCT/28647000,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123890,",",O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123891,fish,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123892,",",O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123893,liver,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123894,",",O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123895,ham,B-http://purl.bioontology.org/ontology/SNOMEDCT/442861000124104;http://purl.bioontology.org/ontology/SNOMEDCT/227018006,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123896,and,I-http://purl.bioontology.org/ontology/SNOMEDCT/442861000124104;http://purl.bioontology.org/ontology/SNOMEDCT/227018006,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123897,salami,I-http://purl.bioontology.org/ontology/SNOMEDCT/442861000124104;http://purl.bioontology.org/ontology/SNOMEDCT/227018006,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123898,",",O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123899,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123900,and,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123901,butter,B-http://purl.bioontology.org/ontology/SNOMEDCT/226888007,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123902,",",O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123903,and,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123904,retinol,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123905,),O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123906,may,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123907,be,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123908,greater,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123909,or,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123910,restricted,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123911,to,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123912,older,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123913,individuals,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123914,(,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123915,i.e.,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123916,",",O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123917,>,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123918,or,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123919,=,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123920,70,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123921,yrs,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123922,of,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123923,age,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123924,),O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
123925,.,O,4318.0,"There was also a clue that the unfavorable influence of frequent intake of a few food items ( i.e. meat , fish , liver , ham and salami , milk and butter , and retinol ) may be greater or restricted to older individuals ( i.e. , > or = 70 yrs of age ) ."
124210,Wine,O,4330.0,Wine proteins not only influence wine stability but are also being discussed as potential allergens .
124211,proteins,O,4330.0,Wine proteins not only influence wine stability but are also being discussed as potential allergens .
124212,not,O,4330.0,Wine proteins not only influence wine stability but are also being discussed as potential allergens .
124213,only,O,4330.0,Wine proteins not only influence wine stability but are also being discussed as potential allergens .
124214,influence,O,4330.0,Wine proteins not only influence wine stability but are also being discussed as potential allergens .
124215,wine,O,4330.0,Wine proteins not only influence wine stability but are also being discussed as potential allergens .
124216,stability,O,4330.0,Wine proteins not only influence wine stability but are also being discussed as potential allergens .
124217,but,O,4330.0,Wine proteins not only influence wine stability but are also being discussed as potential allergens .
124218,are,O,4330.0,Wine proteins not only influence wine stability but are also being discussed as potential allergens .
124219,also,O,4330.0,Wine proteins not only influence wine stability but are also being discussed as potential allergens .
124220,being,O,4330.0,Wine proteins not only influence wine stability but are also being discussed as potential allergens .
124221,discussed,O,4330.0,Wine proteins not only influence wine stability but are also being discussed as potential allergens .
124222,as,O,4330.0,Wine proteins not only influence wine stability but are also being discussed as potential allergens .
124223,potential,O,4330.0,Wine proteins not only influence wine stability but are also being discussed as potential allergens .
124224,allergens,O,4330.0,Wine proteins not only influence wine stability but are also being discussed as potential allergens .
124225,.,O,4330.0,Wine proteins not only influence wine stability but are also being discussed as potential allergens .
125012,Here,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125013,we,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125014,review,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125015,how,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125016,Westernized,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125017,high,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125018,-,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125019,fat,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125020,diets,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125021,and,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125022,excessive,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125023,alcohol,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125024,intake,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125025,can,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125026,influence,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125027,inflammation,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125028,within,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125029,the,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125030,liver,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125031,microenvironment,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125032,",",O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125033,stimulating,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125034,both,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125035,primary,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125036,and,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125037,metastatic,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125038,liver,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125039,tumorigenesis,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125040,.,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125213,Replacing,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125214,fatty,B-http://purl.bioontology.org/ontology/SNOMEDCT/227110001;http://purl.bioontology.org/ontology/SNOMEDCT/735971005,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125215,fish,I-http://purl.bioontology.org/ontology/SNOMEDCT/227110001;http://purl.bioontology.org/ontology/SNOMEDCT/735971005,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125216,with,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125217,vegetables,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125218,was,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125219,associated,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125220,with,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125221,a,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125222,higher,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125223,risk,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125224,of,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125225,MI,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125226,(,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125227,HR,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125228,1·23,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125229,;,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125230,95,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125231,%,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125232,CI,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125233,1·05,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125234,",",O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125235,1·45,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125236,),O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125237,",",O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125238,whereas,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125239,an,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125240,inverse,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125241,",",O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125242,statistically,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125243,non,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125244,-,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125245,significant,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125246,association,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125247,was,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125248,found,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125249,for,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125250,lean,B-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125251,fish,I-http://purl.bioontology.org/ontology/SNOMEDCT/735971005,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125252,(,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125253,HR,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125254,0·93,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125255,;,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125256,95,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125257,%,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125258,CI,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125259,0·83,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125260,",",O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125261,1·05,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125262,),O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125263,.,O,4369.0,"Replacing fatty fish with vegetables was associated with a higher risk of MI ( HR 1·23 ; 95 % CI 1·05 , 1·45 ) , whereas an inverse , statistically non - significant association was found for lean fish ( HR 0·93 ; 95 % CI 0·83 , 1·05 ) ."
125264,Substituting,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125265,poultry,B-http://purl.bioontology.org/ontology/SNOMEDCT/28230009,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125266,with,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125267,vegetables,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125268,was,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125269,not,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125270,associated,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125271,with,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125272,risk,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125273,of,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125274,MI,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125275,(,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125276,HR,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125277,1·00,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125278,;,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125279,95,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125280,%,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125281,CI,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125282,0·90,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125283,",",O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125284,1·11,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125285,),O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125286,.,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 1·00 ; 95 % CI 0·90 , 1·11 ) ."
125878,Frequent,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125879,consumption,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125880,of,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125881,salad,B-http://purl.bioontology.org/ontology/SNOMEDCT/227927005,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125882,vegetables,I-http://purl.bioontology.org/ontology/SNOMEDCT/227927005,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125883,(,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125884,once,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125885,or,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125886,more,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125887,per,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125888,day,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125889,),O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125890,decreased,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125891,the,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125892,risk,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125893,by,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125894,40,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125895,%,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125896,(,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125897,RR,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125898,=,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125899,0.60,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125900,;,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125901,95,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125902,%,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125903,CI,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125904,=,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125905,0.30,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125906,-,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125907,1.22,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125908,),O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125909,",",O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125910,in,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125911,comparison,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125912,to,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125913,no,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125914,consumption,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
125915,.,O,4390.0,"Frequent consumption of salad vegetables ( once or more per day ) decreased the risk by 40 % ( RR = 0.60 ; 95 % CI = 0.30 - 1.22 ) , in comparison to no consumption ."
126913,Dietary,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126914,energy,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126915,density,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126916,appeared,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126917,to,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126918,mediate,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126919,the,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126920,associations,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126921,between,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126922,particular,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126923,foods,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126924,and,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126925,beverages,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126926,and,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126927,overall,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126928,energy,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126929,intake,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
126930,.,O,4417.0,Dietary energy density appeared to mediate the associations between particular foods and beverages and overall energy intake .
127075,Dietary,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127076,intake,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127077,data,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127078,were,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127079,collected,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127080,via,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127081,three,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127082,-,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127083,day,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127084,24,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127085,-,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127086,h,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127087,food,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127088,records,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127089,",",O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127090,and,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127091,sugar,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127092,intake,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127093,was,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127094,calculated,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127095,for,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127096,the,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127097,total,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127098,sugar,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127099,content,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127100,of,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127101,foods,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127102,using,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127103,our,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127104,database,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127105,compiled,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127106,from,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127107,various,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127108,sources,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127109,.,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127796,Forty,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127797,-,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127798,eight,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127799,Holstein,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127800,cows,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127801,were,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127802,used,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127803,to,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127804,determine,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127805,the,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127806,effects,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127807,of,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127808,short,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127809,-,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127810,term,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127811,oral,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127812,drenches,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127813,of,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127814,propylene,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127815,glycol,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127816,(,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127817,PG,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127818,),O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127819,and,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127820,Ca,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127821,-,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127822,soaps,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127823,of,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127824,palm,B-http://purl.bioontology.org/ontology/SNOMEDCT/226907001,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127825,oil,I-http://purl.bioontology.org/ontology/SNOMEDCT/226907001,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127826,fatty,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127827,acids,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127828,(,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127829,fat,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127830,),O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127831,on,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127832,plasma,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127833,concentrations,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127834,of,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127835,key,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127836,metabolites,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127837,",",O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127838,liver,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127839,composition,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127840,",",O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127841,and,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127842,milk,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127843,production,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127844,during,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127845,the,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127846,first,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127847,3,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127848,wk,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127849,of,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127850,lactation,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127851,.,O,4449.0,"Forty - eight Holstein cows were used to determine the effects of short - term oral drenches of propylene glycol ( PG ) and Ca - soaps of palm oil fatty acids ( fat ) on plasma concentrations of key metabolites , liver composition , and milk production during the first 3 wk of lactation ."
127960,Administration,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127961,of,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127962,either,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127963,PG,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127964,or,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127965,fat,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127966,increased,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127967,plasma,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127968,glucose,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127969,and,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127970,liver,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127971,glycogen,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127972,concentrations,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127973,compared,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127974,to,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127975,the,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127976,control,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127977,or,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127978,PG,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127979,plus,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127980,fat,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127981,treatments,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127982,.,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
128593,Approximately,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128594,half,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128595,of,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128596,these,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128597,patients,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128598,had,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128599,symptoms,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128600,(,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128601,especially,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128602,oral,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128603,allergy,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128604,syndrome,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128605,),O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128606,after,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128607,eating,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128608,these,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128609,products,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
128610,.,O,4471.0,Approximately half of these patients had symptoms ( especially oral allergy syndrome ) after eating these products .
129188,Consuming,O,4494.0,Consuming dietary fats that are not associated with increased risk of disease can be a part of a healthful diet .
129189,dietary,O,4494.0,Consuming dietary fats that are not associated with increased risk of disease can be a part of a healthful diet .
129190,fats,O,4494.0,Consuming dietary fats that are not associated with increased risk of disease can be a part of a healthful diet .
129191,that,O,4494.0,Consuming dietary fats that are not associated with increased risk of disease can be a part of a healthful diet .
129192,are,O,4494.0,Consuming dietary fats that are not associated with increased risk of disease can be a part of a healthful diet .
129193,not,O,4494.0,Consuming dietary fats that are not associated with increased risk of disease can be a part of a healthful diet .
129194,associated,O,4494.0,Consuming dietary fats that are not associated with increased risk of disease can be a part of a healthful diet .
129195,with,O,4494.0,Consuming dietary fats that are not associated with increased risk of disease can be a part of a healthful diet .
129196,increased,O,4494.0,Consuming dietary fats that are not associated with increased risk of disease can be a part of a healthful diet .
129197,risk,O,4494.0,Consuming dietary fats that are not associated with increased risk of disease can be a part of a healthful diet .
129198,of,O,4494.0,Consuming dietary fats that are not associated with increased risk of disease can be a part of a healthful diet .
129199,disease,O,4494.0,Consuming dietary fats that are not associated with increased risk of disease can be a part of a healthful diet .
129200,can,O,4494.0,Consuming dietary fats that are not associated with increased risk of disease can be a part of a healthful diet .
129201,be,O,4494.0,Consuming dietary fats that are not associated with increased risk of disease can be a part of a healthful diet .
129202,a,O,4494.0,Consuming dietary fats that are not associated with increased risk of disease can be a part of a healthful diet .
129203,part,O,4494.0,Consuming dietary fats that are not associated with increased risk of disease can be a part of a healthful diet .
129204,of,O,4494.0,Consuming dietary fats that are not associated with increased risk of disease can be a part of a healthful diet .
129205,a,O,4494.0,Consuming dietary fats that are not associated with increased risk of disease can be a part of a healthful diet .
129206,healthful,O,4494.0,Consuming dietary fats that are not associated with increased risk of disease can be a part of a healthful diet .
129207,diet,O,4494.0,Consuming dietary fats that are not associated with increased risk of disease can be a part of a healthful diet .
129208,.,O,4494.0,Consuming dietary fats that are not associated with increased risk of disease can be a part of a healthful diet .
129228,Most,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129229,Seventh,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129230,-,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129231,day,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129232,Adventists,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129233,do,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129234,not,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129235,smoke,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129236,cigarettes,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129237,or,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129238,drink,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129239,alcohol,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129240,",",O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129241,and,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129242,there,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129243,is,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129244,a,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129245,wide,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129246,range,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129247,of,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129248,dietary,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129249,exposures,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129250,within,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129251,the,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129252,population,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129253,.,O,4496.0,"Most Seventh - day Adventists do not smoke cigarettes or drink alcohol , and there is a wide range of dietary exposures within the population ."
129460,Intake,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129461,of,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129462,legumes,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129463,was,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129464,negatively,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129465,associated,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129466,with,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129467,risk,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129468,of,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129469,colon,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129470,cancer,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129471,in,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129472,nonvegetarians,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129473,and,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129474,risk,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129475,of,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129476,pancreatic,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129477,cancer,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129478,.,O,4501.0,Intake of legumes was negatively associated with risk of colon cancer in nonvegetarians and risk of pancreatic cancer .
129571,Although,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129572,acute,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129573,trials,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129574,show,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129575,reductions,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129576,in,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129577,postprandial,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129578,glycemia,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129579,in,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129580,healthy,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129581,individuals,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129582,ingesting,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129583,60,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129584,to,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129585,90,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129586,g,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129587,almonds,B-http://purl.bioontology.org/ontology/SNOMEDCT/256350002,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129588,",",O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129589,trials,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129590,have,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129591,not,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129592,been,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129593,conducted,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129594,using,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129595,a,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129596,single,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129597,serving,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129598,of,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129599,almonds,B-http://purl.bioontology.org/ontology/SNOMEDCT/256350002,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129600,(,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129601,28,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129602,g,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129603,),O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129604,in,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129605,individuals,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129606,with,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129607,type,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129608,2,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129609,diabetes,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129610,mellitus,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129611,.,O,4506.0,"Although acute trials show reductions in postprandial glycemia in healthy individuals ingesting 60 to 90 g almonds , trials have not been conducted using a single serving of almonds ( 28 g ) in individuals with type 2 diabetes mellitus ."
129612,This,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129613,randomized,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129614,crossover,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129615,trial,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129616,examined,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129617,the,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129618,impact,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129619,of,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129620,one,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129621,serving,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129622,of,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129623,almonds,B-http://purl.bioontology.org/ontology/SNOMEDCT/256350002,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129624,at,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129625,mealtime,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129626,on,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129627,postprandial,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129628,glycemia,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129629,",",O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129630,insulinemia,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129631,",",O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129632,and,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129633,plasma,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129634,glucagon,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129635,-,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129636,like,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129637,peptide-1,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129638,in,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129639,healthy,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129640,individuals,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129641,and,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129642,individuals,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129643,with,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129644,type,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129645,2,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129646,diabetes,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129647,mellitus,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129648,.,O,4507.0,"This randomized crossover trial examined the impact of one serving of almonds at mealtime on postprandial glycemia , insulinemia , and plasma glucagon - like peptide-1 in healthy individuals and individuals with type 2 diabetes mellitus ."
129780,Insulinemia,O,4511.0,Insulinemia and glucagon - like peptide-1 at 30 minutes postmeal were not impacted by almond ingestion for either group .
129781,and,O,4511.0,Insulinemia and glucagon - like peptide-1 at 30 minutes postmeal were not impacted by almond ingestion for either group .
129782,glucagon,O,4511.0,Insulinemia and glucagon - like peptide-1 at 30 minutes postmeal were not impacted by almond ingestion for either group .
129783,-,O,4511.0,Insulinemia and glucagon - like peptide-1 at 30 minutes postmeal were not impacted by almond ingestion for either group .
129784,like,O,4511.0,Insulinemia and glucagon - like peptide-1 at 30 minutes postmeal were not impacted by almond ingestion for either group .
129785,peptide-1,O,4511.0,Insulinemia and glucagon - like peptide-1 at 30 minutes postmeal were not impacted by almond ingestion for either group .
129786,at,O,4511.0,Insulinemia and glucagon - like peptide-1 at 30 minutes postmeal were not impacted by almond ingestion for either group .
129787,30,O,4511.0,Insulinemia and glucagon - like peptide-1 at 30 minutes postmeal were not impacted by almond ingestion for either group .
129788,minutes,O,4511.0,Insulinemia and glucagon - like peptide-1 at 30 minutes postmeal were not impacted by almond ingestion for either group .
129789,postmeal,O,4511.0,Insulinemia and glucagon - like peptide-1 at 30 minutes postmeal were not impacted by almond ingestion for either group .
129790,were,O,4511.0,Insulinemia and glucagon - like peptide-1 at 30 minutes postmeal were not impacted by almond ingestion for either group .
129791,not,O,4511.0,Insulinemia and glucagon - like peptide-1 at 30 minutes postmeal were not impacted by almond ingestion for either group .
129792,impacted,O,4511.0,Insulinemia and glucagon - like peptide-1 at 30 minutes postmeal were not impacted by almond ingestion for either group .
129793,by,O,4511.0,Insulinemia and glucagon - like peptide-1 at 30 minutes postmeal were not impacted by almond ingestion for either group .
129794,almond,O,4511.0,Insulinemia and glucagon - like peptide-1 at 30 minutes postmeal were not impacted by almond ingestion for either group .
129795,ingestion,O,4511.0,Insulinemia and glucagon - like peptide-1 at 30 minutes postmeal were not impacted by almond ingestion for either group .
129796,for,O,4511.0,Insulinemia and glucagon - like peptide-1 at 30 minutes postmeal were not impacted by almond ingestion for either group .
129797,either,O,4511.0,Insulinemia and glucagon - like peptide-1 at 30 minutes postmeal were not impacted by almond ingestion for either group .
129798,group,O,4511.0,Insulinemia and glucagon - like peptide-1 at 30 minutes postmeal were not impacted by almond ingestion for either group .
129799,.,O,4511.0,Insulinemia and glucagon - like peptide-1 at 30 minutes postmeal were not impacted by almond ingestion for either group .
129800,In,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129801,the,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129802,pilot,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129803,study,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129804,",",O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129805,regular,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129806,almond,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129807,ingestion,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129808,for,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129809,12,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129810,weeks,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129811,reduced,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129812,hemoglobin,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129813,A(1c,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129814,),O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129815,by,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129816,4,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129817,%,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129818,(,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129819,P,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129820,=,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129821,.045,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129822,for,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129823,interaction,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129824,),O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129825,but,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129826,did,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129827,not,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129828,influence,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129829,fasting,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129830,glucose,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129831,concentrations,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129832,.,O,4512.0,"In the pilot study , regular almond ingestion for 12 weeks reduced hemoglobin A(1c ) by 4 % ( P = .045 for interaction ) but did not influence fasting glucose concentrations ."
129889,Information,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129890,was,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129891,collected,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129892,about,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129893,smoking,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129894,history,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129895,and,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129896,alcohol,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129897,and,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129898,dietary,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129899,intake,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129900,.,O,4515.0,Information was collected about smoking history and alcohol and dietary intake .
129995,Frequent,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
129996,consumption,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
129997,of,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
129998,fruit,B-http://purl.bioontology.org/ontology/SNOMEDCT/72511004,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
129999,was,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130000,also,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130001,inversely,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130002,associated,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130003,with,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130004,this,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130005,cancer,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130006,.,O,4521.0,Frequent consumption of fruit was also inversely associated with this cancer .
130269,Scratch,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130270,tests,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130271,with,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130272,common,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130273,spices,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130274,were,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130275,performed,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130276,in,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130277,"1,120",O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130278,atopic,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130279,and,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130280,380,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130281,non,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130282,-,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130283,atopic,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130284,patients,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130285,.,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130333,A,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130334,high,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130335,correlation,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130336,between,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130337,positive,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130338,skin,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130339,test,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130340,reactions,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130341,to,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130342,spices,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130343,",",O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130344,especially,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130345,to,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130346,curry,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130347,and,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130348,its,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130349,components,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130350,",",O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130351,and,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130352,tree,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130353,pollens,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130354,",",O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130355,fruits,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130356,and,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130357,vegetables,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130358,was,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130359,demonstrated,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130360,",",O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130361,suggesting,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130362,that,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130363,there,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130364,may,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130365,be,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130366,a,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130367,group,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130368,of,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130369,cross,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130370,allergies,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130371,.,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130505,In,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130506,the,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130507,present,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130508,studies,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130509,",",O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130510,dosing,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130511,relied,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130512,on,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130513,injection,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130514,of,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130515,oil,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130516,into,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130517,live,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130518,feeder,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130519,fish,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130520,for,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130521,oral,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130522,dosing,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130523,of,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130524,these,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130525,piscivorous,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130526,birds,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130527,",",O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130528,or,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130529,applying,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130530,oil,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130531,to,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130532,body,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130533,contour,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130534,feathers,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130535,resulting,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130536,in,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130537,transdermal,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130538,oil,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130539,exposure,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130540,and,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130541,oral,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130542,exposure,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130543,through,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130544,preening,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130545,.,O,4540.0,"In the present studies , dosing relied on injection of oil into live feeder fish for oral dosing of these piscivorous birds , or applying oil to body contour feathers resulting in transdermal oil exposure and oral exposure through preening ."
130636,Birds,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130637,exposed,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130638,to,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130639,oil,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130640,externally,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130641,consumed,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130642,more,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130643,fish,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130644,than,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130645,control,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130646,birds,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130647,",",O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130648,indicating,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130649,metabolic,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130650,compensation,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130651,for,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130652,thermal,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130653,stress,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130654,.,O,4544.0,"Birds exposed to oil externally consumed more fish than control birds , indicating metabolic compensation for thermal stress ."
130716,Extensive,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130717,research,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130718,has,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130719,identified,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130720,several,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130721,molecular,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130722,targets,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130723,that,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130724,can,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130725,potentially,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130726,be,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130727,used,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130728,for,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130729,the,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130730,prevention,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130731,and/or,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130732,treatment,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130733,of,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130734,cancer,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130735,.,O,4548.0,Extensive research has identified several molecular targets that can potentially be used for the prevention and/or treatment of cancer .
130959,As,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130960,tomato,B-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130961,sauces,I-http://purl.bioontology.org/ontology/SNOMEDCT/734881000,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130962,are,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130963,usually,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130964,cooked,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130965,with,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130966,the,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130967,addition,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130968,of,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130969,oil,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130970,",",O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130971,some,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130972,studies,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130973,have,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130974,pointed,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130975,out,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130976,that,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130977,both,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130978,processes,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130979,may,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130980,increase,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130981,the,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130982,bioavailability,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130983,of,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130984,the,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130985,bioactive,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130986,compounds,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
130987,.,O,4554.0,"As tomato sauces are usually cooked with the addition of oil , some studies have pointed out that both processes may increase the bioavailability of the bioactive compounds ."
131195,However,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131196,",",O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131197,the,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131198,changes,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131199,of,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131200,plasma,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131201,IL-6,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131202,and,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131203,vascular,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131204,cell,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131205,adhesion,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131206,molecule-1,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131207,(,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131208,VCAM-1,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131209,),O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131210,",",O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131211,and,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131212,lymphocyte,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131213,function,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131214,-,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131215,associated,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131216,antigen-1,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131217,(,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131218,LFA-1,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131219,),O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131220,from,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131221,T,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131222,-,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131223,lymphocytes,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131224,and,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131225,CD36,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131226,from,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131227,monocytes,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131228,were,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131229,significantly,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131230,greater,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131231,after,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131232,TSOO,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131233,than,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131234,after,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131235,RT,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131236,and,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131237,TS,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131238,interventions,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131239,.,O,4560.0,"However , the changes of plasma IL-6 and vascular cell adhesion molecule-1 ( VCAM-1 ) , and lymphocyte function - associated antigen-1 ( LFA-1 ) from T - lymphocytes and CD36 from monocytes were significantly greater after TSOO than after RT and TS interventions ."
131295,Histone,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131296,modification,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131297,is,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131298,controlled,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131299,by,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131300,the,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131301,balance,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131302,between,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131303,histone,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131304,acetyltransferase,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131305,and,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131306,(,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131307,HAT,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131308,),O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131309,and,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131310,histone,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131311,deacetylase,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131312,(,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131313,HDAC,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131314,),O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131315,enzymes,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131316,.,O,4564.0,Histone modification is controlled by the balance between histone acetyltransferase and ( HAT ) and histone deacetylase ( HDAC ) enzymes .
131515,HDACi,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131516,exhibit,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131517,their,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131518,antitumor,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131519,effect,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131520,by,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131521,the,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131522,activation,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131523,of,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131524,cell,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131525,cycle,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131526,arrest,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131527,",",O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131528,induction,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131529,of,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131530,apoptosis,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131531,and,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131532,autophagy,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131533,",",O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131534,angiogenesis,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131535,inhibition,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131536,",",O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131537,increased,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131538,reactive,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131539,oxygen,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131540,species,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131541,generation,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131542,causing,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131543,oxidative,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131544,stress,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131545,",",O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131546,and,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131547,mitotic,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131548,cell,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131549,death,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131550,in,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131551,cancer,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131552,cells,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131553,.,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131554,This,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131555,review,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131556,summarizes,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131557,the,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131558,HDACs,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131559,classification,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131560,",",O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131561,their,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131562,aberrant,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131563,expression,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131564,in,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131565,cancerous,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131566,tissue,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131567,",",O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131568,structures,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131569,",",O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131570,sources,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131571,",",O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131572,and,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131573,the,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131574,anticancer,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131575,mechanisms,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131576,of,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131577,HDACi,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131578,",",O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131579,as,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131580,well,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131581,as,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131582,HDACi,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131583,that,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131584,are,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131585,either,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131586,FDA,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131587,-,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131588,approved,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131589,or,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131590,under,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131591,clinical,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131592,trials,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
131593,.,O,4572.0,"This review summarizes the HDACs classification , their aberrant expression in cancerous tissue , structures , sources , and the anticancer mechanisms of HDACi , as well as HDACi that are either FDA - approved or under clinical trials ."
132097,Furthermore,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132098,",",O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132099,the,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132100,low,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132101,de,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132102,novo,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132103,diet,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132104,significantly,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132105,increased,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132106,the,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132107,concentration,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132108,of,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132109,nonesterified,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132110,fatty,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132111,acids,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132112,and,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132113,d,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132114,-,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132115,beta,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132116,-,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132117,hydroxybutyrate,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132118,in,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132119,blood,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132120,plasma,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132121,",",O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132122,the,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132123,latter,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132124,was,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132125,also,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132126,increased,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132127,in,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132128,milk,B-http://purl.bioontology.org/ontology/SNOMEDCT/70813002,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132129,.,O,4592.0,"Furthermore , the low de novo diet significantly increased the concentration of nonesterified fatty acids and d - beta - hydroxybutyrate in blood plasma , the latter was also increased in milk ."
132251,Many,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132252,environmental,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132253,and,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132254,genetic,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132255,factors,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132256,are,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132257,suspected,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132258,to,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132259,play,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132260,an,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132261,important,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132262,role,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132263,in,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132264,the,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132265,development,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132266,of,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132267,the,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132268,disease,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
132269,.,O,4598.0,Many environmental and genetic factors are suspected to play an important role in the development of the disease .
